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Chapter 1
Introduction

C/iapter 7
Introduction >
Colorectal cancer contributes considerably to the incidence of cancer in the
Netherlands, like in most westernized countries. Each year a malignant tumor of the
colon or rectum is newly diagnosed in about 7,000 Dutch men and women.'
Colorectal cancer is the third most common cancer among men, after cancer of the
lung and the prostate, and the second most common among women, behind breast
cancer.' Although new methods of surgery, chemotherapy and radiotherapy are
being developed and applied, mortality rates of colorectal cancer remain relatively
high. New developments in treatment are not expected to markedly increase survival
rates in the near future, which makes prevention of this type of cancer even more
important.
A role of dietary factors in colorectal carcinogenesis seems biologically plausible
and is also widely recognized. Changes in dietary patterns may provide important
clues in colorectal cancer prevention. Both experimental research and analytical
epidemiology provide possibilities to unravel the various aspects of a westernized
diet involved in the aetiology of colorectal cancer. The results of these studies,
however, have not yielded clues for preventive measures that can be implemented
easily in the population at large.
Like a diet rich in vegetables and fruits, a high consumption of fermented dairy
products, such as yogurt, buttermilk and cheese, might decrease colorectal cancer
risk. Fermentation of dairy products with lactic acid bacteria is an ancient method
of preservation, and for centuries several of these bacteria species have been
believed to contribute to the prevention and treatment of gastro-intestinal
disturbances. Already in 1908, Eli Metchnikoff developed a theory that lactic acid
bacteria in the digestive tract could prolong life." More recently, a protective effect
on tumor development has been suggested for these specific dairy products.'" This
hypothesis mainly derives from experimental research, as epidemiological studies
considering the effect of fermented dairy products on cancer are scanty. In addition
to their content of lactic acid bacteria, fermented dairy products are an important
source of calcium. Experimental and epidemiological studies suggest a protective
effect of calcium in colorectal carcinogenesis. However, the results of
epidemiological studies are still controversial and a higher intake of this nutrient is
not generally recommended yet.
2 of this thesis provides an overview of current knowledge on the aetiology
of colorectal cancer and summarizes results of experimental and epidemiological
studies on the associations between consumption of fermented dairy products, intake
of calcium and colorectal cancer risk which have been published before and during
the studies included in this thesis.
In most epidemiological studies, the consumption of dairy products and calcium is
just one of the many dietary factors studied. The specific aim of the research
described in this thesis was to study whether the consumption of fermented dairy
products and the intake of calcium is inversely associated with the risk of colorectal
cancer and thus might become tools in its prevention. The thesis includes four
epidemiological studies described in Chapters 3 through 8, which differ with respect
to disease end-point, study design, methods of exposure assessment and study
population.
CTiap/er 3 describes results of two ongoing prospective studies at the Harvard
School of Public Health in Boston, US: the Nurses' Health Study and the Health
Professionals Follow-up Study. The analyses focus on the association with
colorectal adenomatous polyps, which are considered to be precursors of colorectal
cancer.
Chapters 4 through 7 describe the results of a case-control study on colon cancer
conducted in the Netherlands between 1990 and 1993. This study was intentionally
conducted in the Netherlands, since the consumption of fermented dairy products is
traditionally integrated in the Dutch food pattern. This case-control study is one of
the first population-based case-control studies in the Netherlands in which the
Cancer Registry was successfully used for case recruitment; furthermore, an
alternative procedure of control recruitment was applied. These aspects of design
and conduct are discussed in detail in C/iap/er 4. In C/iopfer 5 the main hypothesis
is tested, while C/ia/tfers 6 and 7 deal with other life-style and dietary factors which
were additionally explored.
Finally, CTiapter S describes the association between fermented dairy products,
calcium and colorectal cancer as studied prospectively in the ongoing Netherlands
Cohort Study on diet and cancer.
C/iapfer 9 integrates the results of the four studies and reviews the strengths and
limitations of the studies. Moreover, results are discussed in the context of
previously published epidemiological and experimental studies.
Chapters 3, 5, 6, 7 and 8 are included in this thesis in the form in which they have
been published, accepted or submitted for publication in international journals.
C/iapter 7
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Aetiology of colorectal cancer
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Current concepts
n, adenoma anrf carcmo/na /ormar/on
The classical view of carcinogenesis included two stages: initiation, which involved
mutation of the DNA, and promotion, in which expansion of initiated cells
occurred. Nowadays, carcinogenesis is considered to be a multistage process,
involving 5 or more different changes.' In the past decades, several of the different
stages in colorectal cancer development are more precisely identified. It is believed
that tumorigenesis of colorectal adenocarcinomas proceeds through mucosal cell
hyperproliferation to adenoma formation, growth, and malignant transformation.*
Studies on a inherited greatly predisposing condition for colon cancer, Familial
Adenomatous Polyposis (FAP), confirm this hypothesized pathway. In FAP patients
as well as disease free relatives, an increased thymidine labelling index, expansion
of the proliferative zone, surface labelling and acceleration of migration rate in the
flat mucosa between existing polyps and tumors as well as in the mucosa prior to
polyp formation have been identified/'' Increased colonie epithelial cell proliferation
has also been observed in sporadic colorectal cancer cases/
It has been observed that a high proportion of large adenomas contain focal areas
of malignancy, and a high proportion of early colorectal tumors contain remnants of
adenomatous tissue/ It has been suggested that all colorectal carcinomas have a
precursor adenoma stage, although most adenomas do not progress to malignancy
and remain benign/ Adenomatous polyps antedate the clinical diagnosis of
colorectal cancer by an average of approximately ten years.*
Whereas adenomas are evenly distributed along the large intestine/ carcinomas
are more likely to develop in the sigmoid colon or rectum. Large adenomas are also
more common in the sigmoid colon, suggesting that factors that cause the initial
formation of an adenoma differ from those that cause its subsequent growth/
The risk of developing an adenoma might depend on both genetic and
environmental factors, with the former determining which members of a uniformly
exposed population are at greatest risk of developing the disease and the latter
determining the proportion of the high-risk component of the population that
actually does so/
on r/ie mo/ecn/ar /eve/
Vogelstein and colleagues have provided extensive evidence that there is an
accumulating series of chromosomal and genetic alterations that accompany the
transition from the normal colonie mucosa to carcinoma/ According to this model
(Figure 2.1), the accumulation of at least four or five genetic changes are required
to ' • v :u^ • \v- • • C/iap/er 2
to produce a malignant tumor, their order not being of critical relevance.' Several
different genetic alterations which occur during colorectal tumorigenesis have been
identified, involving activation of oncogenes coupled with the inactivation of tumor
suppressor genes. : : .; . -srfT
normal epithelium
T
hyper-proliferation
5q mutation or loss FAP
• - " i i !
early adenoma
intermediate adenoma
late adenoma
T
metastasis
DNA hypomethylation
12p mutation K-ras
18q loss dec
17p loss p53
other alterations
Figure 2.1 Hypothesized genetic model for colorectal tumorigenesis according to Fearon and
Vogelstein; the accumulation of changes rather than their order is considered
relevant in this model for determining the tumor's biological properties.'
Although the order of genetic changes is not critical, a given order might be more
frequently observed. One of the earliest genetic changes accompanying tumor
progression is a significant loss of methyl groups in DNA7 The role of this
hypomethylation is still unclear. It has been suggested that folate deficiency induces
hypomethylation."''
Mutation of the ras oncogene was found in less than 10% of early-stage
adenomas and in approximately 50% of intermediate-stage adenomas, late-stage
adenomas and colon carcinomas.'" Three different ras-genes have been isolated: Ha-
ras, Ki-ras and N-ras. Ki-ras mutations are most common." The Ki-ras gene
encodes for a G-protein (p21) which may be involved in signal transduction.
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Mutations in this gene may lead to uncontrolled cell growth." Ki-ras mutations can
be induced by methylating carcinogens."
Allelic deletions were discovered in chromosomes 5, 17 and 18, which might
harbour tumor-suppressor genes. Deletions on the short arm of chromosome 17
(17p) are common and occur in more than 75% of colorectal adenomas. These
deletions appear to be relatively late events and are associated with the transition
from the benign adenoma to the malignant carcinoma.'^ The allelic loss on
chromosome 17 has been shown to be the p53 gene, which codes for a phospho-
protein involved in the control of cell proliferation.'^ It is speculated that a mutated
p53 gene in a colorectal carcinoma can provide selective growth advantage by
promoting tumor progression even in the presence of a normal p53 allele.'* P53
mutations are also common in other cancers, as breast, lung and stomach cancer."
Exogenous and endogenous mutagens influence the type and site of the p53 gene
base substitutions.'*
Allelic losses on chromosome 18 are also common and occur in less than 10% of
small and intermediate stage adenomas,''' 45% of large adenomas and in
approximately 75% of colorectal carcinomas, which suggest that these events occur
before p53 alterations. The deletion site (dcc=deleted in colorectal carcinomas) on
chromosome 18q has been identified as a gene coding for a cell-adhesion molecule,
mediating cell growth and differentiation."
Allelic deletion in chromosome 5q has been found in almost 40% of colorectal
carcinomas and sporadic adenomas studied.'" The tumor suppressor gene
(mcc = mutated in colorectal carcinomas) is believed to be connected with
G-protein activation, which is important in transducing signals in the cell.
Additional studies are needed to elucidate the relationship between mcc gene
mutations and sporadic colorectal cancers and to determine whether mcc is mutated
in familial adenomatous polyposis coli families.'"
The above is a reflection of current insight. The rapid developments in this area
require regular updating.
77te ro/e o/ d/ef and /i/e-sfy/e
Environmental factors are suggested to be the driving forces behind the
transformation of the normal colonie mucosa to cancer, among these, diet and life-
style are considered to be highly important." These factors influence the content of
the colonie lumen, the enzymatic activity of the colonie flora and consequently the
exposure of the epithelial cells to carcinogenic or promoting substances.*"* Several
nutritive and non-nutritive components of our diet might be involved."**
One of the relatively old, well-established hypotheses suggests an elevated risk as
a consequence of our westernized high fat, low fiber diet." ^
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Biological and -more recently- molecular explanations have been proposed. The
'physiological' explanation for this elevated risk is the bile acid/volatile fatty acid
hypothesis. Dietary fat increases the bile acid and fatty acid excretion in the colonie
lumen." The microbial flora hydrolyses the polar glyco and tauro conjugate bile
acids to form secondary bile acids in the faeces.' Secondary bile acids in their
ionized form and free fatty acids may damage the colonie epithelium, stimulating
cell proliferation.*"^' Two bacterial enzymes have been proposed to be important in
the colonie bile-acid metabolism: 7-dehydroxylase and 4-5 nuclear dehydrogenase,
which are more frequently present in populations with a high risk of colorectal
cancer.'"' The activity of these enzymes is not favoured by acidic conditions.*
Moreover, it has been suggested that the colonie flora converts free fatty acids in
diacylglycerol (DAG) which is an activator of protein kinase C, inducing cell
replication signals."
Dietary fiber binds bile acids and free fatty acids, increases stool bulk, and can be
fermented to volatile fatty acids. These may be directly anti-carcinogenic" and by
lowering pH may reduce the conversion of primary to secondary bile acids as
well."
In order to explain the role of a high fat/low fiber diet on the molecular level,
these dietary factors have been viewed as indicators for carcinogenic and anti-
carcinogenic substances. Vegetables and fruits are not only important sources of
fiber, but also contain vitamin C, carotenoids, phenols, flavonoids and indoles, with
a variety of anti-carcinogenic properties.*''" Vegetable consumption has been
consistently shown to be inversely associated with colon cancer risk in
epidemiological studies, though inverse associations with fruit consumption have
been less frequently observed.***" Howe and colleagues completed a meta-analyses
of 13 case-control studies and concluded that a higher overall fiber intake decreases
colon cancer risk." A high fat diet might be a source of arylamines from meat
proteins'" and cancer promoters resulting from high temperature cooking." In
ecological studies both a high fat and a high meat diet have been correlated with
colorectal cancer risk." As reviewed by Potter et al./" analytical epidemiological
studies on fat, protein and meat consumption show, almost consistently, a positive
association with risk of colorectal cancer.
In addition to this 'established' theory, other factors which have been suggested
to exert an effect on colorectal cancer risk are physical activity, alcohol
consumption, parity (see hormonal factors), use of nonsteriodal anti-inflammatory
drugs, cholecystectomy, caffeine and smoking.
Physical activity stimulates colon peristalsis and decreases random, nonpropulsive
segmentation activity.'" The resulting shortened stool transit time and decrease in
segmentation-induced mixing may give putative fecal carcinogens less contact with
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the colonie mucosa. In epidemiologic studies, physical activity has been consistently
associated with an increased risk of colon cancer.'"' Total energy intake is often
considered to be an acceptable proxy for physical activity. In most prospective
studies, no association with total energy has been found. In most case-control
studies, an elevated risk has been observed with increasing energy intake, but this
might be attributed to a general overreporting of the cases.
The mechanism by which alcohol entails an increased risk for colorectal cancer is
not clear. One hypothesis involves its effects on lipid secretion and metabolism.
Moderate alcohol intake decreases cholesterol saturation of bile by increasing bile
acid concentration/* Longnecker and colleagues conducted a meta-analysis on
alcohol and colorectal cancer including 27 epidemiologic studies, and concluded
that because the magnitude of the association between alcohol and risk of colorectal
cancer was small, the findings regarding a causal role of alcohol were
inconclusive.'"
Non-steroidal anti-inflammatory drugs inhibit the synthesis of prostaglandins
which might play a role in cell proliferation, neoplasia and immune response.**
Cholecysectomy might increase colon cancer risk by the alteration of the bile acid
secretion that follows after removal. A meta-analyses on 33 case-control and 6
cohort studies conducted by Giovannucci and colleagues, showed a significant
positive association between cholecystectomy and risk of colorectal cancer from the
case-control data, while the results from cohort studies were generally null. Time
since cholecystectomy appeared to be important. Although risk varied by study
design and in most studied time since cholecystectomy was not reported, the authors
conclude that some characteristics of bile-acid metabolism increases the risk of
cancer of the proximal colon.'"
Caffeine might increase serumcholesterol.'*' If the mechanism leading to higher
cholesterol levels involves a reduction in the excretion of bile acids, coffee
consumption might reduce the risk of colorectal cancer. However, in his review of
the epidemiologic literature Rosenberg concludes that although some studies suggest
an inverse association, 'the data are not compelling and a biological mechanism is
not established'.'"
The physiological mechanism by which smoking might increase colon cancer risk
is unclear. One possibility might be via the production and swallowing of
compounds such as arylamines. Although several epidemiological studies suggest an
association between smoking and colorectal adenoma risk, only recently
Giovannucci and colleagues reported a significant positive association with
colorectal cancer in the Nurses Health Study and the Health Professionals Follow-
up study.•**••" They point to the fact that the induction period between the start of
smoking and the diagnosis of cancer is important in this respect and might be at
least 35 years.
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Although colon cancer is essentially the only cancer that occurs with approximately
equal frequency in men and women, the rates tend to show an excess among
women before the age of 50 years and an excess among men after that age, as
reviewed by Potter and colleagues.*' Subsite risk has also been shown to vary by
sex: women have higher rates of right-sided carcinoma."" Possibly, there are sex
differences in etiology, which may be explained by environmental and or hormonal
factors.'" In 1980, McMichael and Potter proposed that higher parity, early age at
first birth, and use of oral contraceptives would each be associated with a reduced
risk of colon cancer as a result of changes in lipids and bile acids that occur with
changes in the hormonal milieu." Sex hormones might also moderate cell
proliferation and differentiation other than by intraluminal sterol metabolism.*"
Most case-control studies confirm an inverse association between parity and
colorectal cancer risk, while the studies of other reproductive factors such as age at
first birth, age at menarche and age at menopause are more limited and less
persuasive.* The review by Potter et al. indicated that the results of prospective
studies do not suggest an association with parity and age at first birth.''" The authors
suggest that it is only in older women that higher parity is associated with reduced
risk, which is comparable to the suggested association between parity and breast
cancer risk.*'
Both case-control and cohort studies do not consistently support a substantial
reduction of colon cancer risk with the use of exogeneous hormones.''"
Another observation which might explain differences in colorectal cancer risk
between men and women is that gender-related differences in gut metabolism exists.
Men and women show, under controlled experimental conditions, differences in
large bowel function (stool bulk, transit time, volatile fatty acid production) and bile
acid excretion."
Fermented dairy products and calcium: a hypothesis
Besides the 'established' risk factors, relatively new hypotheses concern the
potential protective role of fermented dairy products*' (e.g. yogurt, buttermilk,
cheese) and calcium" in colorectal carcinogenesis.
Associations between colorectal cancer incidence or mortality and national
consumption of milk or milk products have been reported by several investigators.
Alder and McKeown-Eyssen reviewed these ecological data" and concluded that 6
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out of 12 studies conducted before 1988 observed a positive association, while the
other half reported a negative association. All studies reporting a negative
association controlled for dietary fat intake in the analysis. Their own ecological
study among 38 countries, using food disappearance data'* suggests an inverse
association between the availability of total dairy products and colon cancer
mortality, adjusting for animal fat and cereal fiber intake (r = -0,36, p < 0.05). The
inverse relationship with dairy product intake in the 38-countries study was mainly
attributable to two of the countries included, i.e. Finland and Iceland." In Finland,
the intake of dairy products, non-fermented as well as with Lactobacilli fermented
milk products is highest in the world. In a cross-sectional study in Scandinavia
comparing various risk factors in men from a high risk (Copenhagen) and low risk
area (rural Finland), representing a threefold difference in colon cancer incidence,
the intake of milk and dietary fiber was higher in low risk areas, whereas no
difference in saturated fat intake was observed.™ A higher number of faecal
Lactobacilli were counted among the low-risk Fins as compared to the high-risk
Danish men/" However, in an extension of this study including two additional study
areas with intermediate incidences (rural Denmark and Helsinki), the association
with milk and milk product intake did not remain significant." As the intake of
milk products in Denmark is relatively high as well, the difference in intake
between the Finnish and Danish may not be high enough to observe an association.
In a study by Benno et al."' higher numbers of fecal lactobacilli were found in
Japanese at low risk of colon cancer compared to Canadians at high risk.
As previous ecological studies did not specifically address fermented dairy
products, we investigated the correlation between per capita consumption of
fermented milk and the incidence of colon cancer among 16 countries. In these
analyses, fermented milk intake per capita in 1981*' was not correlated with colon
cancer incidence" perse, but after adjusting for % energy from fat a negative
correlation (r = -0.49, p = 0.05) was demonstrated (Figure 2.2). When Finland was
excluded from these analyses, the correlation did not remain significant.
Dairy products contribute significantly to daily calcium intake. In the Netherlands
70% of calcium intake is from dairy sources. It has been suggested from ecological
as well as experimental studies that a protective effect of dairy products in general
may be attributed to the calcium content of dairy products.''* In the US the intake of
calcium is lowest in the north-eastern states where colon cancer mortality is
highest." However, in the 38-countries study, no association with calcium was
observed."
In general, one should be careful interpreting results from ecological studies as
the assessment of intake and incidence data is hardly comparable between countries.
Furthermore, since data necessary to control for confounding at an individual level
16 C/iapfer 2
are not available, results from these international correlations require confirmation
by individual based analytical epidemiology." • •'•
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Figure 2.2 Per capita consumption of fermented milk consumption and colon cancer incidence.
In contrast to ecological studies, case-control and cohort studies provide the
possibility to adjust for potential confounding variables.
As we started our investigation on the association of fermented dairy products,
calcium and colorectal cancer in 1990, results from other comparable studies
conducted before and in or after 1990 will be discussed in chronological order.
Table 2.1a shows the main characteristics and results of 13 case-control studies
conducted before 1990. which addressed the relationship between the consumption
of (fermented) dairy products, calcium intake and colorectal cancer or polyp risk.
Two retrospective studies addressed the intake of fermented milk (yogurt and
buttermilk).""" An inverse association with fermented milk and colon cancer was
observed in a American study conducted by Young and Wolf (OR = 0.65, 95%
CI = 0.41-1.01)," while a Japanese study observed a positive non-significant
association with yogurt (OR = 1.52 (ns)).** In the American study an inverse
association with cheese consumption was found (OR = 0.72, 95% CI = 0.51-1.05),"
which was also not confirmed in the Japanese study (OR = 1.36 (ns)).** A French
case-control study mentioned a non-significant inverse association with cheese
consumption (OR = 0.9) for colorectal cancer,*' and a non-significant positive
association (OR = 1.2) for colorectal polyps.*" In a Belgium study an OR of 1.0 was
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found for cheese consumption.*'
For total dairy products, Slattery and colleagues™ observed a significant negative
association in Utah, while an Australian" and an American study" observed weak
non-significant negative associations and a study in Greece describes a weak non-
significant positive association.^
Approximately, one third of the case-control studies included in Table 2.1a
support an inverse association with milk or calcium. In the study conducted by
Slattery et al. a significant negative association with colon cancer was observed.™
Kune and colleagues observed a non-significant decreased risk with high milk, high
calcium consumption after adjustment for many confounding variables/' Non-
significant inverse associations were observed in three other studies for colon
cancer"™" and in one other for rectal cancer."" Miller et al.™ and Manousos et al."
both observed slightly elevated risk associated with high milk consumption. After
adjustment for fat intake, this association was not longer significant. A non-
significant positive association with calcium was also observed in the Belgian study
by Tuyns et al ."
Prospective cohort studies conducted before 1990 were not conclusive either
(Table 2.2a). One of the four studies conducted addressed the consumption of
cheese, which intake was significantly positively associated with colon cancer death
in men, and non-significantly inversely associated with colon cancer death in
women.™ In the same study, milk consumption was inversely associated with colon
cancer death in men.™ However the number of deaths in the reference category was
too small to draw firm conclusions.
Calcium was found to be significantly inverse associated in one of these four
studies. In this study by Garland and colleagues," two dietary histories were
obtained one year apart from a cohort of approximately 2,000 men who were
followed for a period of 19 years. The risk of colorectal cancer was found to be
about three times higher in men who consumed the lowest levels of calcium
compared to those with the highest consumption and a dose-response relationship
was observed. In contrast, two other prospective studies by Heilbrun et al.*' and Wu
et al."' did observe no association and a non-significant inverse association
respectively. In both studies no association with fat intake was observed. None of
the prospective results addressed colorectal polyps.
After 1989. while we were conducting our study, another 12 case-control and 4
prospective studies reported their results on dairy products, calcium and colorectal
cancer. One large case-control study by Peters and colleagues on colon cancer
addressed the consumption of yogurt: an odds ratio of 0.8 per 10 grams of yogurt
was observed assuming a log-lineair dose-response, and adjusted for dietary
calcium.™
Table 2.1a. Daily products, calcium, colorectal polyps and colorectal cancer: 13 case-control studies 1975-1989.
First author,
year [ref]
Miller, 1983
[76]
Manousos,
1983 [73]
Pickle, 1984
[72]
Tajima, 1985
[66]
Macquart-
Moulin, 1986
[67]
Mac-quart-
Moulin, 1987
[68]
Tuyns, 1987
[77]
Tuyns, 1988
[69]
Population
Canada
Greece
US,
Nebraska
Japan
France,
Marseilles
region
France,
Marseilles
region
Belgium
Belgium
No. of cases/
endpoint
542 colorectal
cancer
100 colorectal
cancer
86 colorectal
cancer
93 colorectal
cancer
399 colorectal
cancer
223 colorectal
adenoma and
29 villous
polyps
818 colorectal
cancer
818 colorectal
cancer
Controls/source
535 hospital and
neighbourhood
100 hospital
176 hospital
186 hospital
399 hospital
238hocpital
2,851 population
2,851 population
Dietary
method
diet hist
diet hist
(i=80)
diet hist
(i=57)
ffq
diet hist
0=158)
diet hist
0=158)
diet hist
diet hist
Risk estimates (OR) highest vs
lowest intake
milk: ORCM
ORCF
ORRM
ORRP
milk and milk
OR
dairy products
OR<
ORR
yogurt: OR<
ORR
cheese: ORc
ORR
calcium: OR,
ORR
cheese: OR
milk: OR
calcium: OR
cheese: OR
milk: OR
calcium: OR
calcium: OR^
ORR
milk: ORc
ORR
cheese: OR^
ORR
= 1.2(ns)
= 1.3(ns)
= 1.1 (ns)
= 1.2 (ns)
products:
= 1.2(0.6,2.4)
= 0.74 (ns)
= 0.92 (ns)
= 1.5 (ns)
= 1.7(ns)
= 1.4(ns)
= 1.2(ns)
= 1.1 (ns)
= 0.5 (ns)
= 0.9 (ns)
= 0.7 (ptr<0.05)
= 0.7 (ns)
= 1.2(ns)
= 0.9 (ns)
= 1.2(ns)
= 1.3(ns)
= 1.0
= 1.8(ptr<0.0001)
= 1.7(ptr<0.01)
= 1.0
= 1.0
Calcium intake (or
contrast) among
controls (mg/day)
nm
nm
nm
nm
nm
median:
men = 831
women = 772
mean: 700
Adjusted for
age, saturated fat
-
age, sex, ancestry,
usual residence '
age, sex
age, sex, calories,
weight
age, sex, calories,
weight
age, sex, province,
calories
age, sex, province
Kune, 1987
[71]
Graham, 1988
[74]
Slattcry, 1988
[70]
Young. 1988
[65]
Lee, 1989
[75]
Australia,
Melbourne
US, West.
New York
State
Utah
US, New
York
Singapore
Chinese
715 colon
cancer
428
colon cancer
231
colon cancer
353
colon cancer
203
colorectal
cancer
727 population
428 hospital and
neighbourhood
391 population
618 population
425 hospital
diet hist
(i=300)
diet hist
qffq
0=99)
diet hist
qffq
milk products:
OR
milk drinks:
OR
OR»
calcium: OR
OR»
ORp
= 0.9 (0.6, 1.3)
- i n
— 1 .U
= 0.8(0.5, 1.3)
= 0.9(0.6, 1.2)
= 1.4(0.9,2.2)
= 0.5 (0.3, 0.8)
= 0.8(0.6, 1.1)
= 1.1 (0.7, 1.7)
= 0.6(0.4, 1.0)
estimate not given
calcium: ns
dairy products:
ORc*
ORcp
calcium: ORçv
ORCP
cultured milk:
OR =
cheese: OR =
milk: OR =
milk: ORç =
OR» =
calcium: OR<- :
, = 0.4 (0.2, 0.8)
= 0.5 (0.2, 1.1)
, = 0.4 (0.2, 0.9)
= 0.5 (0.3, 1.0)
0.7(0.4, 1.0)
0.7(0.5, 1.1)
1.1 (0.8, 1.5)
 0.8(0.5, 1.3)
 1.1 (0.6,2.1)
= 0.9(0.5, 1.5)
= 0.8(0.4, 1.5)
<597,
>1150 (men)
<528,
>1043 (women)
nm
<641,
> 1,402 (men)
<592,
>1,141 (women)
nm
mean:
men: 338+177
women: 356 + 194
unknown
age, education,
phosphorus, fat
age, religion, fiber,
calories
age, sex, age*sex
age, sex, Chinese
dialect group,
occupation
C = colon cancer or polyps; R = rectal cancer or polyps; F = female; M = male; ptr = p for trend; nm = not mentioned; (q)ffq =(semi quantitative) food frequency
questionaire; i = number of items; diet hist = dietary history.
Table 2.1b. Dairy products, calcium and colorectal polyps and colorectal cancer: 12 case-control studies 1990-1993.
Author, year Population No. of cases/
end point
910
colorectal cancer
286
colorectal cancer
905
colorectal cancer
Controls/
source
1,032
hospital
499
population
and
hospital
2,488
population
Dietary
method
ffq (i=29)
ffq
diet hisi
0=84)
Risk estimates (OR) highest vs
lowest intake
milk: OR = 1 . 0 ( 0 . 7 , 1 . 3 )
cheese: ORc =1 .1 (0.8, 1.4)
OR, = 1.3(1.0, 1.8)
calcium: ORc =1 .1 (0.8, 1.6)
ORR = 1.2(0.8, 1.9)
dairy products:
ORc = 1.07 (ns)
ORR = 3.08 (ptr <0.01)
OR» = 4.30 (ptr <0.05)
ORp = 1.66 (ptr <0.05)
calcium: ORc< 1.0 (ns)
ORR < 1.0 (p <0.01)
Calcium intake
(or contrast)
among controls
(mg/day)
nm
nm
nm
Aborted for
age, sex, education.
residence, pasta, rice.
meat, green vegetables,
coffee
age, sex, weight, SES,
physical activity, no.
meals per day, cereals.
potatoes, meat.
vegetables, eggs
age, sex, saturated fat
Negri, 1990
[83]
Benito, 1990
[90]
Whittemore,
1990
[85]
Benito, 1991
[91]
Kune, 1991
[92]
Peters, 1992
[82]
Bidoli, 1992
[84]
Italy
Majorca
China and
Chinese in
US
Majorca
Australia,
Melbourne
US, Los
Angeles
286 colorectal
cancer
49 colorectal
adenoma 2 1 cm
746 colon cancer
499
population
and hospital
ffq
North- 248
eastern Italy colorectal
727 diet hist
population (i=300)
746 qffq (i=139)
population
699 hospital diet hist
calcium: OR = 1.48 (ns)
milk drinks:
OR» = 3.7 (1.5, 9.5)
ORp = 0.7 (0.2, 2.0)
yogurt: OR per 10 grams
= 0.8(0.7, 1.0)
calcium: OR = 0.4 (0.3, 0.7)
milk: ORc = 1.0
ORR = 1.0
cheese: ORc = 1.4 (ptr=O. 17)
ORR = 1.6(ptr=0.08)
1,049 + 504 age, sex, (calcium),
sources of calories,
family history, weight,
physical activity,
(pregnancy history)
age, sex, ses, bread,
polenta, eggs, tomatoes
Iscovich, 1992
[88]
Zaridze, 1993
[86]
Meyer and
White, 1993
[87]
Steinmetz and
Potter, 1993
[89]
Benilo, 1993
[93]
Argentina,
La Plata
area,
Russia,
Moscow,
Khabarovsk
US,
Washington
State
Australia
Adelaide
Spain,
Majorca
110 colon cancer
217
colorectal cancer
424 colon cancer
220 colon cancer
101 colorectal
adenoma
220
neighbour-
hood
217
population
and
neighbour-
hood
414
population
438
population
242
population
diet hist
0=140)
diet hist
ffq
ffq
ffq
dairy products:
OR = 3.0
whole milk:
OR = 1.6
cheese:
OR = 1.9
calcium:
milk:
calcium:
dairy foods:
OR
OR
OR»
= 1.1
= 1.6
dairy products:
OR
cheese: OR
calcium: OR
milk: OR
(1.2, 7.6)
(0.8, 3.1) (uv)
(0.9, 4.0) (uv)
= 0.5(0.2, 1.1)
= 0.5(0.3, 1.0)
= 1.1 (0.9, 1.4)
= 0.7(0.6, 1.0)
(0.6, 2.2)
(0.8, 3.4)
= 1.2 (ptr >0.05)
= 0.7 (ptr >0.05)
= 0.9 (ptr=O)
= 1.0 (ptr >0.05)
nm
men:
< 747,9,
> 1,477,9
women:
<890,4,
>1,545,1
median: 896
nm
median cases
and controls:
725
education, bmi, meat,
fish, eggs, vegetables
energy intake, education
age, interviewer, calories,
alcohol, Tiber
age, sex, occupation,
bmi, alcohol, (age at First
live birth)
age, sex, calories,
physical activity, rural
residence
C = colon cancer or polyps; R = rectal cancer or polyps; F = female; M = male; ptr = p for trend; nm = not mentioned; (q)ffq =(semi quantitative) food frequency
questionaire; i = number of items; diet hist = dietary history.
Table 2.2a. Dairy products, calcium and colorectal cancer. 4 prospective studies 1975-1989.
First
author.year
[ref]
Garland, 1985
[79]
Phillips, 1985
[78]
Heilbrun,
1986 [80]
Wu, 1987
[81]
Population
US Mid
West
US
California
Hawaii
Japanese
US,
Los
Angeles
Follow-up
(years)
19
21
13-16
4.5
No. of cases,
endpoint/
cohort
49 male colorectal
cancer/
1,954
182 colorectal
cancer deaths/
25,493
99 male colorectal
cancer/378
controls
(nested case-
control)
126 colorectal
cancer/
11,888
Dietary
method
28d-diet
hist (2x)
ffq (i=21)
24h-recall
ffq (i=56)
Risk estimates (RR) highest vs
lowest intake
calcium:
RRM
cheese:
RRC.M
R R C F
RR,
milk:
RRC.M
RRC.P
RRR
calcium:
RRM
high
high
calcium:
RRM
RRF
= 0.3 p < 0.05
= 1.9 (1.0-3.6) p«r< 0.05
= 0.8(0.5-1.4)
= 1.0(0.5-2.2)
= 0.5'(0.2-l.l)ptr>0.05
= 1.1 (0.5-2.2)
= 1.2(0.6-2.7)
= 0.7, p > 0.05 (in
phosphate a 1,032,
fat a 61 group)
= 0.9 (0.4-1.7)
= 0.9 (0.5-1.6)
Calcium
intake (or
contrast)
cohort
(mg/day)
328/
1,000 kcal
nm
median:
501
nm
Adjusted for
•
age, smoking, bmi,
other dietary
variables
age, (sex)
age
• — • • • • - ' • • ' • • •
C = colon cancer or colon polyps; R = rectal cancer or rectal polyps; F = female; M = maie; ' = based on small number of deaths; ptr • p for trend;
nm = not mentioned; (q)ffq = (semi quantitative) food frequency questionaire; i = number of items; diet hist = dietary history.
Table 2.2b. Dairy products, calcium and colorectal cancer: 4 prospective studies 1990-1993.
First
author,year
[ref]
Stemmermann,
1990 [94]
Ursin, 1990
[95]
Willett, 1990
[131]
Bostick, 1993
[96]
Population
US,
Japanese
Norway
US
US, Iowa
Follow-up
(years)
19-22
11.5
6
4
No. of cases,
endpoint/
cohort
323 male
colon
cancer/7,472
155
colorectal
cancer/
15,914
150 female
colon cancer/
88,751
212 female
colon cancer/
35,216
Dietary
method
24h-recall
ffq
qffq (i=61)
qffq
(i=127)
Risk estimates (RR) highest vs
lowest intake
calcium:
RRM = 0.6 (0.4-0.9) (sigmoid)
RRM =0.8 (0.6-1.1) (total colon)
milk:
RR = 0.9 (ns)
estimates not given
cheese ns .,.
whole milk ns
calcium ns •
calcium:
RRF =0.7(0.4-1.0)
calcium diet:
RRF = 1.0 (0.6-1.6)
calcium suppl.:
RRF =0.7(0.4-1.0)
dairy products:
RRF = 0.7 (0.4-1.4)
Calcium
intake (or
contrast)
cohort
(mg/day)
age-adjusted
mean non-
cases: 503
nm
nm
total
calcium:
1,119 ± 3
dietary
calcium:
835 ± 2
Adjusted for
age
age, sex, place of
residence
unknown
age, calories,
height, parity,
vitamin E, total
vitamin E'age,
low-fat meat
C = colon cancer or colon polyps; R = rectal cancer or rectal polyps; F = female; M = male; ' = based on small number of deaths; ptr = p for trend;
nm = not mentioned; (q)ffq = (semi quantitative) food frequency questionaire; i = number of items; diet hist = dietary history.
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Cheese consumption was addressed in two Italian case-control studies:"*' non-
significant positive associations were found.
In about half of the studies which mentioned milk and/or calcium intake, inverse
associations were observed.*^*" An important observation was the clear dose-
response effect of calcium in the large US case-control study by Peters et al." In an
other US case-control study an inverse association with calcium intake was
observed for women only, for men a non-significant positive association was
observed.*" In a relatively small Argentinean study, a non-significant positive
association was observed for whole milk consumption, while the intake of dairy
products in general significantly increased risk.*" Positive associations with the
intake of dairy foods or calcium and colon or rectum cancer risk were observed in
two other studies.™*"
Two case-control studies on colorectal polyps were conducted. The results of a
small study in Australia indicated a significant positive association with milk drinks
among men, while in women a non-significant inverse association was found. ^  An
Italian study found no important association with dairy product, milk or calcium
intake.* In the same study, a non-significant inverse association with cheese
consumption was found.'"
None of the prospective studies published after 1989 addressed fermented dairy
products. In three of the four prospective studies addressing milk and/or calcium, an
inverse association was observed.*"* In the study conducted by Stemmermann et al.
in a Japanese Hawaiian population using a 24h recall method the association with
calcium and sigmoid cancer was significant (RR = 0.6, 95% CI = 0.4-0.9).** For the
colon as a whole this association was less strong and not significant (RR = 0.8). In
the most recent study published, the Iowa Women Health Study, calcium from
supplements (mean intake among non-cases:283 mg/day) was associated with risk
(RR = 0.66, 95% CI = 0.43-1.02), while only a very weak inverse association was
observed with calcium from dietary origin (RR = 0.95, 95% CI = 0.57-1.61) (mean
intake among non-cases: 835 mg/day).*
The diversity in findings among case-control as well as prospective studies may
be partially explained by differences in populations, differences in methodology and
differences in the bacterial strains used to ferment dairy products. Most studies are
conducted among populations with a relatively low and homogeneous dairy product
intake. Only a few studies addressed the interactions with dairy products, calcium
and other nutrients as fat or fiber, or focused on different stages of tumor
development as the outcome or stratified disease according to subsites within the
colon.
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Lactic acid bacteria
Diet affects the composition of the intestinal flora, and carcinogenic substances
derived from food may be produced by bacteria within the colon.^'^ It has been
suggested that lactic acid bacteria, which belong to the normal intestinal microflora,
contribute to the stabilization of the bacterial flora and maintain resistance against
pathogens."
Since the oral administration of commercial and simulated yogurt containing
Z.acfo6aa//us bu/garicus and Streptococcus f/iermop/ii/us inhibited initial Ehrlich
ascites tumor growth in mice* and supplements with Z-acfofcaaV/us acu/op/ii/us
delayed the occurrence of DMH-induced colon cancer in rats," several short-term
animal and human experimental studies have been conducted studying the
mechanisms by which suppletion of lactobacilli might exert anti-carcinogenic
properties.'"
Three different mechanisms have been suggested (see Table 2.3). Lactobacilli
might modulate the colonie flora, thereby influencing enzyme activity and reducing
the conversion of procarcinogens to carcinogens in the colon. The activity of
specific bacterial enzymes is elevated by a high meat, western-type diet."
Supplementation of the human diet with milk containing viable L. acidopAi/iu of
human origin, which is bile resistant, caused a significant decline in faecal bacterial
enzymes supposed to be involved in the carcinogenic process, such as
p-glucuronidase, 7-a-dehydroxylase, nitroreductase and azoreductase."'"*" It is not
clear whether ingested lactobacilli reduce enzyme activity due to implantation of the
viable strain or to suppression of enzyme activity in other intestinal bacteria by
viable and unviable strains.""
The second hypothesized mechanism involves a stimulation of the immune
respons, locally as well as systematically. Oral administration of milk containing L.
feu/gan'cM5 or £. case/ to mice"" was shown to activate lymphocytes and
macrophages. Addition of yogurt to human peripheral blood lymphocyte cultures
stimulated by a mitogen (Con-Canavalin A)'™ increases the production of
y-interferon, a cytokine which has anti-proliferative properties and has been able to
activate Natural Killer cells.
Thirdly, in vitro studies have shown that lactic acid bacteria have the ability to
absorb cooked food mutagens.'** Human experimental studies have shown that
intake of L. acidbp/ii'/us significantly reduced mutagen excretion after consumption
of fried meat.""
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Table 2.3 Mechanisms suggested for the protective effect of fermented dairy products on
colorectal cancer risk.
First author, year [ref] Human/animal Strain Observations
Modulation colonie
flora
Ayebo, 1980 [132]
Goldin, 1984 [53]
Marteau, 1990 [100]
Lidbeck, 1991 [1331
healthy humans *•• a «
colon cancer patients
P-glucuronidase -(3x)
nitroreductase - (2x)
azoreductase - (lx)
(3-glucosidase - (lx)
Immunology
Perdigon, 1986 [102] mice I .
De Simone, 1986 [103] human lymphocytes L.
macrophages +
Y-interferon +
Mutagen absorption
Zhang and Ohta, 1991 in vitro
[104]
Lidbeck, 1992 [105] healthy humans
Z.. acidop/ii/us, food mutagen binding
B. fei/ù/u/n, S. cremoris capacity +
faecal mutagen
binding capacity +
+ increase; - decrease.
For Lactobacilli to exert an effect on the intestinal microflora, survival through
the intestinal tract might be important. Robins-Brown and Levine"* have shown that
L. ac/dop/i//MX and L. bu/gan'cMs, when taken with milk, have the ability to pass
through the stomach in equal numbers. Jejunal fluid samples were taken from
volunteers at varying intervals and lactobacilli were cultured on a selective medium.
Z,. acirfop/ii/us was recovered from more samples and in higher counts that L.
fen/gan'cMs. When given 500 ml L. addop/n/MS fermented milk per day, within one
week the number of lactobacilli increased markedly in human volunteers.""'"*
However, one week after supplementation was stopped, the numbers of lactobacilli
had decreased to almost the same levels as before administration. This implies that
colonization is not established and consumption of lactobacilli might need to be at
least very frequent to exert an effect.
Although promising, experimental research on lactic acid bacteria and fermented
dairy products is preliminary.
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Calcium
Several biological mechanisms have been suggested for a protective effect of
calcium in colon carcinogenesis. Calcium'"' or -more recently- calciumphosphate,""
might reduce colorectal cancer risk by binding bile acids and free fatty acids,
thereby diminishing the proliferative stimulus of these compounds on the colon
mucosa. This hypothesis has been supported by animal experiments."*•"'•"* An
alternative hypothesis, based on in vitro studies in human epithelial c e l l s , " " "
proposes that calcium might inhibit the proliferation of colonie epithelial cells
directly by inducing differentiation. Furthermore, administration of calcium reduced
chemical carcinogen-induced tumor yield in rodents,'"""' and reduced Ki-ras G to
A mutations in colorectal neoplasms in rats.'*" For calcium to influence cell
proliferation directly, absorption into the cells is necessary. Vitamin D increases
calcium absorption. Experimental studies suggest inhibition of cell proliferation by
vitamin D, which might be due to vitamin D itself or its effect on calcium
absorption.'"'
Before 1990, 4 out of 6 small trials, which were not placebo-controlled, have
shown that supplemental calcium reduces cell proliferation in man (Table
2 4a) ii3.ii4.ii6.i2i Lipjdii and Newmark reported the first trial in 10 persons with a
family history of colon cancer."^ Calcium (1250 mg administered as
calciumcarbonate) was added to their normal diets for a period of three months and
rectal biopsies were obtained before and after supplementation. The average level of
proliferation of epithelial cells in the colon was lower after calcium
supplementation. However, since no control group was used, these changes could be
attributable to temporal fluctuations in cell proliferation. Furthermore, it was unclear
whether all subjects experienced a reduction in cell proliferation or whether this was
confined to those individuals whose levels were initially the highest and who might
therefore be expected to show reduced levels during a repeated examination through
chance variation. In a small randomized, placebo-controlled trial no decrease in
proliferation activity was noticed using the same method of proliferation
assessment.'""
The baseline intake of calcium, as assessed through dietary questionnaires, was
similar among the studies and was usually slightly less than the adult recommended
dietary allowance (RDA) of 800 mg/day. Doses of supplementation were
comparable between studies and the tritiated thymidine method was used in all
studies to assess the labelling index. The labelling index reflects the proliferative
state of the mucosa: the more proliferating cells, the higher the labelling index. In
the study by Grégoire and colleagues the duration of supplement use was shorter
than in the other studies.'" However, since the turnover rate of the rectal mucosa is
a few days, a significant effect was demonstable after as little as one month.'"
28
Table 2.4a Human experimental studies on calcium and distal colonie epithelial proliferation
1985-1989.
First author
year
[ref]
Lipkin, 1985
[113]
Buset, 1986
[114]
Buset, 1986
[114]
Rozen, 1989
[121]
Lipkin, 1989
[116]
Lipkin, 1989
[116]
Grégoire,
1989 [122]
Design
uncon-
trolled"
uncontrolled
uncontrolled
uncontrolled
uncontrolled
uncontrolled
placebo-
controlled
Study
population/
No. of
subjects
HNPCC/10
FCC/5
sporadic
adenoma/3
FCC and
sporadic
adenoma/35
HNPCC/21
FAP/7
colonie
resection/30
Ca-
diet
mg/
day
700
nm
nm
nm
700
700
669
Ca-supplement*
dose duration
g/day /months
1.25
1.5
1.5
1.3-
1.5
1.3-
1.5
1.3-
1.5
1.2
2-3
1-2
1-2
3
3-4
3-4
1
Method
r"
T
T
T
T
T
T
Change
in
labelling
index
-
0
-
variable
response
+
(p=0.06)
* Calcium carbonate unless otherwise indicated; •* Without a placebo control group;
•*• Labelling index determined using tritiated thymidine; - decrease; + increase; 0 no effect;
FCC Family history of Colorectal Cancer; HNPCC Family members of Heriditary Non-
Polyposis Colon Cancer; FAP Familial Adenomatous Polyposis; nm = not mentioned.
An important striking difference between the trials mentioned was that the
reported baseline labelling index in the trials by Lipkin and colleagues (16.7%,
12.1% and 9.1% respectively)"^ was twice as high as those reported by Grégoire et
al. (4.9%)'" and Rozen et al. (5.3%).'"
After 1989, 7 different research groups publiced the results of 11 trials (Table
2.4b). In five trials a significant reduction in cell proliferation could be
determined,'^"'*' in two a non significant reduction was observed,'" two did not
observe any reduction'"'** and in two an increase in proliferation was observed.'*'
In the study by Barsoum et al. , '" a stathmokinetic method examining colonie crypt
cell production rate was used to assess cell proliferation. This method takes the cell
cycle time, growth fraction and the crypt cell population into account.'"
Kleibeuker et al.'"'' and O'Sullivan et al . '" determined labelling index using
5-bromodeoxyuridine and immunohistochemistry. Both studies did not use a
placebo-treated control group.
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Table 2.4b Human experimental studies on calcium and distal colonie epithelial proliferation
1990-1993.
First author, Design Study Ca-diet Ca-supplement Method Change
year population/ mg/day in
[ref] . No. of dose duration .. , labelling
subjects g/day /months index
Stern, 1990
[127]
Barsoum,
1992 [126]
Wargovich,
1992 [123]
Wargovich,
1992 [123]
Wargovich,
1992 [123]
Wargovich,
1992 [123]
Bostick,
1993 [128]
Kleibeuker,
1993 [129]
Kleibeuker,
1993 [129]
O'Sullivan,
1993 [125]
Thomas,
1993 [126]
randomized,
placebo-
controlled
placebo-
controlled,
double blind
randomized,
placebo-
controlled,
single-
blinded
randomized,
placebo-
controlled,
single-
blinded
randomized,
placebo-
controlled,
single-
blinded
randomized,
placebo-
controlled,
single-blind
randomized,
double blind,
placebo-
controlled
uncontrolled
uncontrolled
uncontrolled
double blind
placebo-
controlled
FAP/31 1,102 1.2 9 T 0
adenoma/14 nm 1.3 2 C
previous 702 1.5 3 T
sporadic (p=0.08)
adenoma/6
previous 702 2.0 1 T
sporadic
adenoma/6
sporadic 729 2.0 1 T
adenoma/6
sporadic 729 2.0 IT
adenoma/6 (p=0.06)
sporadic 951 1.2 2 T
adenoma/21
adenoma/17 nm 1.5 3 B
adenoma/7 nm 1.5 12 B
adenoma/20 nm 1-2 IB
adenoma/25 nm 1.5 6 C
* Calcium carbonate unless otherwise indicated; T = tritiated thymidine; B = 5-bromode-
oxyuridine and histochemistry; C = colonie crypt cell production rate; - = decrease;
+ = increase; 0 = no effect; FAP = Familial Adenomatous Polyposis; nm = not mentioned.
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Wargovich et al. experimented with different doses of supplementation.'" They
published two small controlled trials, in which a dose of 1.5 g/day resulted in an
insignificant 20% decrease in the labelling index, whereas a dose of 2.0 g/day
resulted in a 29% decrease which was significant.
In a double blinded controlled trial'** with calcium supplementation of 1.2 grams
a day, the difference between change in the mean Labelling Index from baseline to
8 weeks' follow-up in the placebo group versus the calcium group was not
statistically significant. Kleibeuker et ai."" report an increase of the labelling index
after 3 months as well as one year of supplementation. This is the only study which
used biopsies from the mid sigmoid, all other studies used rectal biopsies to
determine cell proliferation.
During these past 5 years a considerable number of placebo-controlled trials on
calcium and cell proliferation are conducted. The results were not conclusive,
however, partially because the techniques used to study cell-proliferation and the
preferable end-point studied are still discussed.'"*'
Overall, it can be concluded that, despite the research activities on fermented
dairy products and calcium as related to colorectal cancer risk, results remain
contradictory and our studies still provide a relevant contribution.
References
1. Harris CC. Chemical and physical carcinogenesis.: advances and perspectives for the 1990s.
Cancer Res l99l;51suppl:5023S-5044S.
2. Hill MJ, Morson BC, Bussey HJ. Aetiology of adenoma-carcinoma sequence in large bowel.
Lancet 1978; 1:245-247.
3. Lipkin M. Phase 1 and phase 2 proliferativc lesions of colonie epithelial cells in diseases
leading to colorectal cancer. Cancer 1974;34:878.
4. Terpstra OT, Van Blankcnstein M, Decs J, Eilers GAM. Abnormal pattern of cell
proliferation in the entire colonie mucosa of patients with adenoma or cancer.
Gastroentcrology 1987;92:704-708.
5. Hill MJ. Aetiology of colorectal cancer: current concepts. Baillières Clinical
Gastroentcrology 1989;3:567-591.
6. Fearon ER and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell
1990;61:759-767.
7. Goelz S, Vogelstein B, Hamilton S, Feinberg A. Hypomethylation of DNA from benign and
malignant human colon neoplasms. Science 1985;228:187-190.
8. Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine, and alcohol intake and
risk of colorectal adenoma. J Natl Cancer Inst 1993;85:875-884.
9. Anonymus. Folatc, alcohol, mcthioninc and colon cancer risk: is there a unifying theme?
Nutr Rev 1994;52:18-28.
10. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human
colorectal cancers. Nature 1987;327:293-297.
11. Barbacid M. Ras genes. Annu Rev Biochem 1987;56:779-827.
12. Baker S, Fearon ER, Nigro JM, et al. Chromosome 17p deletions and p53 gene mutations in
colorectal carcinomas. Science 1989;244:217-221.
13. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human
Ae/fo/ogy 0/ co/orec/a/ cancer 31
tumour types. Nature 1989;342:705-708. • - , * ••'"•: • .'!*
14. Cho KR and Vogelstein B. Genetic alterations in the adenoma-carcinoma sequence. Cancer
1992; 1727-1731.
15. Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers.
Science 1991;253:49-53.
16. Vogelstein B and Kinzler K. Carcinogens leave fingerprints. Nature 1992;355:209-210.
17. Fearon E, Cho K, Nigro J, et al. Identification of a chromosome 18q gene that is altered in
colorectal cancers. Science 1990;247:49-56.
18. Vogelstein B, Fearob E, Hamilton S, et al. Genetic alterations during colorectal tumor
development. N Engl J Med 1988;319;525-532.
19. Doll R and Peto R. The causes of cancer. Quantitative estimates of avoidable risks of cancer
in the United States today. Oxford Univ. Press, Oxford, 1981.
20. Hill MJ. Microbes and human carcinogenesis. Edward Arnold. London, 1986.
21. Goldin BR, Dwyer J, Gorbach SL, Gordon W, Swenson L. Influence of diet and age on
fecal bacterial enzymes. Am J Clin Nutr 1978;31:S136-S140.
22. Rafter JJ, Bakke J, Larsen H, Gustafsson B, Gustafsson J-A. Role of the intestinal microflora
in the formation of sulfur-containing conjugates of xenobiotics. Rev Biochem Toxicol
1983;5:387-408.
23. Willed WC. The search for the causes of breast and colon cancer. Nature 1989;338:389-394.
24. Bingham SA. Diet and large bowel cancer. J Roy Soc Med 1990;83:420-422.
25. Cummings JH, Wiggins HS, Jenkins DJ, et al. Influence of diets high and low in animal fat
on bowel habit, gastro-intestinal transit time, faecal microflora, bile acid and fat excretion. J
Clin Invest 1978;61:953-963.
26. Reddy BS, Watanabe K, Weisburger JH, Wynder EL. Promoting effect of bile acids in colon
carcinogenesis in germfree and conventional F344 rats. Cancer Res 1977;37:3238-3242.
27. Deschner EE, Cohen BI, Raicht RF, et al. Acute and chronic effect of dietary cholic acid on
colonie epithelial cell proliferation. Digestion 1981 ;21:290-296.
28. Bull AW, Soullier BK, Wislon PS, Hayden MT, Nigro ND. Promotion of azoxymethane-
induced intestinal cancer by high-fat diet in rats. Cancer Res 1979;39:4959-4965.
29. Lapré JA, Termont DSML, Groen AK, Van dcr Meer R. Lytic effects of mixed micelles of
fatty acids and bile acids. Am J Physiol 1992;263:G333-G337.
30. Hill MJ. The role of colon anaerobes in the metabolism of bile acids and steroids and its
relation to colon cancer. Cancer !975;36:2387-2400.
31. Morotomi M, Guillem JG, Logefro P, Weinstein IB. Production of diacylglycerol, an
activator of protein kinase C, by human intestinal microflora. Cancer Res
1991;50:3595-3599.
32. Stephen A and Cummings J. Mechanisms of action of dietary fiber in the human colon.
Nature 1980;284:283-284.
33. Cummings JH. Fermentation in the human large intestine: evidence and implications for
health. Lancet 1983;1:1206-1209.
34. Steinmetz KA and Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes
Control 1991;2:427-442.
35. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the
epidemiological evidence. Nutr Cancer 1992; 18:1-29.
36. Steinmetz KA and Potter JD. Vegetables, fruit, and cancer. 1. Epidemiology. Cancer Causes
Control 1991;2:325-357.
37. Howe GR, Beniti E, Castellato R, et al. Dietary intake of fiber and decreased risk of cancers
of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J
Natl Cancer Inst 1984;72:1323-1325.
38. Sigimura T and Sato S. Mutagens-carcinogens in foods. Cancer Res 1983;43(suppl):2415s-
2421s.
39. Corpet D, Stamp D, Medline A, Minkin S, Archer MC, Bruce WR. Promotion of colonie
microadenoma growth in mice and rats fed cooked sugar or cooked casein and fat. Cancer
Res 1990;50:6955-6958.
32
40. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the
epidemiology. Epidemiol Rev 1993; 15:499-545.
41. Holdstock DJ, Misiewicz JJ, Smith T, et al. Propulsion (mass movement) in the human
colon and its relationship to meals and somatic activity. Gut 1970; 11:91-99.
42. Thronton J, Symes C, Heaton K. Moderate alcohol intake reduces bile cholesterol saturation
and raises HDL cholesterol. Lancet 1983;ii:819.
43. Longnecker MP, Orza MJ, Adams ME, Vioque J, Chalmers TC. A meta-analysis of
alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes
Control 1990; 1:59-69.
44. Heath CW. Rheumatoid arthritis, aspirin, and gastrointestinal cancer. J Natl Cancer Inst
1993;85:258-259.
45. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of .
colorectal cancer. Gastroenterology 1993;105:l 30-141.
46. Jacobsen BK and Thelle DS. Coffee, cholesterol and cancer incidence: is there a link? Brit
Med J 1986;294:4-5.
47. Rosenberg L. Coffee and tea consumption in relation to the risk of large bowel cancer: a
review of epidemiologic studies. Cancer Lett 1990;52:163-171.
48. Giovannucci E, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking
and risk of colorectal adenoma and colorectal cancer in United States women. J Natl Cancer
Inst 1994;86:192-199.
49. Giovannucci E, Rimm EB, Stampfer MJ, et al. A prospective study of cigarette smoking and
risk of colorectal adenoma and colorectal cancer in United States men. J Natl Cancer Inst
1994;86:183-191.
50. DeCosse JJ, Ngoi SS, Jacobson JS, Cennerazzo WJ. Gender and colorectal cancer. Eur J
Cancer Prev 1993;2:105-l 15.
51. Potter JD and McMichael AJ. Reproduction, endogeneous and exogeneous sex hormones and
colon cancer: a review and hypothesis. J Natl Cancer Inst 1980;65:1201.
52. Lampe JW, Fredstrom SB, Slavin JL, Potter JD. Sex differences in colonie function: a
randomized trial. Gut 1993;34:531-536.
53. Goldin BR and Gorbach SL. The effect of milk and lactobacillus feeding on human
intestinal bacterial enzyme activity. Am J Clin Nutr 1984;39:756-761.
54. Newmark HL, Wargovich MJ, Bruce WR. Colon cancer and dietary fat, phosphate, and
calcium: a hypothesis. J Natl Cancer Inst 1984;72:1323-1325.
55. Alder RJ and McKeown-Eyssen G. Calcium intake and risk of colorectal cancer. Front
Gastrointest Res 1988; 14:177-187.
56. McKeown-Eyssen GE and Bright-See E. Dietary factors in colon cancer: international
relationships. An update. Nutr Cancer 1985;7:251-253.
57. McKeown-Eyssen GE and Bright-See E. Dietary factors in colon cancer: international
relationships. Nutr Cancer 1984;6:160-170.
58. International Agency for Research on Cancer, Intestinal Microbiology Group. Dietary fiber,
transit time, faecal bacteria, steroids and colon cancer in two Scandinavian populations.
Lancet 1977;2:207-211.
59. Jensen OM, MacLennan R, Wahrendorf J on behalf of the IARC Large Bowel Group. Diet,
bowel function, fecal characteristics, and large bowel cancer in Denmark and Finland. Nutr
Cancer 1982;4:5-19.
60. Benno Y, Suzuki K, Suzuki K, Narisawa K, Bruce WR, Mitsuoka T. Comparison of the
fecal microflora in rural Japanese and urban Canadians. Microbiol Immunol 1986;30:521-
532.
61. International Study Group of Fermented Fresh Milk Product Research. The production of
fermented milk in the world. IDF-bulletin 1984; 179:8-15.
62. World Health Organization, International Agency for Research on Cancer and International
Association of Cancer Registries. Age-standardized and cumulative (0-64, 0-74) incidence
rates by sites. In: Muir C, Waterhouse J, Mack T, Powell J, Whelan S, ed. Cancer Incidence
in five continents. Volume V. Lyon: IARC scientific publications no.88, 1987:852-853.
Ae/io/ogy o/ co/orec/a/ cancer 33
63. Sorenson AW, Slattery ML, Ford MH. Calcium and colon cancer: a review. Nutr Cancer
1988; 11:135-145.
64. Rothman KJ. Modern Epidemiology. 1st ed. Little Brown & Co. Boston/Toronto, 1986.
65. Young TB and Wolf DA. Case-control study of proximal and distal colon cancer and diet in
Wisconsin, lnt J Cancer 1988;42:167-175.
66. Tajima K and Tominaga S. Dietary habits and gastro-intestinal cancers: a comparative case-
control study of stomach and large intestinal cancers in Nogoya, Japan. Jpn J Cancer Res
1985;76:705-716.
67. Macquart-Moulin G, Riboli A, Cornée J, Charnay B, Berthezène P, Day N. Case-control
study on colorectal cancer and diet in Marseilles, lnt J Cancer 1986;38:183-191.
68. Macquart-Moulin G, Riboli E, Cornée J, Kaaks R, Berthezène P. Colorectal polyps and diet:
a case-control study in Marseilles. lnt J Cancer 1987;40:179-188.
69. Tuyns AJ, Kaaks R, Haelterman M. Colorectal cancer and the consumption of foods: a case-
control study in Belgium. Nutr Cancer 1988;11:189-204.
70. Slattery ML, Sorenson AW, Ford MH. Dietary calcium intake as a mitigating factor in colon
cancer. Am J Epidemiol 1988;128:504-514.
71. Kune S, Kune G A, Watson IF. Case-control study of dietary etiological factors: The
Melbourne colorectal cancer study. Nutr Cancer 1987;9:21-42.
72. Pickle LN, Greene MH, Ziegler RG, et al. Colorectal cancer in rural Nebraska. Cancer Res
1984;44:363-369.
73. Manousos O, Day NE, Trichopoulos D, Gerovassilis F, Tzonou A, Polychronopoulou A.
Diet and colorectal cancer: a case-control study in Greece, lnt J Cancer 1983;32:l-5.
74. Graham S, Marshall J, Haughey B, et al. Dietary epidemiology of cancer of the colon in
western New York. Am J Epidemiol 1998; 128:490-503.
75. Lee HP, Gourley L, Duffy SW, Estève J, Lee J, Day NE. Colorectal cancer and diet in an
Asian population-a case-control study among Singapore Chinese. lnt J Cancer 1989;43:1007-
1016.
76. Miller AB, Howe GR, Jain M, Craib KJP, Harrison L. Food items and food groups as risk
factors in a case-control study of diet and colorectal cancer. lnt J Cancer 1983;32:155-161.
77. Tuyns AJ, Haelterman M, Kaaks R. Colorectal cancer and the intake of nutrients:
oligosaccharides are a risk factor, fats are not: a case-control study in Belgium. Nutr Cancer
1987;10:181-196.
78. Phillips RL and Snowdon DA. Dietary relationship with fatal colorectal cancer among
Seventh-day Advcntists. J Natl Cancer Inst 1985;74:307-317.
79. Garland CF, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary
calcium and vitamin D and risk of colorectal cancer: a 19-year prospective study in men.
Lancet 1985; 1:307-309.
80. Hcilbrun LK, Hankin JH, Nomura A, Stemmermann GN. Colon cancer and dietary fat,
phosphorus, and calcium in Hawaiian-Japanese men. Am J Clin Nutr 1986;43:306-309.
81. Wu AH, Paganini-Hill A, Ross RK, Henderson BE. Alcohol, physical activity and other risk
factors for colorectal cancer: a prospective study. Brit J Cancer 1987;55:687-694.
82. Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles County,
California. Cancer Causes Control 1992;3:457-473.
83. Negri E, La Vecchia C, D'Avanzo B, Franceschi S. Calcium, dairy products and colorectal
cancer. Nutr Cancer 1990; 13:255-262.
84. Bidoli E, Franceschi S, Talamini R, Barra S, La Vecchia C. Food consumption and cancer of
the colon and rectum in North-Eastern Italy. lnt J Cancer 1992;50:223-229.
85. Whitemore AS, Wu-Williams AH, Lee M, et al. Diet, physical activity, and colorectal cancer
among Chinese in North America and China. J Natl Cancer Inst 1990;82:915-926.
86. Zaridze D, Filipchenko V, Kustov V, Serdyuk V, Duffy S. Diet and colorectal cancer: results
of two case-control studies in Russia. Eur J Cancer 1993;29A:112-115.
87. Meyer F and White E. Alcohol and nutrients in relation to colon cancer in middle-aged
adults. Am J Epidemiol 1993; 138:225-236.
88. lscovich JM, L'Abbé KA, Castelleto R, et al. Colon cancer in Argentina. I: risk from intake
34
of dietary items. Int J Cancer 1992;51:851-857.
89. Steinmetz KA and Potter JD. Food group consumption and colon cancer in the Adelaide
case-control study. II. Meat, poultry, seafood, dairy foods and eggs. Int J Cancer
1993;53:720-727.
90. Benito E, Obrador A, Stiggelbout A, et al. A population-based case-control study of
colorectal cancer in Majorca. 1. Dietary factors. Int J Cancer 1990;45:69-76.
91. Benito E, Stiggelbout A, Bosch FX, et al. Nutritional factors in colorectal cancer risk: a
case-control study in Majorca. Int J Cancer 1991 ;49:161 -167.
92. Kune GA, Kune S, Read A, Macgowan K, Penfold C, Watson LF. Colorectal polyps, diet,
alcohol, and family history of colorectal cancer: a case-control study. Nutr Cancer
1991; 16:25-30.
93. Benito E, Cabeza E, Moreno V, Obrador A, Bosch FX. Diet and colorectal adenomas: a
case-control study in Majorca. Int J Cancer 1993;55:213-219.
94. Stemmermann GN, Nomura A, Chyou PH. The influence of dairy and nondairy calcium on
subsite large bowel cancer risk. Dis Colon Rectum 1990;33:190-194.
95. Ursin G, Bjelke E, Heuch I, Vollset SE. Milk consumption and cancer incidence: a
Norwegian prospective study. Brit J Cancer 1990;61:454-459.
96. Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Folsom AR. Relation of
calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women.
The Iowa Women's Health Study. Am J Epidemiol 1993;137:1302-1317.
97. Lidbeck A, Nord CE, Gustafsson J-A, Rafter J. Lactobacilli, anticarcinogenic activities and
human intestinal microflora. Eur J Cancer Prev 1992; 1:341-353.
98. Reddy GV, Friend BA, Shahani KM, Farmer RE. Antitumor activity of yogurt components.
J Food Prot 1983;46:8-11.
99. Goldin BR and Gorbach SL. Effect of /ac»o/>aci7/wj acirfop/ii/u.s dietary supplements on 1,2
dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J Natl Cancer Inst
1980;64:263-265.
100. Marteau P, Pochart P, Flourié B, et al. Effects of chronic ingestion of a fermented dairy
product containing /ac/obac/7/Mi acufo/>/»7us and />i/Wofcacfen'um fc(/ï</«m on metabolic
activities of the colonie flora in humans. Am J Clin Nutr 1990;52:685-688.
101. Gilliland SE. Properties of yoghurt. Therapeutic properties of fermented milks. In: Robinson
RK, ed. Therapeutic effects of yoghurt. Essex, England: Elseviers Science Publishers LTD,
1991:65-80.
102. Perdigon G, Alvares S, Nader de Macias ME, Margni RA, Oliver G, Pesce de Ruiz Holgado
AA. Lactobacilli administered orally induce release of enzymes from peritoneal macrophages
in mice. Milchwissenschaft 1986;41:344-348.
103. De Simone C, Bianchi Salvadori B, Negri R, Ferrazzi M, Baldinclli L, Vesely R. The
adjuvant effect of yogurt on production of gamma-interferon by con A-stimulated human
peripheral blood lymphocytes. Nutr Rep Int 1986:33:419-433.
104. Zhang XB and Ohta Y. In vitro binding of mutagenic pyrolyzates to lactic acid bacterial
cells in human gastric juice. J Dairy Sci 1991;74:752-757.
105. Lidbeck A, Overvik E, Rafter J, Nord CE, Gustafsson J-A. Effect of Laciobuci//us
acit/op/ii/us supplements on mutagen excretion in faeces and urine in humans. Microb Ecol
Hlth Dis 1992;5:59-67.
106. Robins-Brown RM and Levine MM. The fate of ingested lactobacilli in the proximal small
intestine. Am J Clin Nutr 1981;34:514-519.
107. Lidbeck A, Gustafsson J-A, Nord CE. Impact of /ac/ot>ac(7/u5 acà/op/ii/us supplements on
the human oropharyngeal and intestinal microflora. Scand J Infect Dis 1987;19:531-537.
108. Lidbeck A, Edlund C, Gustafsson J-A, Kager L, Nord CE. Impact of /acfobaciV/us
acirfop/ii/i'iAs on the normal intestinal microflora after administration of two antimicrobial
agents. Infection 1988; 16:329-336.
109. Wargovich MJ, Eng VWS, Newmark HL, Bruce WR. Calcium ameliorates the toxic effect
of deoxycholic acid on colonie epithelium. Carcinogenesis 1983;4:1205-1207.
110. van der Meer R, Termont DSML, De Vries HT. Differential effects of calcium ions and
Aefio/ogy 0/ co/orecto/ cancer 35
calcium phosphate on cytotoxicity of bile acids. Am J Physiol 1991;260:G142-G147.
111. Skraastad O and Reicheit K.L. An endogenous colon mitosis inhibitor and dietary calcium
inhibit the increased colonie cell proliferation induced by cholic acid. Scan J Gastroenterol
1988:23:801-807.
112. Wargovich MJ, Eng VWS, Newmark HL, Bruce WR. Calcium inhibits the damaging and
compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Letters
1984;23:253-258.
113. Lipkin M and Newmark H. Effect of added dietary calcium on colonie epithelial-cell
proliferation in subjects of high risk for familial colonie cancer. N Engl J Med
1985;313; 1381-1384.
114. Buset M, Lipkin M, Winawer S, Swaroop S, Friedman E. Inhibition of human colonie
epithelial cell proliferation in vivo and in vitro by calcium. Cancer Res 1986;46:5426-5430.
115. Buset M, Lipkin M, Winawer S, Friedman E. Direct and indirect protection of human
colonie epithelial cells by calcium. Gastroenterology 1987;92:1334.
116. Lipkin M, Friedman E, Winawer SJ, Newmark HL. Colonie epithelial cell proliferation in
responders and non-responders to supplemental dietary calcium. Cancer Res 1989;49:248-
254.
117. Appleton GVN, Davies PW, Bristol JB, Williamson RCN. Inhibition of intestinal
carcinogenesis by dietary supplementation with calcium. Brit J Surg 1987;74:523-525.
118. Wargovich MJ, Allnutt D, Palmer C, Anaya P, Stephens LC. Inhibition of the promotional
phase of azoxymethane-induced colon carcinogenesis in the F344 rat by calcium lactate:
effect of simulating two human nutrient density levels. Cancer Lett 1990;53:17-25.
119. Sitrin MD, Halline AG, Abrahams C, Brasitus TA. Dietary calcium and vitamin D modulate
1,2-dimethylhydrazine-induced colonie carcinogenesis in the rat. Cancer Res 1991 ;51:5608-
5613.
120. Llor X, Jacoby RF, Teng BB, Davidson NO, Sitrin MD, Brasitus TA. K-ras mutations in
1,2-Dimethylhydrazine-induced colonie tumors: effects of supplemental dietary calcium and
vitamin D deficiency. Cancer Res 1991 ;51:4305-4309.
121. Rozen P, Fireman Z, Fine N, Wax Y, Ron E. Oral calcium suppresses increased rectal
epithelial proliferation of persons at risk of colorectal cancer. Gut 1989;30:650-655.
122. Grégoire RC, Stern HS, Yeung KS, et al. Effect of calcium supplementation on mucosal cell
proliferation in high risk patients for colon cancer. Gut 1989;30:376-382.
123. Wargovich MJ, Isbell G, Shabot M, et al. Calcium supplemention decreases rectal epithelial
cell proliferation in subjects with sporadic adenoma. Gastroenterology 1992; 103:92-97.
124. Barsoum GH, Hendrickse C, Winslet MC, et al. Reduction of mucosal crypt cell
proliferation in patients with colorectal adenomatous polyps by dietary calcium
supplementation. Brit J Surg 1992;79:581-583.
125. O'Sullivan KR, Mathias PM, Beattle S, O'Morain C. Effect of oral calcium supplementation
on colonie crypt cell proliferation in patients with adenomatous polyps of the large bowel.
Eur J Gastroenterol Hepatol 1993;5:85-89.
126. Thomas MG, Thomson JPS, Williamson RCN. Oral calcium inhibits rectal epithelial
proliferation in familial adenomatous polyposis. Brit J Surg 1993;80:499-501.
127. Stern HS, Grégoire RC, Kashtan H, Stadler J, Bruce RW. Long-term effects of dietary
calcium on risk markers for colon cancer in patients with familial polyposis. Surgery
1990; 108:528-533.
128. Bostick RM, Potter JD, Fosdick L, et al. Calcium and colorectal epithelial cell proliferation:
a preliminary randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer
lnst 1993;85:132-141.
129. Kleibeuker JH, Welberg JWM, Mulder NH, et al. Epithelial cell proliferation in the sigmoid
colon of patients with adenomatous polyps increases during oral calcium supplementation.
Brit J Cancer 1993;67:500-503.
130. Zimmerman J. Does dietary calcium supplementation reduce the risk of colon cancer? Nutr
Rev 1993;51:109-112.
131. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and
36
fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med
1990;323:1664-1672.
132. Ayebo AD, Angelo IA, Shahani KM. Effect of ingesting LacfobaciY/tts ac;Wop/i(7ùs milk
upon fecal flora and enzyme activity in humans. Milchwissenschaft 1980;35:730-733.
133. Lidbeck A, Gletner Allinger U, et al. Impact of iac/ofcaciV/us acù/op/ii'/us supplements on
the faecal micro flora and soluble faecal bile acids in colon cancer patients. Microb Ecol Hith
Dis 1991;4:81-88.
t. V,i '.
Chapter 3
Calcium, vitamin D, dairy foods and the occurrence of
colorectal adenomas among men and women in two
prospective studies
Ellen Kampman, Edward Giovannucci, Pieter van 't Veer, Eric Rimm, Meir J. Stampfer,
Graham A. Colditz, Frans J. Kok, Walter C. Willett. American ./our/ia/ o/ fpw/e/w/o/ogy
7994,759:76-29
38 C/iapfer J
Abstract
A high intake of calcium, vitamin D or specific dairy products is thought to reduce the
incidence of colorectal cancer. The association of these nutrients and foods with the
occurrence of colorectal adenomas, precursors of cancer, was studied in two large US
cohort studies. " *
Cases were patients with a diagnosis of adenomatous polyps of the left colon or
rectum (331 men, 1986-1990; 350 women, 1980-1988) controls were persons with
endoscopie findings negative for adenoma (9,159 men and 8,585 women).
After adjustment for age, total energy, family history of colorectal cancer, body mass
index, alcohol consumption, folate, intake of saturated fat and fiber, indications for
endoscopy, and previous endoscopy, total calcium intake was not associated with
adenoma (relative risk (RR), highest versus lowest quintile of intake: men, 1.13, 95%
confidence interval (CI) 0.76-1.66; women, 1.17, 95% CI = 0.81-1.69).
Total vitamin D intake was unrelated to the risk for adenoma in men (RR = 1.29,
95% CI = 0.87-1.93). An inverse nonsignificant association was observed in women
in the 1980-1988 analyses (RR = 0.68, 95% CI = 0.41-1.13, trend p = 0.09), mainly
attributable to the intake of multivitamin supplements, but an analysis of 4-year data
(1984-1988) using a more detailed dietary assessment showed no association with
vitamin D (RR = 1.04, 95% CI = 0.65-1.67).
Milk consumption and intake of total fermented dairy products were not related to
adenoma risk.
In conclusion, the occurrence of colorectal adenoma was neither related to calcium
intake nor to milk consumption, whereas vitamin D from supplements but not diet was
slightly, but not significantly, inversely associated with risk among women only.
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Introduction ,^ ; i ei
It has been hypothesized that diets high in fat and low in dietary fiber increase the risk
for colon cancer.' An increased risk has also been attributed to the consumption of red
meat' * and a decreased risk to the consumption of vegetables and fruits/ An additional
hypothesis suggests a protective effect of calcium or the consumption of calcium-rich
milk products/ Support for this relation derives from clinical and experimental
studies" and from ecological data on colorectal cancer/ '" It has been hypothesized
that calcium reduces the risk for colon cancer by forming insoluble soaps with ionized
fatty acids and secondary bile acids in the colon lumen, potentially diminishing the
proliferative stimulus of these substances on the colon mucosa/* A direct effect of
calcium on the proliferative activity of the mucosa has also been suggested/ However,
case-control and cohort studies of colorectal cancer are not conclusive; some studies
observed an inverse association with calcium or milk consumption," " while others
suggested only a slight non-significant association"*" or no relation."""'"
Other nutrients or products associated with calcium intake may also be important.
For instance, a high phosphate/calcium ratio in the diet may modify the possible
inverse association with calcium/ Epidemiologic^*' and experimental studies*''"
suggest a distinct protective mechanism of vitamin D that possibly involves cell
proliferation. Furthermore, apart from the calcium and vitamin D content of milk, a
protective effect against tumor development has been suggested for fermented dairy
products,"""'" which contain micro-organisms that may influence the normal colonie
flora"*"' or activate the immune system."" Although in physiologic studies, only
specific strains of viable microorganisms seem to influence tumor occurrence or
growth,** recent epidemiologic studies in the United States suggest an inverse
association between the consumption of yogurt and cheese and colon cancer / '*
An effect of calcium or vitamin D on cell proliferation or an altered bacterial
metabolism of fermented milk products may be particularly important for the early
stages of tumor development represented by the formation and growth of colorectal
polyps. Previous studies considering the association between calcium or milk
consumption and colorectal polyps*"* have been limited by retrospective diet
assessment. To our knowledge, no studies on colorectal adenomas have addressed the
intake of vitamin D or fermented milk products other than cheese.
To study prospectively the associations of the intake of calcium, vitamin D and dairy
products with the occurrence of colorectal adenoma in men and women, we used data
from two large US cohort studies: the Health Professionals Follow-Up Study (HPFS)
and the Nurses' Health Study (NHS). The associations of saturated fat, dietary fiber,
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meat, vegetables and fruits with the risk for colorectal adenoma in the HPFS has been
described previously.""
Materials and methods ^
In 1986, the HPFS enrolled 51,529 male dentists, pharmacists, optometrists, osteopaths,
podiatrists, and veterinarians, aged 40 to 75 years. In 1976, the NHS enrolled 121,700
female registered nurses, aged 30-55 years. Detailed dietary intake data were collected
in 1980 and 1984 in the NHS and in 1986 in the HPFS, by means of a mailed semi-
quantitative food frequency questionnaire. Each biennial follow-up questionnaire
contains items on date of birth (to confirm identity) and current weight, height and
tobacco use. Family history of colon or rectal cancer, professionally diagnosed medical
conditions, screening activities, medications and physical activity are updated
periodically. Up to 1990, more than 96% of the subjects had responded to follow-up
questionnaires mailed to the entire cohort.'" Both cohorts are described in more detail
in earlier publications/*"**
Dietary
In 1980, the NHS semi-quantitative food-frequency questionnaire included 61 food
items, and the 1984 questionnaire was increased in length to 121 items. The
questionnaire used in the HPFS in 1986 included 131 foods. Multivitamin use (dose,
frequency, brand and duration) was also assessed. In each questionnaire, participants
were asked how often on average they consumed a specified commonly used portion
size of each food during the past year. There were nine possible responses, ranging
from almost never or less then once per month up to six or more times per day. In
1980, the questionnaire included seven specific dairy foods: skim or low fat milk,
whole milk, ice cream, yogurt, cottage cheese, hard cheese and butter. The 1984 and
1986 questionnaires included these seven items and four more: cream, sour cream,
sherbet or ice-milk and cream cheese.
Nutrient intakes were computed as the frequency of intake multiplied by the nutrient
composition'"'" of the specific portion size, and are computed with and without vitamin
and mineral supplements. Analyses were conducted with energy-adjusted nutrient
intakes based on residuals from the regression of nutrient intake on total caloric
intake.*
Evaluations of the reproducibility and validity of the 1980, 1984 and 1986 versions
of the food frequency questionnaire indicated that this questionnaire provides useful
information about intake of a wide variety of nutrients and foods consumed over an
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extended period.*"' The intraclass correlation coefficients for calcium intake assessed
by questionnaires 1 year apart, using the 1986 HPFS version, was 0.64 for total
calcium and 0.70 for calcium without supplements.* Correlation coefficients between
the energy-adjusted calcium intakes measured by diet records and by the second
questionnaire were 0.53 for calcium with and without supplements.'" At the time of the
validation studies, diet record values for vitamin D were not available. However, the
major dietary sources of vitamin D (dairy products, especially low-fat or skim milk)
were measured reasonably well. Pearson correlation coefficients between the second
questionnaire and the average of the two 1-week diet records for dairy foods were 0.70
in men" and 0.79 for low fat or skim milk consumption in women.*'*
Subjects with no history of colorectal polyps, cancer (except nonmelanoma skin
cancer), polyposis coli or ulcerative colitis at the beginning of the follow-up period
were eligible for analysis (HPFS: 47,037 men; NHS: 88,396 women). All individuals
with implausible total caloric intake (outside the range of 800-4,200 kcal for men and
600-3,500 kcal for women) or with whole sections of the baseline questionnaire left
blank were excluded. The vast majority of polyps were diagnosed in individuals who
had endoscopy either for routine screening or for symptoms unrelated to the polyps.
Thus, to minimize detection bias, we restricted data analysis to men and women who,
in the 1990 questionnaire, reported having undergone a sigmoidoscopy or colonoscopy
within the follow-up period (HPFS 1986-1990: 9,490 men; NHS 1980-1988: 8,925
women).''' Since only adenomatous polyps are considered precursors of cancer, subjects
with hyperplastic polyps were excluded from the analyses. Because most of the
endoscopie procedures were sigmoidoscopies, which are essentially limited to the
rectum and distal colon (sigmoid and descending colon), only cases with polyps at
these sites are included in the analysis.
Of the men reporting an endoscopy in the 1990 HPFS questionnaire, 825 reported
one or more newly diagnosed colorectal polyps during the 1986-1990 follow-up period.
Of these men 784 (95%) were contacted, of which 666 (85%) confirmed they had a
polyp and gave permission for review of medical records. Histopathologic reports were
available for 640 men (96%), resulting in confirmation of 589 cases of colorectal
polyps (adenomatous plus hyperplastic) after 4 years of follow-up. The 51 unconfirmed
cases included inflammatory nodules, ulcerative colitis, hemorrhoids, or undiagnostic
tissue. After proximal colon adenomas and hyperplastic polyps were excluded, 331
male cases remained for analysis.
Among the women in the NHS who underwent an endoscopy, 724 reported one or
more newly diagnosed polyps of the colon or rectum between 1980 and 1988. Of those
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women, 659 (91%) were contacted, of which 593 (90%) confirmed they had a polyp
and gave permission for review of medical records. After 8 years of follow-up, 509
colorectal polyp cases were confirmed, 350 being adenomatous polyps of the distal
colon or rectum.
In total, the 4-year follow-up analyses of the HPFS included 9,490 men (251 with
adenomas of the descending/sigmoid colon, 80 with rectal adenoma and 9,159 noncases
or controls). The 8-year follow-up in the NHS, included 8,935 women (224 with
adenomas of the descending/ sigmoid colon, 126 with rectal adenomas, and 8,585
controls).
Because the 1984 questionnaire provided more detailed information, for some
analyses we also assessed the occurrence of polyps in women between 1984 and 1988,
using the 1984 questionnaire as the baseline. The 1984-1988 analyses included 7,271
women (180 with adenomas of the descending/sigmoid colon and 103 with rectal
adenomas). Most of the subjects in the 1984-1988 follow-up were also in the 1980-
1988 follow-up (99%), the exceptions being the small number of women who
completed a valid food-frequency questionnaire in 1984 but not in 1980.
The nutrients of interest were analyzed using quintiles of intake, according to the
distribution in the studied population. Calcium and vitamin D intake were considered
with and without the intake of supplements, and from both dairy and non-dairy origin.
The prevalence rate ratio, based on the prevalence of polyps detected at endoscopy,
was used to calculate the relative risk. Relative risks (RR) were calculated using the
lowest quintile of intake as the reference and 95% confidence intervals were calculated
between the high and low quintiles. We tested for overall trends by using the median
of each quintile of calcium or vitamin D intake as a continuous variable.
The consumption of individual dairy products was studied by grouping the foods
into four or five frequency categories, based on the distribution of intake of the product
in the population at large. Relative risks and 95% confidence intervals were calculated
comparing participants who consumed a particular food with those who reported a
frequency of less than once a month. We tested for trend by modeling the reported
frequencies as a continuous variable.
The consumption of fermented milk products combined was studied using quintiles of
the summed frequencies of consumption of each product (yogurt, cottage cheese, hard
cheese, sour cream) weighed by the standard portion sizes or calcium content.
To control for several potentially confounding and modifying variables
simultaneously, we used multiple logistic regression models including age (in seven
categories), total energy intake, history of colon cancer in either parent, indication for
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endoscopy, endoscopies before the study period, body mass index (in quintiles),
smoking (never, past, current), physical activity and quintiles of intake of saturated fat,
dietary fiber, alcohol, and folate. Since the time of polyp occurrence is not known and
the outcome is the prevalence of polyps at endoscopy, we used logistic regression
analysis instead of a prospective approach. Because the study population was selected
by endoscopy, we adjusted for indication of endoscopy. To study the possible effect
modification of the intake of saturated fat, vitamin D and phosphorus, we assessed the
association with calcium (in tertiles) within tertiles (low, medium, high) of these
nutrients. A high phosphorus intake relative to the intake of calcium was evaluated
using quintiles of the calcium/phosphorus ratio with the lowest quintile as the
reference. Similar analyses were conducted separately for cases with left colon and
rectal polyps and for cases with small (< 1 cm) and larger (a 1 cm) polyps. When
there was more than one polyp, the size of the largest was considered.
Results
c/iaracferz'sf/'cs
Table 3.1 presents the characteristics of the male and female study population and the
prevalence of possible risk factors for colorectal adenoma, according to intake of
calcium and vitamin D. Men and women with the highest intake of calcium or vitamin
D tended to be a little older at endoscopy, had higher intakes of dietary fiber, protein
and phosphorus, a lower intake of alcohol, and smoked less. Men and women in the
highest quintiles of calcium and vitamin D intake more often reported having
undergone an endoscopy before the study period than persons with the lowest intake.
About 26% of the male and 16% of the female cases (34% of the 1984-1988 follow-up
population) had undergone an endoscopy before the study period with negative
findings, and are defined here as 'incident' cases. For these cases, the risk for positive
findings at endoscopy within the study period was lower and dietary intake was
measured closer to the onset of disease than among those who had not previously
undergone endoscopy. As no important differences between incident and prevalent
cases were seen in intake of calcium, vitamin D, and dairy products or in other
variables of interest, both incident and prevalent cases were included in the analysis.
The occurrence of adenomatous polyps increased with age, and a history of colon
or rectal cancer in either parent was positively related to the risk for developing an
adenoma. Total energy intake was not associated with risk for adenoma. All subsequent
analyses included age, total energy intake and family history of colorectal cancer.
Table 3.1 Characteristics" of the male and female study population, by the lowest and highest quintiles of calcium and vitamin D intake: The Health
Professionals Follow-up Study (HPFS) and The Nurses' Health Study (NHS).
HPFS, 1986 - 1990
calcium vitamin D
Ql* Q5' Ql Q5
NHS, 1984 - 1988
calcium vitamin D
Ql Q5 Ql Q5
NHS, 1980 - 1988
calcium vitamin D
Ql Q5 Ql Q5
Participants (no.)
Cases (%)
Mean age at endoscopy
(years)
Mean total energy intake
(kcal)
Mean intake'/day of
calcium (mg)
vitamin D (IU)
Mean intake'/day of dietary
fiber (g)
saturated fat (g)
protein (g)
alcohol (g)
phosphorus (mg)
Family history (%)
Previous endoscopy (%)•
1,897
3.1
57.8
1,877
547
285
22
24
86
18
1,180
12
43
1,898
3.0
59.2
1,915
1,649
653
25
25
96
10
1,659
12
47
1,898
3.9
56.3
1,866
707
118
22
26
85
16
1,213
12
44
1,898
4.0
59.9
1,778
1,256
954
25
23
94
12
1,539
12
47
1,454
3.8
54.7
1,640
471
189
17
22
67
10
929
13
33
1,454
4.1
56.7
1,643
1,663
527
20
21
77
6
315
15
36
1,455
4.1
54.3
1,690
647
85
17
22
67
10
.955
13
32
1,456
4.1
56.8
1,569
1,249
758
20
21
77
7
1,261
14
37
1,787
3.7
54.7
1,585
388
184
15
29
72
9
928
12
23
1,784
3.6
55.7
1,582
1,232
489
18
27
86
5
1,518
14
25
1,785
4.6
54.6
1,520
500
59
17
29
75
9
1,004
12
23
1,787
3.0
55.5
1,417
909
744
18
27
80
7
1,306
13
26
Indication for endoscopy
(%): blood in stool
occult blood
abdominal pain
diarrca
routine screening
Mean body mass index
(kg/m*)
Current smoker (%)
17
3
7
6
65
25
9
15
3
7
5
68
25
6
17
4
8
6
63
26
9
15
3
7
4
70
25
6
23
6
16
15
43
25
27
20
5
14
15
49
24
19
22
5
17
16
45
24
30
20
5
14
17
48
24
25
24
5
17
18
40
24
27
21
5
16
14
47
24
20
24
4
16
15
44
25
28
21
5
15
15
46
24
20
Standardized for age at baseline.
* Ql = quintile 1; 05 = quintile 5.
' Adjusted to total energy intake, by regression analysis.
• The percent age of cases with previous negative endoscopies in the three study populations was 26%, 34% and 16% respectively (see text).
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Among the men, screening was the indication for endoscopy in 53% of cases and 67%
of the controls; among the women, 33% of cases had endoscopy for screening,
compared to 46% of the controls.
Bleeding, occult blood and family history were more important among male cases
(21% vs. 15%; 9% vs. 3%, 11% vs. 7%, respectively) and female cases (37% vs. 22%;
7% vs. 4%, 19% vs. 13%, respectively). In multivariate models, indicator variables for
previous endoscopies, indication for endoscopy, body mass index, alcohol, folate,
dietary fiber and saturated fat intake were included. Physical activity was not
significantly related to the risk in men or women and was not included in multivariate
analyses. The mean size of polyps in both men and women was 1.0 centimeter.
The median intakes of calcium in men, adjusted to 2,000 kcal/day, ranged from 560
mg/day in the lowest quintile to 1,500 mg/day in the highest. In women, based on the
1980 questionnaire, the quintiles of median total calcium intake, adjusted to 1,600
kcal/day, ranged from 400 to 1,160 mg/day, whereas the quintiles of median intake
based on the extended 1984 questionnaire (which included specific questions on
calcium supplements) were comparable to those of men: 480-1,550 mg/day.
The total energy-adjusted calcium intake was not associated with the risk for
colorectal adenoma in men or women (relative risk (RR), highest vs. lowest quintile
of intake: men, 0.91,95% confidence interval (CI) 0.63-1.32; women, 1984-1988, 1.00,
95% CI = 0.68-1.46; women, 1980-1988, 0.94, 95% CI = 0.66-1.33). This finding
persisted after potentially confounding variables in further multivariate models were
controlled for (Table 3.2) and after stratification (based on tertiles) by saturated fat
intake, although a modest non-significant inverse association was suggested at higher
intakes of saturated fat (RR for high calcium/high fat vs. low calcium/high fat: men,
0.80, 95% CI = 0.49-1.29; women, 0.79, 95% CI = 0.49-1.25; RR for high calcium/low
fat vs. low calcium/low fat; men, 1.17, 95% CI = 0.71-1.93; women, 0.95, 95% CI =
0.56-2.86).
Dietary calcium (excluding supplement use) was also unrelated to the risk for
adenoma after age, total energy and family history were controlled for (RR, highest vs.
lowest quintile of dietary calcium intake, men, 0.90, 95% CI = 0.63-1.28; women,
1984-1988, 1.05, 95% CI = 0.71-1.55; women, 1980-1988, 0.98, 95% CI = 0.69-1.39),
and in further multivariate models (Table 3.2). Neither calcium from dairy nor from
non-dairy sources was related to adenoma risk (data not shown).
The calcium/phosphorus ratio was not related to polyp risk (RR adjusting to
potentially confounding variables for the highest vs. lowest quintile of this ratio: men,
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1.21, 95% CI = 0.84-1.74; women, 1.01, 9 5 % CI = 0.71-1.44), nor was there any
evidence of effect modification of calcium by level of phosphorus intake.
Higher intake of calcium was non-significantly inversely related to the risk for
adenoma among men in the lowest tertile of vitamin D intake (RR = 0.52, 9 5 % CI =
0.22-1.21, for high vs. low tertile of calcium) but no such association existed in women
(RR = 1.10, 9 5 % CI = 0.55-2.17). , . •.,«,.•-
Table 3.2 Relative risk' of colorectal adenoma among men and women, by quintiles of calcium
intake and vitamin D intake: The Health Professionals Follow-up Study (HPFS) and
The Nurses' Health Study (NHS).
HPFS, 1986-1990
Study population
NHS, 1984-1988 NHS, 1980-1988
Total Dietary Total Dietary Total Dietary
Quintile
l(ref)
2
3
4
5
95% CI* Q5
vs. Ql*
Trend p'
Vitamin D
Quintile
l(ref)
2
3
4
5
95% CI Q5
vs. Ql
Trend p*
1,00
1.36
1.41
1.33
1.13
0.76-1.66
0.98
Total
1.00
0.%
0.83
0.68
1.29
0.87-1.93
0.32
1.00
0.98
1.10
1.21
1.01
0.70-1.46
0.77
Dietary
1.00
0.90
1.00
0.78
1.05
0.74-1.49
0.82
1.00
0.91
1.29
1.15
1.16
0.78-1.72
0.37
Total
1.00
0.89
0.91
0.82
1.04
0.65-1.67
0.86
1.00
1.19
1.01
1.59
1.18
0.79-1.78
0.27
Dietary
.00
0.92
0.80
0.80
1.09
0.75-1.58
0.64
1.00
1.04
1.49
1.13
1.17
0.81-1.69
0.47
Total
1.00
1.09
0.80
0.88
0.68
0.41-1.13
0.09
1.00
1.07
1.50
1.11
1.21
0.84-1.74
0.42
Dietary
1.00
0.86
1.07
0.90
0.97
0.68-1.38
0.93
Adjusted for age, total energy intake, body mass index, alcohol consumption, folate, saturated
fat and fiber intake, indications for endoscopy, history of endoscopy prior to the study period,
and family history in logistic regression analysis.
Cl = 95% confidence interval.
Energy-adjusted by regression analysis.
Test for trend calculated by using the median of each quintile of intake as a continuous
variable in logistic regression.
Table 3.3 Relative risk* of left colon and rectal adenoma among men and women, by quintiles
of energy-adjusted' calcium and vitamin D intake: The Health Professionals Follow-
up Study and The Nurses' Health Study (NHS).
Nutrient . . . . . . .
Tola/ ca/ciu/n isi/aAe
Quintile 1 (ref)
2
3
4
5
95% CI Q5 versus Ql*
Trend p*
To*/vi te»* D,>««te
Quintile 1 (reO
2
3
4
5
95% CI Q5 versus Ql
Trend p'
HPFS,
Left colon
(n=251)
1.00
1.25
1.15
1.22
1.02
0.66-1.58
0.86
Left colon
1.00
0.96
0.83
0.72
1.35
0.86-2.13
0.26
Study
1986-1990
Rectum
(n=80)
1.93
239
1.85
1.61
0.68-3.82
0.78
Rectum
1.00
0.95
0.86
0.58
1.00
0.44-2.26
0.82
population
NHS,
Left colon
(n=224)
1.00
0.91
1.52
1.17
1.33
0.85-2.08
0.15
Left colon
1.00
1.26
0.91
1.15
1.05
0.56-1.93
0.98
1980-1988 ' '"
Rectum
(n=126)
1.00
1.26
1.40
1.07
0.90
0.48-1.71
0.50
Rectum
1.00
0.86
0.67
0.54
0.30
0.13-0.71
0.005
Adjusted for age, total energy intake, body mass index, alcohol consumption, folate, saturated
fat and fiber intake, indications for endoscopy, history of endoscopy prior to the study period,
and family history in logistic regression analysis.
Adjusted by regression analysis.
CI, confidence interval.
Test for trend calculated by using the median of each quintile of intake as a continuous
variable in logistic regression.
Calcium intake was not associated with the risk for polyps of the left colon or the
rectum (Table 3.3) and no differences were observed between small and larger polyps
(Table 3.4). Calcium intake was not associated with risk for either prevalent or incident
cases in men (prevalent cases, RR = 1.11, 95% CI = 0.71-1.73; incident cases, RR
= 1.30, 95% CI = 0.57-2.94) and women (data not shown).
D
The median total energy-adjusted vitamin D intake, in men ranged from 125 to 851
IU/day between the first and fifth quintiles, vitamin D intake from dietary sources
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ranged from 101 to 470 IU/day. In women, the median total energy-adjusted intake
ranged from 61 to 653 IU/day in 1980 and from 87 to 682 IU/day in 1984; dietary
vitamin D ranged from 52 to 315 IU/day in 1980, and from 72 to 329 IU/day in 1984.
Table 3.4 Relative risk' of small (< 1 cm) and large (s 1 cm) adenoma among men and women,
by quintiles of energy-adjusted* calcium and vitamin D intake: The Health
Professionals Follow-up Study (HPFS) and The Nurses' Health Study (NHS).
Nutrient
Study population
HPFS, 1986-1990 NHS, 1980-1988
rota/ ca/ciwm (>i/a/te
Quintile 1 (ref)
2
3
4
5
95% CI Q5 versus Ql*
Trend p'
Small
(n=151)
1.00
1.11
1.18
1.13
1.22
0.72-2.09
0.51
Large
(n=128)
1.00
1.73
1.82
1.40
1.16
0.61-2.22
0.72
Small
(n=173)
1.00
0.91
1.71
1.24
1.05
0.62-1.79
0.75
Large
(n=145)
1.00
1.16
1.14
1.13
1.26
0.72-2.19
0.49
Quintile 1 (rcf)
2
3
4
5
95% CI Q5 versus Ql
Trend p*
Small Urge Small Large
1.00
0.77
0.83
0.57
1.05
0.59-1.89
0.94
1.00
1.47
1.01
0.89
1.67
0.87-3.22
0.36
1.00
1.22
1.04
0.87
0.65
0.31-1.34
0.15
1.00
1.04
0.68
1.02
0.85
0.39-1.83
0.71
Adjusted for age, total energy intake, body mass index, alcohol consumption, folatc, saturated
fat and fiber intake, indications for endoscopy, history of endoscopy prior to the study period,
and family history in logistic regression analysis.
Adjusted by regression analysis.
CI = confidence interval.
' Test for trend calculated by using the median of each quintile of intake as a continuous
variable in logistic regression.
'
When age, energy intake and family history were adjusted for, a slight inverse, non-
significant association for energy-adjusted vitamin D intake was observed in men
(RR = 0.85, 95% CI = 0.61-1.19). In multivariate analysis, this association disappeared
(Table 3.2). In the 1984-1988 follow-up among women, a similar lack of association
was observed (Table 3.2). In the 1980-1988 follow-up among women, total vitamin D
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intake was inversely associated with the risk of adenoma (RR = 0.61, 95% CI =
0.43-0.87, p = 0.002), when age, total energy intake and family history were adjusted
for. This association did not remain significant in multivariate analysis (Table 3.2),
which included folate intake. The Pearson correlation between folate and vitamin D
intake in this cohort was 0.58." No clear trend with duration of multivitamin use was
evident.
The inverse association with total vitamin D intake among women in the 1980-1988
follow-up was significant for rectal adenomas (Table 3.3), for which an inverse
association with dietary vitamin D intake was observed as well (RR highest vs. lowest
quintile = 0.64, 95% CI = 0.35-1.17). No important differences were observed between
cases with large polyps versus those with small ones (Table 3.4) or between prevalent
and incident cases in men (prevalent cases, RR = 1.09, 95% CI = 0.68-1.76;
incident cases, RR = 2.07, 95% CI = 0.96-4.46) or women in the 1984-1988 follow-up
(data not shown). The apparent inverse association with vitamin D in the 1980-1988
follow-up was only observed in women who had not previously undergone endoscopy
(prevalent cases, RR = 0.53, 95% CI = 0.30-0.93; incident cases, RR = 2.19, 95% CI
= 0.64-7.53). However, in this follow-up period, the number of incident cases (16%)
was too small for drawing firm conclusions.
Dairy prorfw
After 4 years of follow-up, no association was found between the consumption of
whole milk or low-fat or skim milk and the risk for colorectal adenoma in men or
women (Table 3.5). In the 1980-1988 follow-up, low-fat or skim milk was inversely,
although not significantly, related to the risk for adenoma (RR = 0.87, Table 3.5).
The fermented dairy products (yogurt, sour cream, cottage cheese, cream cheese and
other cheese) combined either by calcium content (data not shown) or by the weight
of the normal portion size were not associated with the risk for adenoma in men (Table
3.5). For women in the 1984-1988 and 1980-1988 follow-ups, a nonsignificant inverse
association was observed. Adjusting for saturated fat intake did not change these
findings appreciably.
For specific fermented dairy products an inverse nonsignificant association was
observed for yogurt in men and women (RR for consumption of 1 cup more than four
times per week vs. almost never: men, 0.66; 95% CI = 0.28-1.46, trend p = 0.07;
women, 1984-1988, 0.85, 95% CI = 0.43-1.70, trend p = 0.10; women, 1980-1988,
0.60, 95% CI = 0.30-1.18 trend p = 0.11).
Among men, this association became weaker when saturated fat intake was adjusted
for (RR for consumption of 1 cup more than four times per week vs. almost
never = 0.70,95% CI = 0.31-1.62, trend p = 0.19) and it further diminished controlling
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for other potential confounders (RR for consumption of 1 cup more than 4 times per
week vs. almost never = 0.89, 95% CI = 0.39-2.07, trend p = 0.63). Among men an
inverse association with sour cream consumption was observed (RR for consumption
of 1 tablespoon more than once per week vs. almost never = 0.67, 95% CI = 0.37-
1.22), and this remained after adjustment for saturated fat intake (RR = 0.61, 95% CI
= 0.33-1.11, trend p = 0.06) and other potential confounders (RR for consumption
more than once a week vs. never = 0.62, 95% CI = 0.34-1.13, trend p = 0.07).
Sour cream consumption was not associated with risk in women in the 1984-1988
follow-up (RR for consumption of 1 tablespoon more than once per week vs.
never = 0.88, 95% CI = 0.48-1.61, trend p = 0.54). In 1980 the questionnaire did not
include this product. Hard cheese, a fermented product with a high fat content was
positively associated with the risk of colorectal polyps in men (RR for consumption
of 1 slice or 1 ounce serving more then 4 times a week vs. never = 1.45 (Table 3.5).
After adjustment for saturated fat intake, this association diminished (RR = 1.28, Table
3.5). Adjusting for other possible confounders did not materially affect this. The
positive association with hard cheese was not observed for women in the 1984-1988
follow-up (RR = 1.16, Table 3.5), nor those in the 1980-1988 follow-up (RR = 0.91,
Table 3.5). The consumption of cottage cheese and cream cheese was not related to
adenoma risk in men and women (data not shown).
Discussion
These prospective data do not support an important association of calcium or milk
intake with the occurrence of colorectal adenomas. Some slight support for the
hypothesis that vitamin D intake is protective against rectal adenoma is provided for
women using the 1980 questionnaire, but no effect of vitamin D on adenoma risk was
observed among men and in the 1984-1988 follow-up among women.
Most studies on calcium or milk intake and colorectal cancer development examined
the ultimate disease and not colorectal adenomas. If calcium indeed influences the cell
proliferation of colonie epithelium,"' the failure to find an inverse association with
cancer could be due to a long time period required for the development of cancer. Our
analyses do not suggest an effect of calcium on adenoma development or progression,
as no differences between small and larger adenomas were observed. Our findings on
calcium and milk intake are consistent with a hospital-based case-control study" on
adenomas (RR for calcium, highest versus lowest quartile = 1.28; RR for milk, highest
versus lowest quartile = 0.90).^
Table 3.5 Relative Risk' of colorectal adenoma among men and women, by categories of dairy product consumption: The Health Professionals
Follow-up Study (HPFS) and The Nursus' Health Study (NHS).
Dairy product
Milk
(whole)
Milk (skim/low
fat)
Fermented dairy
products*
Category' of consumption
95% CI* highest vs. lowest
Trend p'
Category' of consumption
95% CI highest vs. lowest
Trend p
Category' of consumption
95% CI highest vs. lowest
Trend p
1 (ref)
2
3
4
5
intake
1 (ref)
2
3
4
5
intake
Href)
2
3
4
5
intake
HPFS,
RR'
1.00
1.14
1.12
0.99
0.94
0.38-2.34
0.88
1.00
0.94
1.09
0.91
1.02
0.70-1.49
0.71
1.00
1.18
1.44
1.39
1.10
0.75-1.62
0.90
1986-1990
RR*
1.00
1.07
1.00
0.86
0.75
0.29-1.91
0.51
1.00
0.98
1.14
0.97
1.06
0.72-1.54
0.93
1 .(X)
1.14
1.34
1.33
1.06
0.72-1.57
0.85
Study
NHS,
RR"
1.00
1.10
1.31
0.99
1.61
0.69-3.76
0.25
1.00
0.93
1.21
0.93
1.09
0.73-1.63
0.98
1.00
0.95
0.88
0.89
0.75
0.51-1.11
0.16
population
1984-1988
RR*
1.00
1.10
1.30
1.00
1.70
0.71-4.03
0.23
1.00
0.93
1.20
0.93
1.09
0.73-1.63
0.96
1.00
0.94
0.87
0.88
0.75
0.51-1.11
0.17
NHS,
RR*
1.00
0.60
1.06
0.92
1.46
0.82-2.57
0.61
1.00
0.72
0.73
0.79
0.87
0.50-1.50
0.18
1.00
0.98
1.04
1.06
0.87
0.62-1.23
0.39
1980-1988
RR*
1.00
0.59
1.05
0.89
1.35
0.76-2.41
0.88
1.00
0.73
•. 0.75
0.81
0.91
0.63-1.30
0.29
1.00
0.97
1.03
1.06
0.89
0.63-1.25
0.50
Hard cheese Category" of consumption 1 (ref) 1.00 1.00 1.00 1.00 1.00 1.00
2 0.91 0.88 0.99 0.97 1.23 1.23
3 1.32 1.22 0.98 0.95 0.94 j 0.93
: 4 1.45 1.28 0.85 0.81 1.08 ; 1.04
5 - - 1.16 1.16 0.91 0.81
95% CI highest vs. lowest intake 1.02-2.05 0.88-1.86 0.51-2.63 0.49-2.75 0.45-1.83: 0.40-1.67
Trend p 0.03 0.24 0.48 0.38 0.87 0.65
" Adjusted for age, total energy and family history in logistic regression.
* CI = confidence interval.
* Adjusted for age, total energy, family history and saturated fat intake.
* Frequency of using one 8 oz glass: 1 = almost never; 2 = 1-4 per month (men), 1-3 times per month (women); 3 = 2-4 times per week (men), 1-4
per week (women); 4 = 5-7 times per week; 5 = more then once per day.
' Using consumption frequency as a continuous variable in logistic regression analysis.
' Median of intake (g/day): men: 1=4; 2=14; 3=27; 4=46; 5=111; women 1980(1984): 1 = 10(10); 2=20(21); 3= 36(34); 4=59(60); 5=134(129).
* Yogurt, sour cream, cream cheese, cottage cheese, hard cheese (American, Cheddar etc.).
" Frequency of using 1 slice or 1 oz serving: 1 = less then 3 times per month; 2 = once per week; 3 = 2-4 times per week; 4 = more then 4 times
per week (men), 5-7 times per week (women), 5 = more then once per day (women).
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Moreover, in a screening-based case-control study of colorectal adenomas, no
association was observed (or was not presented).**
Previous epidemiologic studies focusing on colorectal cancer and milk consumption
or calcium intake have not been conclusive. A population-based case-control study in
Utah suggests a significant inverse association between calcium and dairy products and
colorectal cancer risk: men and women in the upper quartile of intake had half the risk
of those in the lowest quartile." A non-significant inverse association between milk
consumption and risk of colon cancer was observed among Seventh Day Adventists
in the United States," while other case-control studies do not support an inverse
association with calcium and/or milk consumption.'*'"
In a prospective study on colorectal cancer among 11,888 residents of a retirement
community in California, that used a self-administered food frequency questionnaire
listing 56 foods or food groups 126 incident cases were confirmed after 4 years of
follow-up."* In this study, a slight, but not significant association with calcium intake
was observed (RR for men, highest vs. lowest tertile = 0.86, 95% CI = 0.4-1.7).
One prospective study, using 28-day dietary histories suggested a significant inverse
association between calcium and the risk for colorectal cancer (49 cases) among 1,954
male employees of the Western Electric Company." Based on the results of this study
and the Utah case-control study, Garland and co-workers suggest a linear dose-response
relation between the intake of 700-1,200 mg of calcium per day and colon cancer risk.
They hypothesize a very low incidence for calcium intake of 1,800 mg/day in men and
1,500 mg/day in women." According to the calculations of Newmark et al.', a calcium
intake of 1,500 mg/day or more is necessary for individuals with diets high in fat (150
g/day), and phosphate (1,500 mg/day), to neutralize the average fatty acid and bile-acid
concentration in the bowel. In our studies, 11% of the male population had an intake
of 1,500 mg/day or more, and 4% of the female population had a daily intake of 1,500
mg/day or more in 1980, compared to 15% in 1984 (calcium-containing supplements
were not included on the 1980 questionnaire). A substantial proportion of participants
in our studies should have been consuming an adequate amount of calcium to
experience the biologic effects, especially since fat intake was lower than used in the
calculations of Newmark et al. (mean, 69 g/day in women and 80 g/day in men).'""™
The failure to demonstrate an association with calcium intake may be explained by
the relatively low intake of saturated fat and high intake of dietary fiber among men
in the HPFS compared to the general male population.** However, the association with
calcium did not differ at different levels of saturated fat or dietary fiber intake. Neither
was the calcium/phosphorus ratio associated with adenoma risk.
In a cohort of Hawaiian-Japanese men, total calcium intake, estimated using 24-hour
recalls, was not related to colorectal cancer on the whole,''*"' but an inverse association
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was observed for sigmoid colon cancer.'* We did not observe a difference of the effect
of calcium between subsites among men or women. Alternatively, the proliferative
effect of fatty acids and bile acids may be especially important for the right side of the
colon." If calcium binds these substances and thereby reduces the risk of colon cancer,
this protective effect may be most important for the caecum and ascending colon. An
effect on right-sided polyp risk could not be assessed in our study.
A possible protective effect of vitamin D was initially suggested by the data for the
women in the 1980-1988 follow-up, but could not be confirmed during the 1984-88
follow-up of the women or the 4-year follow-up of the men. Latency time did not
explain this difference: when the 8-year follow-up using the 1980 questionnaire was
separated into two 4-year periods, the inverse association with total vitamin D intake
remained in both periods. The apparent protective effect among women during the
1980-1988 follow-up seemed to be mainly attributable to multivitamin supplements
containing vitamin D. The 1980 version of the questionnaire included questions on
multivitamin use (dose, frequency, brand name, and duration), but no separate
questions on the intake of calcium or vitamin D supplements. However, the use of
multivitamins contributed substantially to vitamin D intake. The observed association
with total vitamin D intake may be difficult to interpret because of the intercorrelations
with other vitamins and minerals in multivitamin supplements that include folate." As
diet is probably measured closer to the onset of disease in women who did undergo
endoscopy before the study period, a stronger association with vitamin D intake would
have been expected. This was not confirmed by our findings; the association with
vitamin D intake was stronger among 'prevalent' cases. (Note: this study addresses
dietary and supplemental intake of vitamin D, and does not take sunlight exposure into
account).
In the Western Electric cohort, a dietary intake of more than 3.75 /*g (150 IU/day)
of vitamin D per day was associated with a 50% reduction in the incidence of
colorectal cancer in men.'^ In a prospective nested case-control study of 8,006
Hawaiian-Japanese men (159 cases) using a 24-hour recall method, a slight negative
association with rectal cancer risk was observed."
The intake of fermented dairy products as a single food group did not seem to be
related to the risk for colorectal adenomas. The median of intake in the highest quintile
was 111 g/day for men and 128 g/day for women using the 1986 and 1984
questionnaire, respectively. This contrasts with intakes of 225 g/day or more in a Dutch
case-control study in which fermented dairy products were seen to have a protective
effect against breast cancer.^* Thus, the limited range of intake in our population may
have reduced the power to detect the hypothesized association with fermented products.
Combining fermented products into one food group has disadvantages, as the products
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differ in their fat content, strains of microorganisms and enzymes. Different
microorganisms might have different effects on the bowel flora or immunocompetent
cells in the colon mucosa.** Analyses using single food items were limited by the large
number of participants who reported infrequent consumption of particular products and
the restricted range of intake.
In summary, these data do not support an inverse association between calcium intake
and the occurrence of adenomatous polyps in men and women. The slight inverse
association with vitamin D observed in only one of the two data sets of women was
mainly attributable to the use of vitamin supplements that include other potentially
protective components such as folate," and should therefore be interpreted with
considerable caution. However, the observation of a stronger association of rectal
polyps with vitamin D from both supplements and diet in women suggests that further
investigation may be useful. These data generally do not support the existence of other
factors in dairy products protective against colorectal adenoma. However, they do not
exclude an effect of higher levels of intake of dairy products, nor do they exclude an
effect in the proximal colon. In addition, further study is required to examine the
potential influences of dairy products on later stages of carcinogenesis.
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Chapter 4
Design, conduct and validity of the case-control study
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Extended abstract )
Since selection bias is an inherent concern in case-control studies, this chapter
concentrates on recruitment of cases and controls, and discusses its implications
regarding internal and external validity. The different steps in the recruitment
procedures are evaluated, which might be of special interest to those intending to
conduct a case-control study on cancer in the Netherlands. Furthermore, the
collection and validity of the dietary data are discussed and some issues relevant to
potential information bias are evaluated.
Case
Recruitment of cases was planned to cover two and a half years, in which dietary
history data of 250 cases (ICD-0 153) and 250 age- and sex- stratified controls
would be gathered in the catchment area of the Comprehensive Cancer Centre
Middle Netherlands. Cases were invited by surgeons in general hospitals covering
the area. The cancer registry was used as a check of completeness and provided
additional clinical and pathological information. In the first year of study conduct,
two major hospitals in the study area appeared to be non-cooperative and invitation
and participation rates were less than expected. Therefore, recruitment of cases was
extended by half a year to a period of three years and two additional hospitals in
the catchment area of the Comprehensive Cancer Centre Eastern Netherlands were
included.
To check whether invitation and participation of colon cancer cases were subject
to selection, the database of the cancer registries was linked to the study database.
As complete registration by the cancer registries takes place 3 to 6 months after
diagnosis, linkage was conducted three months after the last case was interviewed.
Surprisingly, it appeared that about one third of the 478 invited cases did not fulfil
the eligibility criteria. Main reasons for ineligibility were non-colon tumors
(rectosigmoid, rectum) and secondary primaries.
Of the eligible subjects who got colon cancer during the study period, and who
were treated in cooperating hospitals, 47% were invited by their surgeon; more than
50% of these were invited after the surgeon had been notified by the cancer
registry. Of those invited, 72% replied, 69% filled out a short questionnaire and
60% were additionally willing to participate in the home interview. The 200 eligible
participants differed significantly from the total of eligible patients only according
to tumor status: subjects with Dukes' A and B tumors were overrepresented, since
these less severe cases were invited more frequently by their surgeons.
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To increase response of controls, efficiency of procedures and to match cases to
their source population, controls were recruited using the database of the general
practitioner (GP) of the case interviewed. Of the GP-mediated controls invited, 79%
replied, 75% filled out the short questionnaire, and 57% were willing to be
interviewed. The 259 eligible participants did not differ with respect to age and
gender from those invited, which resembled the distribution among the cases.
Participants lived more frequently in urban areas and were more often privately
insured than the non-participants. The proportion of privately insured (38%) closely
resembled the proportion in the general population in 1992 (32%) according to the
Dutch Central Bureau of Statistics.
To study whether the GP-mediated procedure of control recruitment did indeed
increase response, but introduced some biases, demographic characteristics and
dietary habits of GP controls living in urban areas (n = 249) were compared with an
age-stratified sample (n = 301) drawn from municipal registries of four
representative towns. Response of the urban GP-mediated controls was higher than
that of the municipal controls (78% vs. 71%). GP-mediated and municipal controls
did not differ in frequency of visiting their GP. The urban controls recruited by
these procedures differed in proportion of privately insured (GP-mediated 36%,
municipality-mediated 57%), in the proportion of men (54% vs. 44%) and in intake
of fermented dairy products (in highest category of intake 29% vs. 37%).
Non-response
With a short questionnaire briefly inquiring about dietary patterns, it was planned to
gain information on habits of non-responders, i.e. those who did not participate in
the interview. However, only 23% of the cases not interviewed and 42% of the non-
participating controls completed the questionnaire. Non-participating cases who
filled out the short questionnaire were more frequently female and consumed more
fermented dairy products than interviewed cases. Non-participating controls who
completed the short questionnaire did not differ in demographic or medical factors
nor in dietary patterns. Unfortunately, firm conclusions cannot be drawn from these
observations since those non-participants who completed the questionnaire may not
be representative of the total of non-responders.
Co//ec/j'on anc/ va/ùftry o/ d/efary /w/afce
The structured dietary history questionnaire was based on the validated
questionnaire used in a previous case-control study on breast cancer. The part
assessing the consumption of dairy products was extended and additional cross-
checks on the internal consistency of the frequency of various meal components
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with the total meal pattern were implemented. ••••••• • '
Interviewing was conducted by seven dieticians who interviewed a similar
number of cases and controls. No important differences were observed between
interviewers.
Each retrospective study may be prone to recall bias, which might differ between
cases and controls. As it is expected that cases may generally overestimate their
dietary intake, it is very important to adjust nutrient intakes for total energy intake
in the data analyses. Since the participants were unaware of the hypothesis tested
and dairy products have a relatively positive health-image, it is unlikely that cases
have systematically over- or underestimated their dairy product consumption.
The foregoing might have implications for internal and external validity.
Internal validity implies validity of inference for the study subjects themselves. A
loss of power of 6% is due to the fact that about 30% of the orginally interviewed
cases turned out not to be eligible for the study. Still the power to detect an odds
ratio (OR) of 0.5, assuming a = 0.05 two-sided and p = 0.1, will be ca. 80% when
200 cases and 259 controls are included in the analyses. For reasons of efficiency,
cases who were 75 years old at diagnosis and 76 years old when interviewed will
be included in the study.
Moreover, since the definition of rectosigmoid might differ between clinicians and
the cancer registries, analyses may be conducted including as well as excluding the
28 assumed rectosigmoid cases.
The fact that participating cases have a better prognosis than non-participants may
have a positive effect on the validity of the dietary data. No association between
tumor status and the consumption of fermented dairy products was observed, which
implies that the inclusion of cases with a relatively better prognosis in the study is
not likely to influence the results importantly.
The consumption of fermented dairy products might differ between participating
and non-participating cases and between participating and non-participating controls
in a different way. Although the data must be interpreted with considerable caution
due to the small group of non-participating cases who filled out the short non-
response questionnaire, the consumption of fermented dairy products may be lower
for the participating cases than for the total case group. Although the difference was
not significant, participating controls consumed fermented dairy products more
frequently than those only filling out the non-response questionnaire. The possible
selection of cases and controls will strenghten the hypothesized inverse association.
As a consequence, when a significant inverse association will be observed, one
should be cautious interpreting the results.
64
Controls recruited via municipal registries appear to be less representative of the
population at large than controls recruited via the GP of the cases. Using municipal
controls might erroneously strengthen the potential inverse association.
External validity or the generalizability of the study results is associated with the
internal validity of the study. Given the data presented, the internal validity of this
study is thought to be appropriate. The results of the study will be applicable to less
severe colon cancer cases and may be extended to more severe cases since no
association was observed between Dukes' status and fermented dairy product
consumption or calcium intake.
In conclusion, the results of this case-control study are not likely to be strongly
influenced by selection or information bias, and the choice for GP controls rather
than municipal controls has beneficially affected the validity of the study.
Study population
Principles
o/ cases am/ co/i/ro/s
Cases were defined as subjects with newly diagnosed adenocarcinoma of the colon
(ICD-0 153). Cases and controls were Dutch-speaking western Europeans, without a
history of cancer (excluding non-melanoma skin cancer), who were 75 years old or
younger. Persons with inflammatory bowel diseases, such as ulcerative colitis or
Crohn's disease, were excluded from this study. The control group closely
resembled the case group in age and gender distribution and resided in the same
study area.
The study population was recruited from the central and eastern parts of the
Netherlands, the catchment areas of the Comprehensive Cancer Centres Middle
Netherlands and Eastern Netherlands respectively.
size
Study size is determined by power considerations. In Table 4.1 study sizes and the
related power to detect a possible association are presented. According to the
literature, assuming a linear dose-response relationship between calcium and the risk
of colon cancer in the United States, an intake per day of 1500 mg in men and
1800 mg in women may be related to a decrease in risk of 50%.' An odds ratio
(OR) of 0.5 between the highest and lowest quartile of intake, corresponding with
an intake of more than 1500 mg compared to less than 500 mg per day in the
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Netherlands, can be detected with a power of 86% (a = 0.05) when 250 cases and
250 controls are included in the study.
Table 4.1 Study size and statistical power to detect an association.*
Cases „ Controls Power for OR = 0.5
Q4 versus Ql '
53%
64%
68%
•••• 77%
'" . 79%
-- , 83%
100
125
150
175
200
225
250
a = 5 % (one-sided).
100
125
150
- 175
200
225
250
Based on cancer registry incidence data of 1985-1989, about 200 cases with
adenocarcinoma of the colon, meeting the inclusion criteria, can be expected
annually in the catchment area of the Comprehensive Cancer Center Middle
Netherlands. Given a 80% cooperation rate of surgeons, a 80% invitation rate and a
80% response rate, which were estimated from a previous case-control study on
breast cancer in the Netherlands/ a study period of two and half years was
considered to yield the required number of subjects.
The actual recruitment of cases in time is presented in Figure 4.1. In August
1990, recruitment of cases started in 13 of the 14 hospitals in the central part of the
Netherlands. Since case recruitment started slowly and organizational difficulties
were experienced in two major hospitals, data collection was extended to two
important hospitals in the region of the Comprehensive Cancer Registry Eastern
Netherlands by July 1991. The cooperation of surgeons (81%) was comparable to
the previous breast cancer study, but the actual invitation rate of cases was far
below the estimated 80%: 47% of the eligible cases were invited (see 'recruitment
of cases'). The former figure was probably too optimistic, since at the time the
breast cancer study was conducted, it could not be based on a formal cancer registry
yet. The lower response of the invited cases (60% as compared to 80%) (see
'recruitment of cases') may be due to the more direct relationship between colon
cancer and dietary patterns or the higher mean age of the participants.
Thus, to be able to include 250 cases in the study with these invitation and
response rates, the recruitment period was extended to three years.
Figure 4.1 Recruitment of cases in time.
Recruitment of cases
Procedures o/ case
To be able to approach as many eligible cases as possible, two complementary
procedures of case recruitment were applied (Figure 4.2).
According to the first procedure, surgeons identified patients meeting the eligibility
criteria, and gave them a letter of invitation during their stay in the hospital, shortly
after diagnosis. All cases seen by the surgeon were notified to the researchers;
demographic characteristics (gender, date of birth and place of residence) were
reported. If the patient was not invited for medical or psychological reasons, or
because the patient did not match the inclusion criteria, the reason for non-invitation
was recorded.
The second recruitment procedure was meant to identify cases possibly missed by
the first procedure because they were not invited by the surgeon. Demographic data
from the list of cases notified to the researchers were linked to the database of the
cancer registries involved. If an eligible case appeared not to have been invited in
the first procedure, the cancer registries notified the surgeons and asked to mail the
letter of invitation to the patient's home address or to invite the patient during the
first check up.
Design, conduct
Procedure 1 Procedure 2
Criteria OK?
ELIGIBLE
yes
Invitation
by specialist
no
Respons Reminder
Cancer registry
yes
Figure 4.2 Recruitment of cases by two complementary procedures.
The cooperation of the cancer registry in case recruitment appeared to be crucial
as 50% of those invited and 49% of the eligible interviewed cases were recruited
through this procedure (Figure 4.3).
number of cases
500 ,—
400 —
300 —
200 —
100 —
total invited invited eligibles participants
directly invited
via CR
239
239
152
180
103
97
Figure 4.3 Invitation and participation of cases according to recruitment procedure: by direct
invitation (procedure 1) or via Cancer Registry (procedure 2).
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Recruitment procedures appeared to differ among hospitals. In some hospitals, the
majority of the cases were asked to participate directly after surgery when they
were still in the hospital, without interference of the cancer registry, while other
hospitals relied mainly on the cancer registry procedure. Besides these differences in
procedures used, the actual rate of invitation differed among hospitals. In Figure
4.4. the cooperating hospitals are ordered according to number invited as a
proportion of those eligible. The invitation rates in the different hospitals varied
between 78% and 6%. Figure 4.4 shows that participation rates of cases varied
among hospitals as well, which might be explained by the different personal
approaches used by the surgeons and the different recruitment procedures used. Of
the eligible cases who were invited directly by the surgeon 68% (103/152)
participated, while the participation rate was 54% (97/180) for the cases invited
after interference of the cancer registry (Figure 4.3).
EH% eligible H % invited/eligible E£% parlicipaling/elig
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13
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Figure 4.4 Recruitment per hospital.
£%jfci/ify o/ mvj'fed cases
Figure 4.5 presents the relation between the study database and the cancer registry
Des/gn, conduct and a/ia/ysis
data, for different stages in recruitment. From August 1990 to August 1993, 2064
colon cancer cases were recorded by the Comprehensive Cancer Centres Middle and
Eastern Netherlands (Figure 4.5), of which 1412 were seen in cooperating hospitals.
Of these 1412 colon cancer patients, 677 (48%) met the inclusion criteria known by
the cancer registries (adenocarcinoma, 75 years or younger, no previous tumors),
and did not decease before they could be invited. Of these 677 eligible cases, 445
(66%) were reported to the research team during the study. During the recruitment
period, surgeons notified another 47 cases to the research team of which 36 seemed
to be eligible; these cases however did not appear in the cancer registry database.
This might be mainly due to the fact that comparison with the cancer registry
database took place three months after the last interview, while final registration
lasts until six months after surgery.
These facts explain why the number of participants (Figure 4.1) exceeds the
number of interviewed eligible cases (n = 200) in Figure 4.5.
During three years of recruitment, 478 patients were invited (Figure 4.1 and 4.3).
Unexpectedly, for the researchers as well as the cancer registries, 146 (31%) of
these cases did not meet the eligibility criteria. Most of these inéligibles were
identified through linkage to the cancer registries (87%), whereas 19 cases (13%)
were found to be ineligible during the home interview. The main reasons for
ineligibility were the site of the tumor (according to the cancer registries: 43
rectosigmoid, 41 rectum, 3 other sites outside the large bowel) and the fact that 36
colon tumors were secondary primaries. Further ineligibility resulted from the
malignancy grade or morphology of the tumor (7 tumors in situ, 4 metastasis of
other primaries, 2 non-adenomatous) or was related to non-tumor related criteria (7
cases older than 75, 1 did not speak Dutch, 2 were not western Europeans and 5
deceased before the interview could take place). As final registration of cases by the
cancer registry, including the more precise localization of the tumor, takes place six
months after surgery, these types of errors are difficult to prevent. After all, to
diminish recall bias and the number of deceased subjects, cases should have been
interviewed as soon as possible after diagnosis, which was before final registration
could take place.
It should be realized that the fact that ineligible cases were invited implies that
ineligible cases participated in the interview (n = 85), and the decision to exclude
them from data analysis would result in a loss of statistical power.
e and participation o/ cases
All invited cases were asked to return a reply form on which they could indicate
their (un)willingness to participate in the detailed interview at home (see 'Collection
and validity of the data'). The reply form included a short questionnaire inquiring
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about dietary patterns. Non-participants and participants in the home interview were
asked to complete the questionnaire to be able to define the non-response (see
'indicators of non-response').
number of cases
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Figure 4.5 Number of colon cancer cases in the study and in the databases of the cancer registries
(CR).
If an invited case replied to be willing to participate, the home interview took
place three to six months after diagnosis. Of the 322 invited eligibles, 240 (72%)
returned the reply form, 230 (69%) completed the short questionnaire, while 200
(60%) participated in the interview (Table 4.2).
in study only
in study and CR
in CR only
47
570
1494
47
570
842
36
445
232
9
191
With the exception of cases under 40 who were invited least frequently, numbers of
eligible colon cancer cases invited were inversely related to age (Table 4.2, first
column). Patients with Dukes' A or B tumors and those who underwent only an
operation were more likely to be invited than patients with Dukes' C or D tumors
or those who underwent a therapy other than an operation or had additional therapy
(e.g. radiation, chemotherapy). Invitation was not related to gender, degree of
urbanization (urban or rural) and tumor site (left- or right- sided) (Table 4.2).
Design, co/wfwcr and ana/ysis 71
Table 4.2 Response rates, stratified according to demographic variables, of eligible colon
cancer cases (n = 713).*
Overa// response
Demograp/u'c vaWaMes
age < 40 years
40-49
50-59
60-69
69-75
gender male
female
regionurban
rural
unknown*
Af erfica/ /ac/ors
tumor status
Dukes' A and B
Dukes' C and D
unknown*
therapy (%)
no therapy
operation
other (additional)
therapies
unknown*
tumor site (%)
right-sided
left-sided
unknown*
Invited'
(%) (n=332)
47
39
54
49
48
43
49
44
88
85
2
58
45 '
31
0
54
43*
32
50
47
35
Replied*
(%)
(n=240)
72
74
82
77
71
66
72
73
69
80
20
76
73
60
0
72
80
67
70
75
67
Filled out
short
questionnaire'
(%) (n=230)
96
100
100
98
94
93
96
96
97
96
0
96
95
97
0
95
100
97
94
97
100
Participated in
interview*
(%) (n=200)
87
82
86
92
86
87
93
81*
86
89
0
89
87
81
0
87
91
82
91
84
85
' invited as a percentage of eligible.
* replied as a percentage of invited.
' short questionnaire as a percentage of replied.
* interview as a percentage of short questionnaire.
*the category 'unknown' was not included in analyses of heterogeneity.
* heterogeneity in response rate (p < 0.05).
Additionally, Table 4.2 presents the response rates by demographic and medical
characteristics for those eligibles who returned the reply form (second column),
those who completed the short questionnaire (third column) and those who
eventually participated in the interview at home (fourth column).
Response rates were somewhat higher among younger persons (except for those
under 40 years) and among those living in rural areas.
Although response rates and the willingness to fill out the short 'non-response'
questionnaire did not differ between genders, men were more inclined to participate
in the interview.
Table 4.3 Distribution of demographic and medical characteristics of total eligible colon
cancer cases and those eligible cases participating in the home interview.
Variables
Colon
Total eligible
(n = 713)
8
9
19
36
29
cancer cases
Participants in
home interview
(n = 200)
7
12
22
36
24
age (%) < 40 years
40-49
50-59
60-69
69-76
gender (% male) 51 57
region (%)'
urban 64 60
rural 36 40
factors
tumor status (%)*
Dukes' A and B
Dukes' C and D
therapy (%)'
no therapy
operation only
other (additional) therapies
tumor site (%)*
right-sided
left-sided
* differs from non-participants (53%; p < 0.05), the category 'unknown' is not included in the
analyses of heterogeneity.
' unknown of total eligible: 47%.
* unknown 28% and 16% respectively.
' unknown 23% and 14% respectively.
* unknown 12% and 9% respectively.
Tumor status, therapies and tumor site were not appreciably related to response
rates. Of course, one should realize that this may simply reflect the fact that the
surgeons had already limited their invitations to subjects who were in fair condition
57
43
2
80
19
47
53
64
36»
0
82
18
49
51
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and able to participate. . ?;,, n
For interpreting the relevance of the separate stages in selection identified above,
the initial and final distribution of demographic and medical characteristics is of
interest. The more frequent participation of less severe cases being the only
exception, the distribution of demographic and medical characteristics of the final
eligible cases participating in the interview did not differ markedly from the initial
eligibles (Table 4.3).
This implies that, relatively, more healthy cases participated in the interview.
However, since illness, radiotherapy and chemotherapy might influence dietary
patterns and thus might hamper the recall of habitual diet, excluding cases with a
worse prognosis is likely to favour the quality of the interview data.
Of course, the crucial issue for inference from the case-control study is whether
the distribution of the exposures of interest, fermented milk consumption and
calcium intake, is altered by the subsequent selection steps. Although this cannot be
studied throughout all subsequent steps, we intended to obtain limited dietary data
from all cases using a short questionnaire. A similar attempt was made among non-
participating controls. Results of both groups are described in 'Indicators of non-
response'.
//np//canofls o/ case
Invitation and participation rates estimated in the planning of the study differed
from those actually observed; invitation and participation were both estimated to be
80% and turned out to be 47% and 60% respectively. Therefore the period in which
case recruitment took place had to be extended from 2Vi to 3 years and two
hospitals in the east part of the Netherlands were included.
Surprisingly, about one third of the interviewed cases did not meet the inclusion
criteria of the study. Instead of the planned power of 86%, an odds ratio of 50%
can be detected with a power of about 80% when 200 cases and 250 controls are
included in the study. For reasons of efficiency, cases who were 75 years old at
diagnosis and 76 years old when interviewed, were included in the study. Moreover,
since the definition of rectosigmoid might differ between clinicians and the cancer
registries,'' analyses were conducted including as well as excluding the 28 assumed
rectosigmoid cases.
Whether a patient was invited was related to tumor status and therapy.
Participating cases did not differ significantly in demographic factors from all cases
who could have been included in the study. As a result of differences in invitation
rates, participants had more Dukes' A or B tumors than the total group of eligibles,
which might benefit the quality of the exposure data. More severe cases might have
changed their diet as a result of the disease, which might make it more difficult to
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recall previous dietary patterns. Furthermore, nausea from chemotherapy, which
occurs more frequently among patients with Dukes' C and D tumors, might
influence both appetite and the ability to talk about food for two hours or more.
Recruitment of controls ;
In this study controls were sampled via the general practitioner of the interviewed
case. This procedure was used to increase response rate and efficiency and to ensure
a justifiable link to the source population. As observed in a previous case-control
study on breast cancer, sampling of controls from municipal population registries
has the disadvantage of relatively low response rates (55% among women).
Additionally, the latter sampling method has a practical disadvantage since the
source population of the cases is difficult to define before cases are recruited; this is
especially true since not all hospitals in a given area are willing or able to cooperate
in a study. Furthermore, the increased awareness of privacy regulations introduces
practical difficulties in sampling from municipal registries.
To investigate the advantages and disadvantages of this GP-mediated procedure as
compared to the municipal registry method, a age- and gender-stratified sample was
recruited from municipal registries of four representative towns.
Procedures /or co/7/ro/
Three persons of the same gender and approximately the same age (± 5 years) as
the case were randomly selected by the general practitioner's of the case. For each
case, the GP received a standardized form with three-letter strings, randomly
obtained from the local telephone directory to initiate the search for controls in his
or her own database; for each string, the first subject who matched the eligible
criteria was send a standard letter of invitation, including a reply form to the
investigator. After two weeks, each non-responder received a reminding letter. The
first or second responder was included in the study.
Since GPs often have separate databases for privately and non-privately insured
patients, they were asked to draw two non-privately insured and one privately
insured patients from their database(s), which resembles the ratio in the general
population.
Cooperar/ort o/genera/ pracf/f/oners
Of the 264 approached general practitioners (GPs), 67% were willing to cooperate.
If the GP refused cooperation a gender-matched control who resembled the patient
as much as possible concerning age, gender and urbanization grade and region was
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selected from controls sampled by other GPs. If not available (5%), a control
sampled from the municipal registry of the town involved was chosen.
GPs were asked to complete a short questionnaire inquiring about the way the
three control subjects were sampled; 100% replied and reported that they had
followed the sampling instructions.
o/ municipa/ regisfnes
The municipal registries of four suburban and two urban towns were invited to
draw a age-stratified sample of 50 to 100 inhabitants. The required number of
controls to be sampled from each five-year age category was calculated on the basis
of colon cancer incidence figures.
Each registry was willing to cooperate, but for budgetary reasons it was decided
to draw samples from three suburban and one urban town only. For privacy reasons,
the urban registry conducted the mailing themselves.
Parf/cipa/j"on o/ GP-wied/a/ed confro/s
Of the 520 GP-mediated controls invited, 79% returned the reply form (60% before
a reminding letter was sent), while 75% filled out the short questionnaire and 57%
was willing to participate in the interview. Age was related to response: persons
under 40 where more inclined to participate in the interview (Table 4.4). Men and
women did not differ in readiness to fill out the questionnaire, although women
tended to be more inclined to participate in the interview. Response rates were
higher in urban regions. From the 294 GP-mediated controls who were willing to be
interviewed, a subsample was selected which resembled the case-population as
closely as possible according to age, gender, region and urbanisation grade.
In total, 266 controls were interviewed. Of those interviewed, five did not meet
the inclusion criteria (3 not western European, 1 previous cancer and 1 Crohn's
disease) and one interview was not completed.
Of the 259 controls participating in the interview 95% were recruited through the
GP-mediated procedure, while 5% were sampled from municipal registries.
The age and gender distribution of the 259 eligible participating controls
resembled closely the distribution of those invited (Table 4.5). The participants were
likely to be more urban citizens and were more often privately insured. In
multivariate logistic regression analysis, with participation being the dependent
variable, both urbanization grade and health insurance contributed significantly to
the model.
The proportion of privately insured controls closely resembles the proportion in
the general population, which is about one third.
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Table 4.4 Response rates, stratified according
controls (n = 520).'
Overall response (%)
Demograp/ii'c van'aWes
age < 40 years
40-49
50-59
60-69
>69
gender male
female
region urban
rural
health insurance
private
non-private
unknown***
Replied' (%)
(n = 409)
79
89
73
77
79
82
78
80
82
73 *
82
76
100
to demographic
Filled out
short
questionnaire'
(%) (n = 389)
95
96
92
98
95
94
95
95
94
97
95
95
96
variables, of invited population
Willing to
participate in
interview'
(%) (n = 294)
76
91
72
79
75
7 0 *
74
77
77
74
79
74
86
Participated
in interview''
(%)
(n = 259)**
88
; w-ni-60
9 0 ' " ^ • ' ' • • ' •
86 •; N-.T. i-
« • •
88
88
90
85
90
88
100
heterogeneity in response (p < 0.05).
replied as a percentage of invited.
short questionnaire as a percentage of replied.
willing to participate as a percentage of short questionnaire.
participated as a percentage of willing to participate.
recruited via general practitioners.
95% recruited via general practioners, 5% sampled from municipal registries.
category 'unknown' not included in analyses of heterogeneity.
an*/ GP-medzared con/ro/s
Of the 424 invited controls sampled from municipal registries, 71% filled out the
short questionnaire as compared to 76% of the suburban and urban GP-mediated
controls. Table 4.6 presents the characteristics of municipal controls as compared to
suburban and urban GP-mediated controls. Selection might have occurred if GPs did
not adhere strictly to the protocol and were more prone to invite persons who
regularly visit their doctor. Consistent with the reported adherence to the sampling
protocol (see 'Cooperation of general practitioners'), the frequency of visits was
similar for GP-mediated and municipal controls (22% versus 25% more than twice
a year). Age, body mass index, gastro-intestinal complaints, changes of diet because
of gastro-intestinal complaints, the consumption of whole-wheat bread, meat and
unfermented dairy products did not differ appreciably between the groups of
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controls recruited via these different procedures. Men tended to be more willing to
cooperate when invited by their GP. Municipal controls who filled out the
questionnaire were more likely to be privately insured; the proportion of private
insured (57%) greatly exceeded the proportion in the general population (33%).
Table 4.5 Distribution of demographic characteristics of invited population controls* and the
actual eligible population controls participating in the home interview.
age (%)
gender
region
health
(%
(%
< 40 years
40-49
50-59
60-69
69-75
male)
urban)
insurance (% private)
Invited (n = 520)
5
12
25
38
20
54
62
34
Actual participants in
interview (n = 259)
5
11
26
40
19
53
66*
38**
* differs from non-participants (58%; p = 0.05).
** differs from non-participants (30%; p = 0.05).
* 95% recruited via the GP-mediated procedure, 5% sampled from municipal registries.
Fermented dairy products were consumed more frequently by the municipal
controls. After stratification for health insurance this difference was no longer
important. However, in multivariate analyses with type of control (GP-mediated or
municipal) being the dependent variable, gender, insurance and the consumption of
fermented dairy products contributed independently.
In summary, comparing the two procedures of control recruitment, the GP-
mediated procedure has two advantages: response of invited controls is slightly
higher and, more importantly, the distribution of privately insured people is
comparable to that in the general population. Since GPs adhered to the protocol and
the numbers of GP visits are similar for the controls recruited by both procedures,
no important selection of controls does seem to occur using the GP databases. It can
be concluded that the GP-mediated procedure is a reliable method for control
recruitment and that it might be preferable to the municipality method used in
previous studies.
o / co/ifro/
The participating controls were similar to those invited in age and gender, which
implies a close resemblance to the case group. Participating controls lived more
frequently in urban areas and were more often privately insured than the total group
of controls invited. As this might imply a higher socio-economic status of the
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participating controls, odds ratios were adjusted for socio-economic level, in data
analysis. ; > > r • ,• ;•• . > • - • V - • « < .,.--;.
As anticipated on, the response of urban GP-mediated controls was higher than
that of the municipal controls (Table 4.6). The controls recruited by these two
procedures differed in the proportion of men, proportion of privately insured people
and the consumption of fermented dairy products. According to the proportion of
men and those privately insured, the GP-mediated controls appear to resemble the
general population more closely.
Table 4.6 Characteristics of (sub)urban population controls recruited via different procedures
who completed the short questionnaire.
Variables Recruitment procedure
via general
practitioner
(n = 249)
via population
registry
(n = 301)
complete refusers (%)
short questionnaire (%)
varj'ab/es
age (years, mean ± SD)
gender (% male)
health insurance (% private)*
body mass index (mean ± SD)
visits to general practitioner
(% more than twice a year)"
gastro-intestinal complaints (% yes)
changes in diet because of
gastro-intestinal complaints (% yes)
Diefary
meat (% every day)
whole-wheat bread (% more than 5 slices per day)
dairy products (% in highest category)
fermented dairy products (% in highest category)
18
78
62 ± 10
54
36
25 ± 3
22
17
5
47
16
32
29
26
71
63 + 10
44
57
25 ± 4
25
16
9
50
17
40
37*
* p = 0.05.
* percent unknown: 4 in both categories.
** percent unknown: 13 and 7 respectively.
Indicators of non-response
The short 'non-response' questionnaire was completed by each case and control
participating in the home interview and by only 30 of 122 non-participating cases
and 95 of 226 controls not willing to participate. Thus, only a small fraction of the
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non-participants completed the questionnaire. Of the 30 eligible non-participating
cases, 13 refused participation for medical or psychological reasons, 10 did not
want to participate for unknown reasons, while 7 did not fill out the reply form at
all. Reasons for non-participation for the other 302 non-participants remain
unknown. ; r > • • • • • • • • • • • . , -
Table 4.7 Health indicators and dietary habits of those eligible colon cancer cases and
controls who only filled out the short questionnaire and those additionally
participating in the home interview.
Colon cancer cases Population controls
short home
questionnaire interview
only (n = 30) (n = 200)
short home
questionnaire interview
only (n = 95) (n = 259)
//ea/f/i i/u/i'cators
body mass index (mean ± SD)
gastro-intestinal complaints (%
yes)
dietary changes because of gastro-
intestinal complaints (% yes)
Dietary /lafrils
meat (% every day)
whole-wheat bread (% more than
5 slices a day)
dairy products* (% highest
category)
fermented milk (% highest
category)'
23 ± 4
37
17
57
7
40
53
25 ± 4
32
9
62
24
31
29»
25 ± 3
18
6
52
17
40
24
26 ± 4
16
9
45
19
35
30
excluding cheese.
* p < 0.05.
Of the 95 non-participating controls 1 deceased, 4 refused participation for
medical reasons, 6 replied not to have time to participate, while 79 did not give a
reason and 13 did not fill out the reply form. For the other 131 non-participants the
reasons for non-participation remain unknown as well.
Thus, it remains unknown to what extent the non-participants who filled out the
short questionnaire are representative of the total group of non-participants as far as
diet is concerned. Nevertheless, in the absence of other information, the above
comparison may suggest the direction of a potential selection in participation.
Table 4.7 presents the distribution of health indicators and relevant dietary habits
for those eligibles interviewed (200 cases and 259 controls) compared to those who
only filled out the short questionnaire.
80
Cases with gastro-intestinal complaints and those who said they had changed their
diet because of these complaints participated less frequently in the interview,
however this difference was not statistically significant (Table 4.7). Body mass
index, meat consumption and the use of dairy products were not strongly related to
participation in cases and controls, while case participants ate more whole-wheat
bread and less fermented dairy products (Table 4.7). Besides chance, these
differences might be explained by a higher socio-economic status of the
participating cases or by the fact that more male cases participated in the interview.
In data analysis, odds ratios were adjusted for gender and indicators of socio-
economic status.
The way in which the above findings bias study results depends not only on
cases, but also on the potential exposure-related selection among controls. Cases
participating in the interview consumed less fermented dairy products than the
eligible cases. Since, participating controls consumed fermented dairy products more
frequently, the odds ratio calculated from the data may be stronger than the
underlying true odds ratio.
4.2 Collection and validity of the data
Data collection involved a short questionnaire, a home interview and collection of
toenail clippings.
S/rorf
The short questionnaire was enclosed in the letter of invitation. This questionnaire
inquired about major dietary patterns and life-style variables of interest. The
objective of this short inquiry was to be able to compare those willing to participate
in the home interview with those not willing and thus to investigate if a certain
selection was introduced by non-response to the request for a home interview. The
same questionnaire was used to compare controls recruited by the GP-mediated
method and the municipal registry procedure.
//ewne
Participating cases and controls were interviewed at their homes by one of seven
trained dieticians. The questionnaire consisted of a dietary history part and questions
considering life-style, medical history and family history of colorectal cancer. The
home interview took about three hours per participant, two hours of which were
taken by the dietary history part.
The interview started with questions regarding special dietary regimens (e.g.
vegetarianism), diets, gastro-intestinal complaints and related dietary changes.
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It continued with a structured dietary history part inquiring about the consumption
of 289 food items from 19 food groups consumed in the preceding year. For cases
the year preceding complaints or diagnosis was asked for. The hierarchically
structured questionnaire was divided into five sections corresponding with the
national pattern and starting with the most intensive part: the main meal (appetizers,
main dishes), followed by breakfast and lunch, desserts, (non)alcoholic drinks and
snacks. To be able to estimate serving sizes, frequently used household utensils and
cups were measured.
Additionally, for products of special interest to this study, changes in the habitual
use as compared to five years earlier were asked for.
At the end of the interview, questions related to life-style (e.g. supplement use,
smoking habits, sunlight exposure) were asked together with questions on previous
or current illnesses, previous or current use of median and family history of
colorectal cancer. Furthermore, the participant was weighed.
To account for seasonal variation in food habits, cases and controls were
interviewed in the same season. To account for differences between interviewers,
each interviewer visited a similar number of cases and controls.
Food items were coded according to the Dutch National Food Table.' To
minimize errors, the dietary history questionnaire was entered into the computer
using a specially designed computer program which included range-checks and
cross-checks. For each food item default values for frequency of use, number of
servings, serving sizes and food code were pre-coded and could be skipped, copied
or changed when a different value was required. Checks on the internal consistency
of the frequency of consumption of various meal components with the total meal
pattern were conducted. When frequencies did not match, a correction factor was
automatically calculated and added to each item in the data file.
Besides the main hypothesis, other issues were planned to be studied, which
sometimes needed an extention or alteration of the original questionnaire. Not all of
the new additions turned out to be successful. Especially with the assessment of
height, physical activity and the combined consumption of fermented dairy products
and nitrate-rich foods practical difficulties were encountered.
In the beginning of the study, both height and weight of the participants were
determined. However, measuring height turned out not to be practically feasible in
the home interview and was therefore considered unreliable.
The section involving the assessment of physical activity was altered in the
general questionnaire on life-style. This part consisted of questions taken from a
validated questionnaire,'' but did not appear to be feasible in this case-control
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interview setting. Originally the physical activity questionnaire was designed to
inquire about current behaviour. In the case-control study it should refer to the
previous year and for cases to the period before diagnosis or complaints, which
could not be reliably answered by the participants. To our knowledge, no validated
questionnaire on physical activity based on a retrospective design was available
during the conduct of the study.
The combined use of fermented dairy products (cheese, buttermilk, yogurt) and
nitrate-rich vegetables was assessed in the original questionnaire. The questions
appeared too difficult to ask and to answer and were skipped from the
questionnaire.
Participants in the home interview were asked to collect toenails. It was originally
planned to analyse these toenails for selenium status. However, considering the
costs and the findings of recently conducted epidemiological studies, which did not
support the hypothesized inverse association between selenium and colon cancer,' it
was decided not to conduct such analyses.
Va/irf/fy o/ die/ary Jam and m/brmar/o/i
The structure of the dietary history questionnaire was similar to that used by van 't
Veer and co-workers in a previous case-control study on breast cancer." The internal
consistency checks and correction procedures are similar to those used in the breast
cancer case-control study and to those used in the semi-quantitative food frequency
questionnaire of the Netherlands Cohort Study on diet and cancer.^
Besides being interviewed with the dietary history questionnaire, 114 controls
who participated in the previous case-control study on breast cancer also filled out
the food frequency questionnaire used in the Netherlands Cohort Study.'" In the
cohort study the food frequency questionnaire was validated against a 3-day record
repeated three times.** With respect to macro- and micronutrients, the dietary history
was related to both the food frequency questionnaire and the dietary record.
Coefficients of correlation were similar for both comparisons.'"
To study whether the food-frequency questionnaire used in the cohort study could
be used in a case-control design, this questionnaire was additionally completed by
77 cases and 80 controls participating in the dietary history interview of our case-
control study. These data will be analysed at a later stage.
To assess significance of differences between interviewers two-way analysis of
variance was conducted. The difference in intake of energy and calcium (and
therefore dairy product consumption) between cases and controls did not differ
markedly between interviewers.
Total energy intake was significantly higher among cases, which is supported by
other case-control studies on colorectal cancer." This might suggest that a high
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energy intake increases the risk of colon cancer but, more likely, it might point to
the fact that cases overestimate their habitual intake. Both explanations, however,
require nutrient intakes to be adjusted for total energy intake in data analysis.
One case was excluded from the analysis since the interviewer evaluated the
dietary history data as unreliable and total energy intake exceeded 25,000 kJ.
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Fermented dairy products, dietary calcium and colon cancer:
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Abstract
To examine whether the consumption of fermented dairy products or the dietary
intake of calcium decreases colon cancer risk, a case-control study was conducted in
the Netherlands. Dietary patterns were assessed in detail among 232 cases and 259
controls (for cases before diagnosis or symptoms occurred) using a structured
dietary history questionnaire.
After adjustment for potential confounding variables, consumption of fermented
dairy products, hard cheese and unfermented dairy products was not significantly
associated with risk of colon cancer: an odds ratio (OR) of 1.1 (95% confidence
interval (CI) = 0.6-1.8) was found for individuals consuming more than one serving
of fermented dairy products per day as compared to those consuming less than 10%
of one serving a day. Adjustment for dietary calcium attenuated the associations.
Total dietary calcium was positively but non-significantly associated with colon
cancer risk after adjustment for age, gender, urbanization level and total energy
intake (OR highest vs. lowest quartile of intake = 1.4; 95% CI = 0.9-2.4).
Additional adjustment for a positive family history of colorectal cancer,
cholecystectomy and energy-adjusted intake of total fat, dietary fiber, vitamin C and
alcohol increased the association (OR highest vs. lowest quartile of intake = 1.8;
95% CI = 1.1-3.1). No differences were observed between calcium from fermented
and calcium from unfermented dairy sources.
The observed associations for fermented dairy products and dietary calcium
differed between men and women: positive significant associations were observed in
men, while in women non-significant inverse associations were found.
These results do not support the hypothesis that an increased intake of
commercially available, commonly used fermented dairy products or dietary
calcium decreases the risk of colon cancer.
dairy products, dietary ca/cin/n and co/on cancer
Introduction
Since colon cancer incidence and mortality are still relatively high in westernized
countries and new treatment strategies are not expected to be available in the near
future, preventive measures seem to be essential in controlling this disease. Minor
changes in dietary patterns might offer substantial possibilities for prevention.'
Already in 1908, Eli Metchnikoff propagated an increased consumption of
fermented foods, especially milk products such as yogurt, cultured milk and cheese,
to suppress colon carcinogenesis." Recent animal and human experimental studies
support the idea that certain strains of lactic acid bacteria might decrease colon
cancer risk.^ Several potential mechanisms of action have been suggested: decrease
in activity of faecal enzymes thought to be involved in colon carcinogenesis by
certain strains of Lac/ofoac/7/«5,^ "^ suppression of tumors through enhancement of the
immune response,*'^ cellular uptake of mutagenic compounds," and antioxidative
properties of specific strains.*
Moreover, fermented dairy products are an important source of calcium in a
westernized diet. Calcium is suggested to decrease colon cancer risk through a
decreased cell proliferation induced either by cell differentiation'" or by binding of
toxic bile acids and free fatty acids in the colonie lumen." Milk products are rich in
phosphate, which has been hypothesized to inhibit the antiproliferative effect of
calcium," while in vitro studies have shown that bile acids are precipitated by
insoluble calcium phosphate.'"
It is still unknown whether generally consumed and commercially available fer-
mented dairy products exert an anticarcinogenic or antimutagenic effect. Few
epidemiological studies have addressed the association between consumption of
fermented dairy products (excluding cheese) and colon cancer r isk."" Two
population-based American case-control studies did observe an inverse association
with the consumption of cultured milk (yogurt and buttermilk)''' and yogurt" after
adjustment for potential confounding factors.
The association with the intake of dairy products in general and/or calcium is
studied more often in case-control and cohort studies, but results remain
inconsistent."'" Some studies suggest stronger associations for women than for
men.'™-*
In contrast with the countries in which these studies have been conducted, the
Netherlands is known for its high per capita consumption of fermented dairy
products (e.g. 18.9 kg per year vs. 2.1 kg per year in the US)** and the substantial
heterogeneity of its consumption patterns. In previous Dutch case-control studies on
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breast cancer" and cancer of the exocrine pancreas^* inverse associations with
fermented dairy product consumption were observed.
We studied the association between fermented dairy products, the intake of
calcium from different dairy and non-dairy dietary sources, and colon cancer risk
among men and women in a case-control study using a structured dietary history
questionnaire to assess usual fermented dairy product consumption and other dietary
variables in greater detail.
Subjects and methods
A case-control study of colon cancer was conducted in the Netherlands between
1989 and 1993. Dutch-speaking men and women of west European origin, up to the
age of 75 at diagnosis, who resided in the central or eastern parts of the Netherlands
and did not have a history of cancer, ulcerative colitis or Crohn's disease were
eligible for this study.
Cases
Cases were defined as newly diagnosed and histologically confirmed patients with
adenocarcinomas of the colon (ICD-0 153). They were recruited as soon as possible
after diagnosis by their medical specialists in 14 regional hospitals. The cancer
registries of the central and eastern parts of the Netherlands were used as a check of
completeness and provided additional clinical and pathological information. For 28
cases, the cancer registry defined the location of the tumor as rectosigmoid while
according to the surgeon the tumor was located in the colon. Analyses were
conducted both including and excluding these cases.
Of all eligible cases diagnosed in the cooperating hospitals, 47% were invited to
participate. Cases invited did not differ importantly from those not invited in age,
gender, urbanization level and site distribution. Cases who were not invited had a
worse prognosis according to Dukes' status and more frequently underwent
radiotherapy and chemical therapy. Of those invited, 60% agreed to be interviewed.
Except for Dukes' status, the distributions of age, gender, tumor site and therapies
of the interviewed cases were comparable to those of all eligible cases. All
participants and 23% of the non-participants completed a short questionnaire which
included questions on the most relevant dietary and life-style factors. Cases
participating in the interview consumed less fermented dairy products than those
non-participants who filled out the questionnaire. The two groups did not differ
markedly in their consumption of unfermented dairy products. The interval between
diagnosis and interview was about three to six months.
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Co/ifro/s
Population controls, of similar age (5-year intervals), gender, region and degree of
urbanization as the cases, were recruited randomly by the general practitioners of
the participating cases. Of the 520 controls invited, 57% agreed to participate in the
interview. Participation was higher among younger people and those living in urban
areas. Dietary and life-style patterns did not differ importantly between those who
participated in the interview and those who refused to participate but completed the
non-response questionnaire (42% of non-participants).
Trained dieticians conducted personal interviews in the participant's home. Each
interviewer visited both a case and a control of the same age, gender, region and
urbanization level. Interviewing cases and controls was balanced over seasons to
account for seasonal fluctuations in food patterns. The interview consisted of a
dietary history part and questions considering life-style, medical history and family
history of colorectal cancer.
The hierarchically structured part" was divided into five sections according to
national habits and starting with the most intensive part, the main meal (appetizers,
main dishes), followed by breakfast and lunch, desserts, (non-)alcoholic drinks and
snacks. The questionnaire covered the complete dietary pattern. The consumption
frequency per month in the preceding year (in cases before diagnosis or symptoms),
number of months duiring which the item was used, number of portions per
consumption and portion size of 289 food items from 19 food groups were inquired.
The questionnaire included all major dairy products consumed in the Netherlands.
To be able to estimate portion sizes, frequently used household utensils and cups
were weighed.
To minimize errors, the dietary history questionnaire was entered into the
computer using a specially designed computer program which included range-
checks and cross-checks. Checks on the internal consistency of the frequency of
consumption of various meal components with the total meal pattern were
conducted. Frequencies of individual items were corrected automatically in order to
agree with the frequency of the total food group.
Average daily intake of dietary calcium and other nutrients was calculated using
the Dutch National Food Table.*' Intake of nutrients was adjusted for energy intake
by regression analysis^' for men and women separately.
To exame the stability of food habits, changes in habits as a result of gastro-
intestinal complaints were inquired.
The non-dietary part of the interview included questions on socio-demographic
indicators (e.g. age, education, occupation, urbanization level), medical history (e.g.
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cholecystectomy), supplement use, family history of colon cancer, reproductive
factors (number of children and age at first birth) and, among female participants,
on menstrual history and use of oral contraceptives. Occupation was used as a
measure of socio-economic status (SES); for married women (including divorcees
and widows), SES was based on their (former) husband's occupation.
In this analysis emphasis was on three groups of dairy products: fermented dairy
products (buttermilk, yogurt, curds and kefir); hard cheese (i.e. Gouda cheese) and
unfermented dairy products (whole-fat milk, skim/low-fat milk, custards, evaporated
milk and porridge). The intake of dairy products is expressed in grams per day.
Categories or quartiles of dairy product use and dietary calcium intake were based
on the distribution among controls. The lowest category or quartile of intake was
used as the reference. Different sources of dietary calcium were explored. Since
these analyses focussed primarily on calcium from dietary sources, supplemental
calcium (alone, with vitamin D, or as multivitamin supplement) was examined as a
confounder and coded as a dichotomous variable (use yes or no).
A high phosphorus intake relative to the intake of calcium was evaluated using
quartiles of the ratio of calcium to phosphorus with the lowest quartile as the
reference.
Odds ratios (OR) as estimators of relative risks and approximate 95% confidence
intervals (95% CI) were calculated by unconditional maximum likelihood estimation
using BMDP software.
Variables for which frequency matching was conducted (age, gender and
urbanization level) were included in all statistical models. Total energy intake was
additionally included to adjust for differential overreporting.
To evaluate the potential confounding effects of energy-adjusted intake of fat,
carbohydrates, dietary fiber and vitamin C, smoking habits, calcium supplement use,
socio-economic status, cholecystectomy and family history of colorectal cancer,
these covariates were added to the logistic regression model one at a time.
Decisions on which covariates to include in the final models were based on: 1)
literature and previous studies,'' 2) biological plausibility, 3) whether the regression
coefficient of the primary independent variable changed by 10% or more after
addition of the potentially confounding variable, and 4) whether the covariate
entered the model at p < 0.10. A priori it was decided to adjust for nutrients instead
of food groups.
We tested for overall trends by using the median of each quartile as a continuous
variable. Since no apparent differences were found in the analyses after exclusion of
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potential rectosigmoid cases (data not shown), results are presented including these
cases. . . . . . . . ,
Results
Table 5.1 shows various characteristics of controls according to high and low intake
of fermented dairy products and dietary calcium. Those in the highest quartile of
fermented dairy product consumption (mean intake 391 g per day excluding cheese)
did not differ importantly in energy intake and energy-adjusted intake of dietary
calcium, dietary fiber and alcohol from those in the lowest quartile (mean intake 4 g
per day).
Energy-adjusted intake of fat was higher among those with the lowest intake,
while vitamin C intake was higher among the most frequent consumers. Women did
consume fermented dairy products more frequently than men and those with the
highest intake were younger. Body mass index and a family history of colorectal
cancer did not differ appreciably between the two categories of intake. Although not
significantly different, cholecystectomy prevalence was higher, socio-economic level
was higher, calcium phosphate ratio was higher and calcium supplements were used
more frequently among those with the highest intake. The highest category of intake
included less current smokers.
Dietary calcium intake was not strongly associated with age, gender, energy-
adjusted intake of fat and alcohol, body mass index, cholecystectomy, calcium
supplement use or history of colorectal cancer. Total energy intake and energy-
adjusted intake of dietary fiber and vitamin C were higher and calcium/phosphorus
ratio was higher among those with the highest dietary calcium intake. Those in the
highest quartile of intake had a higher socio-economic level and less persons
currently smoked.
Table 5.2 illustrates the distribution of colon cancer cases and controls according
to dairy product consumption and dietary calcium intake. The median intake of
fermented dairy products, hard cheese, unfermented dairy products and total dietary
calcium was higher among cases.
In Table 5.3 odds ratios of colon cancer are presented according to dairy product
consumption. The consumption of fermented dairy products, hard cheese and
unfermented dairy products was not significantly associated with colon cancer risk
adjusted for age, gender, urbanization level and total energy intake. For the most
frequently used fermented dairy products, yogurt and buttermilk, a non-significant
positive and inverse association was observed respectively. For neither whole milk
nor skim milk or low-fat milk important associations were observed.
Table 5.1 Characteristics of controls (n = 259) according to highest and lowest quartiles of fermented dairy product consumption and calcium
intake.
Variables
Fermented dairy products (excl. cheese)*
Ql Q4
Calcium
Ql Q4
Age ± SD
Gender (% men)
Dietary factors (mean ± SD)
Fermented dairy (excl. cheese) (g/day)
Hard cheese (g/day)
Unfermented dairy (g/day)
Dietary calcium (mg/day)*
Total energy (kJ/day)
Total fat (g/day)*
Dietary fiber (g/day)*
Vitamin C (mg/day)*
Alcohol (g/day)'
Calcium/phosphorus ratio*
Medical and life-style factors
Body mass index (mean ± SD)
Cholecystectomy (% ± SE*)
Family history of colorectal cancer (%±SE*)
SES (% blue collar ± SE*)
Current smokers (% ± SE*)
Calcium supplement users (% ± SE*)
63.9 ± 9.1
66.7 ± 5.8
4 ± 7
35 ±29
284 ± 223
1,150 ±355
9,062 ± 2,527
108 ± 24
28±8
104 ± 54
16 ±20
0.7 ±0.1
26.6 ± 4.0
3.0 + 2.1
11.1 ±4.0'
45.5 ±6.1
42.2 ± 6.2*
15.4 ± 4.5
60.6 ±8.7 •*
32.8 ±5.8 "
391 ± 171 **
37 ±26
211 ±272 »
1,436 ± 449
9,023 ± 2,893
92 ± 22 "
30 ± 7.7
135 ± 55 ••
11 ± 16
0.8 ± 0.1 **
25.8 ± 4.0
6.3 ± 3.0
9.8 ± 3.8'
35.5 ±6.1
28.1 ±5.6 *
25.0 ± 5.4
62.4 ± 9.9
50.8 ± 6.2
82 ±95
18 ± 12
122 ± 108
905 ± 180
8,047 ± 2,200
103 ± 23
26 ±7
95 ± 40
17 ± 18
0.6 ±0.1
26.5 ± 4.0
4.7 ± 2.6'
11.5 + 4.1'
51.6 ±6.2
51.6 ±6.2'
23.1 ± 5.2
62.0 ± 9.2
60.9 ± 6.1
222 ±241 *•
63 ± 38 *•
488 ±320 •*
1,722 ±412 ••
11,125 ± 2,973 •
101 ± 28
31 ± 9 *•
132 ±60 **
12+ 18
0.8 ± 0.1 ••
26.0 ± 3.7
6.3 ± 3.0
9.8 ± 3.8'
22.6 ± 5.3' *•
26.6 ±5.5 ••
17.2 ± 4.7
buttermilk, yogurt, curds, kefir, other fermented milk drinks, sour cream.
different from Ql; p s 0.1.
different from Ql; p s 0.05.
1,2,3,4 missing values respectively.
adjusted for total energy intake through regression analysis.
instead of SD, SE = v(p(l-p)/n) is given for proportions.
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Table 5.2 Distribution of colon cancer cases (n = 232) and population controls (n = 259)
according to average daily consumption (g) of dairy products and daily intake of
calcium (mg).
Total fermented dairy products (excl cheese)*
Yogurt
Buttermilk
Hard cheese
Other cheeses
Total unfermented dairy products*
Whole milk
Skim/low-fat milk
Total dietary calcium
From fermented dairy products
From unfermented dairy products (incl. cheese)
From non-dairy products
cases
median
107
34
0
37
0
223
0
66
1298
527
319
335
(P25-P75)
(17-229)
(33-100)
(0-101)
(20-57)
(0-4)
(100-473)
(0-0)
(0-258)
(1021-1593)
(336-729)
(158-576)
(280-386)
controls
median
101
26
0
31
0
205
0
43
1209
485
328
345
(P25-P75)
(22-242)
(0-91)
(0-113)
(19-49)
(0-4)
(81-368)
(0-0)
(0-252)
(1010-1480)
(333-683)
(170-530)
(296-402)
* buttermilk, yogurt, curds, sour cream, kefir, other fermented milk drinks.
** whole milk, skim/low fat milk, chocolate milk, other milk drinks, evaporated milk, custards,
porridge.
Additional adjustment for a family history of colorectal cancer, cholecystectomy,
energy-adjusted intake of fat, dietary fiber, vitamin C and alcohol increased the
odds ratios for total fermented dairy products, yogurt and unfermented dairy
products which was especially due to the inclusion of vitamin C, dietary fiber and
cholecystectomy in the model.
However, none of the category specific rates trends were statistically significant.
Socio-economic status, calcium supplement use and smoking status were not
included in the models since they did not further affect the estimates. Adjustment
for dietary calcium diminished the odds ratios (ORs highest vs. lowest quartile for
fermented and unfermented dairy products were 0.90 and 1.26 respectively).
Table 5.4 presents the odds ratios for energy-adjusted dietary calcium intake and
calcium from different dietary sources. In multivariate models total dietary calcium
was positively associated with colon cancer risk. The energy-adjusted intakes of
vitamin C and alcohol acontributed mainly to the increased odds ratio. Neither
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adjustment for vegetables instead of vitamin C and dietary fiber nor adjustment for
meat changed the estimates appreciably.
Table 5.3 Odds ratios of colon
Products (g/day)
Fermented dairy s 22
products
Buttermilk
Yogurt
Hard cheese
Unfermented
dairy product!
Milk whole
Skim milk/
low-fat milk
22-101
101-242
>242
non-users
s 113
> 113
non-users
s 26
26-91
> 91
s 19
19-31
31-49
> 49
^ 8 1
; 81-205
205-368
>368
non-users
s 50
>50
non-users
£ 185
> 185
cancer
Number of
Cases
66
48
62
56
124
54
54
76
29
65
62
55
44
58
75
42
67
46
77
180
16
36
70
90
72
Con-
trols
66
65
64
64
132
63
64
88
42
65
64
65
65
67
62
65
65
65
64
196
32
31
85
88
86
for categories of dairy
Odds ratios (95%
Adjusted for age,
urbanization level,
gender, total
energy
1.00
0.74 (0.44-1.24)
1.00(0.61-1.66)
0.86(0.51-1.44)
1.00
0.94(0.60-1.47)
0.89(0.56-1.39)
1.00
0.84(0.47-1.50)
1.20(0.74-1.93)
1.16(0.71-1.88)
1.00
0.90(0.52-1.52)
1.05 (0.63-1.76)
1.21 (0.72-2.03)
1.00
1.44(0.85-2.46)
0.% (0.55-1.69)
1.36(0.79-2.36)
1.00
0.46 (0.24-0.89)
1.00(0.58-1.73)
1.00
1.38(0.88-2.15)
1.01 (0.64-1.60)
product consumption.
CI)
Multivariate*
1.00
0.84(0.49-1.43)
1.16(0.69-1.96)
1.06(0.61-1.82)
1.00
0.99(0.62-1.58)
0.94(0.59-1.50)
1.00
0.86(0.47-1.55)
1.49(0.90-2.45)
1.49(0.89-2.49)
1.00
0.92(0.53-1.62)
1.08(0.63-1.83)
1.18(0.69-2.01)
1.00
1.59 (0.92-2.76)
1.01 (0.57-1.81)
1.59 (0.89-2.85)
1.00
0.41 (0.21-0.82)
0.95 (0.54-1.68)
1.00
1.44(0.91-2.29)
1.15 (0.71-1.84)
X*
(P)
0.27
(0.60)
0.06
(0.80)
3.11
(0.08)
0.57
(0.45)
1.12
(0.29)
0.02
(0.88)
0.03
(0.85)
* X* for trend multivariate model, p-value in parentheses.
• Adjusted for age, gender, urbanization level, family history, cholecystectomy, total energy
intake, energy-adjusted intake of fat, dietary fiber, vitamin C and alcohol.
Table 5.4 Odds ratios of colon cancer for quartiles of calcium intake.
Nutrient
Ql Q2
Level of consumption
Q3 Q4
Continuous per
200 mg
Total dietary calcium
mg/day
number of cases/controls
OR 1**
OR 2 " '
95% CI
Calcium from fermented dairy products*
mg/day
• number of cases/controls
OR 1 "
OR 2 " *
95% CI
Calcium from unfermented dairy products
mg/day
number of cases/controls
OR 1 "
OR 2 " *
95% CI
Calcium from non-dairy products
mg/day
number of cases/controls
OR 1**
OR 2 " *
95% CI
s 1,010
57/65
1.00
1.00
s 333
57/64
1.00
1.00
s 170
63/64
1.00
1.00
s 2%
74/65
1.00
1.00
1,010-1,209
45/65
0.92
0.94
(0.54-1.63)
333-485
50/65
0.99
1.03
(0.60-1.76)
170-328
57/66
1.15
1.25
(0.73-2.15)
296-345
52/64
0.74
0.77
(0.45-1.31)
1,209-1,480
50/65
0.97
1.15
(0.66-2.00)
485-683
60/65
1.17
1.28
(0.74-2.20)
328-530
50/65
0.97
1.09
(0.63-1.91)
345-402
62/66
0.82
0.89
(0.51-1.54)
> 1,480
80/64
1.42
1.81
(1.05-3.12)
>683
65/65
1.18
1.26
(0.74-2. lé)
>530
62/64
1.00
1.10
(0.63-1.91)
>402
44/64
0.56
0.69
(0.36-1.32)
2.09 (0.15)
5.36 (0.02)
038 (0.45)
1.00(032)
0.05 (0.82)
0.01 (0.94)
3.97 (0.05)
0.91 (0.34)
1.05 (0.96-1.14)
1.09(0.99-1.20)
1.05(053-1.18)
1.08(0.95-1.22)
1.06(0.95-1.18)
1.08 (0.96-1.22)
0.58 (0.36-0.91)
0.68(0.37-1.27)
s
*«
• * •
X* for trend.
fermented milk and cheese.
OR 1: Adjusted for age, gender, urbanization level, total energy intake. , , , , , • ,
OR 2: Adjusted for age, gender, urbanization level, family history, cholecystectomy, total energy intake, energy-adjusted intake of fat, dietary
fiber, vitamin C and alcohol.
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Table 5.5
Variable
Odds ratios* of
men and women.
colon cancer
Contrast"
for dairy
OR for
men
product
contrast
and dietary calcium
(95% CI)
women
intake among
X*
interaction
(P)
Products
Fermented dairy products 250 g/day 1.52(1.00-2.30) 0.77(0.50-1.17) 5.49(0.02)
Unfermented dairy
products
Calcium
Total dietary calcium
250 g/day 1.14 (0.91 -1.42) 1.12 (0.83-1.50) 0.01 (0.92)
200mg/day 1.17(1.04-1.32) 0.% (0.81-1.12) 3.94(0.05)
Calcium from fermented 200 mg/day 1.20(1.02-1.40) 0.87(0.69-1.09) 5.51(0.02)
dairy products
Calcium from unfermented 200 mg/day 1.09(0.94-1.26) 1.08(0.89-1.30) 0.01(0.93)
dairy products
Calcium from non-dairy 200 mg/day 0.80(0.37-1.72) 0.57(0.26-1.28) 0.49(0.48)
products
* adjusted for age, gender, urbanization level, family history, cholecystectomy, total energy
intake, energy-adjusted intake of fat, dietary fiber, vitamin C and alcohol.
•* representing about one serving a day.
Calcium from fermented and unfermented dairy sources was positively, although
non-significantly associated with risk.
Calcium from non-dairy dietary sources was inversely associated with risk
adjusted for age, gender, urbanization level and total energy intake. Additional
adjustment for energy-adjusted intake of vitamin C, alcohol, and cholecystectomy
attenuated this inverse association.
In the multivariate model, energy-adjusted intake of phosphorus (OR for highest
vs. lowest quartile = 1.61, 95% CI = 0.85-3.06) was positively associated with risk.
The calcium/phosphorus ratio was (non-significantly) positively associated with risk
when vitamin C was excluded from the multivariate model (OR for highest vs.
lowest quartile = 1.49, 95% CI = 0.87-2.56). Vitamin C intake was not adjusted for
in this model since its inclusion would remove all the variability in calcium.
Table 5.5 shows that the associations with the use of dairy products and dietary
calcium intake differed significantly between men and women; positive associations
were observed for men, while for women inverse associations were found.
To address recent changes in food patterns, the same analyses were conducted
excluding those who reported having had gastro-intestinal discomfort and thus
having adapted their dietary patterns in the preceding years (33 cases and 10
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controls). No important differences were observed for fermented milk products (OR
for highest vs. lowest intake = 1.28, 95% CI = 0.72-2.28) or dietary calcium
(OR = 1.85, 95% CI = 1.04-3.28).
Discussion
The results of this case-control study are not in line with the hypothesis that an
increased consumption of commercially available fermented dairy products or an
increased intake of dietary calcium would decrease colon cancer risk.
The fact that no association, or even a positive association, was observed may be
subject to chance or potential methodological biases in this retrospective study, such
as information and selection bias. In this study, both cases and controls were
interviewed by the same interviewer in the same season using a structured dietary
history questionnaire. General overreporting could occur if some cases remembered
consuming more foods in general by concentrating more intensely. Adjustment for
total energy intake cannot explain our findings. Since subjects were unaware of the
hypothesis tested and dairy products do not have a negative image, it is unlikely
that cases would specifically overestimate their consumption of dairy products. This
is confirmed in a case-control study of breast cancer by Friedenreich and
colleagues" who observed a similar overestimation of calcium in cases and controls.
Changes in food patterns as a result of digestive complaints might be an
important reason for recall bias. However, exclusion of those who replied to have
changed their dietary habits because of such complaints did not markedly change
the results.
The dietary history questionnaire used in this study was a slightly revised version
of the validated questionnaire used in our previous case-control study on breast
cancer.^ Detailed questions on fermented dairy and non-dairy foods were added,
which might explain the higher intake of dietary calcium in our control population
as compared to the Dutch population in general. Interviewers were trained by one of
the authors (P.v.A-S.), who closely supervised their interviewing and coding. No
differences between interviewers were found.
Non-response is unlikely to have introduced an important bias in our results. Age,
gender and urbanization level of interviewed cases did not significantly differ from
those eligible. Cases participating in the interview did have a better prognosis
according to Dukes' status. Dukes' status was not related to consumption of
fermented dairy products nor to calcium intake. Non-participating cases who filled
out a non-response questionnaire appeared to consume more fermented dairy
products than participating cases and no differences were observed between
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participating and non-participating controls who completed the questionnaire.
However, these findings need to be interpreted with caution since only about 25%
of the non-participating cases and 45% of the non-participating controls filled out
the non-response questionnaire.
In the Netherlands as well as the US," the consumption of fermented dairy
products and calcium is related to a healthier life-style and a higher socio-economic
status. If selection of a relatively healthy, health-conscious control group would
have occurred, we would have observed no association rather than a positive
association for calcium. We recruited the control group via the databases of the
general practitioners of the cases interviewed. When we compared this control
group with the general population we found a comparable distribution of socio-
economic status. Another control group recruited via the municipal registries
included more persons with a higher socio-economic status. Thus, an inverse
association might have been erroneously found when municipality controls had been
used as in previous studies."^ In conclusion, information and selection bias are not
likely to explain our findings.
The absence of an inverse association cannot easily be explained by insufficient
contrast in this population with a relatively high and heterogeneous consumption of
fermented and unfermented dairy products.
The significant positive association with dietary calcium might be the results of
our adjustment strategy. Excluding vitamin C from the multivariate model provided
an odds ratio of 1.67 (95% CI = 0.98-2.87). Other studies, such as the Iowa
Women's Health Study, also observed an increase in the odds ratio for dietary
calcium after adjustment for potentially confounding variables.**
Significant inverse associations with consumption of fermented dairy products
have been found in two American case-control studies.'*" Besides the choice of a
control group, the apparent contradiction between our study and or experimental
studies might be explained by differences in bacterial strains in local American
products and differences in experimentally used strains. In the Netherlands,
Lac/o&ad//MS fe«/gan'c«5 and SfrepfococcHS //ier/no/?/»7«5, S. tremor and 5. /acfts are
the main species used for the fermentation process of yogurt. These strains are
thought to be less resistant to acidic conditions in the stomach while their survival
might be essential for a favourable effect in the colon.'"
Previous epidemiological case-control studies on the role of calcium in colorectal
carcinogenesis have yielded conflicting results. Although some case-control and
prospective studies suggest a protective role of calcium and dairy products against
the risk of colorectal cancer,^'*""" more recent retrospective and prospective studies
do not support a protective effect for dietary calcium'"" or only support an inverse
relation with colon cancer risk in women.**
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Although the calculations of Garland and colleagues** and Newmark et al.'
suggest a considerable reduction of risk with a calcium intake of more than 1,200 or
1,500 mg per day, respectively, dietary intake of calcium in the general population
might not be high enough to observe a decrease in risk. In a recent prospective
cohort of women in Iowa, no protective effect of dietary calcium was observed
(RR = 0.95), while an inverse association was found for calcium from supplements
after adjustment for several covariates (RR = 0.66; 95% CI = 0.43-1.02; p for
trend = 0.32)."
Human experimental studies suggest a decrease in cell proliferation with
supplemental calcium intake of 1,000 to 2,000 mg per day.'"*'"" However, even
with these high doses, some recent experimental studies fail to observe an effect of
calcium on overall cell proliferation."'"'" If calcium exerts an effect on cell
proliferation it may be particularly important in the early stages of tumor
development: i.e. the formation and growth of colorectal adenomas. However, in the
Health Professionals Follow-up Study and the Nurses' Health Study, dietary and
supplemental calcium intake was not associated with colorectal adenoma risk.'*
We observed a difference in risk between men and women, which is supported
by a recent case-control study in Washington stater* a lower risk of colon cancer
was found with higher intakes of calcium among women only. Since women are
traditionally more involved in the preparation of the main dish, they might recall
their habits more accurately than men. To attenuate recall differences between
genders in our study, spouses were asked to be present at the time of the home
interview. If recall of diet cannot explain gender differences in the associations
found, biological mechanisms might differ between men and women. Besides
differences in gut metabolism between men and women, the results of a recent
controlled experimental trial suggest gender differences in colonie bacterial
population and general colonie milieu.'"' It is plausible that differences in bile acid
metabolism exist between men and women.'" As far as fermented dairy products are
concerned, certain strains of lactic acid bacteria might colonize the female colon
more easily than the male colon.
In summary, this case-control study does not provide support for a protective role
of commercially available fermented dairy products or dietary calcium against colon
cancer risk. The lack of an inverse association can probably not be explained by
information or selection bias. Nevertheless, it would be worthwhile to study this
hypothesis prospectively in a population with a similar wide range in intake. It is
suggested that experimental studies focusing on differences between male and
female bile acid metabolism and large bowel flora might explain the observed
differences between men and women.
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Chapter 6
Reproductive and hormonal factors in male
and female colon cancer
Ellen Kampman, Arianne J. Bijl, Caroline Kok, Pieter van 't Veer. European 7owr«a/ o/
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Abstract »^~v -^. .^i^v^. . •• ^ .
We analysed data from a case-control study in the Netherlands in order to
investigate whether reproductive events and hormonal factors are similarly related to
colon cancer risk in men and women after adjustment for dietary factors. In total,
232 colon cancer cases (102 women, 130 men) and 259 controls (123 women, 136
men) were interviewed about life-style, medical conditions, and usual dietary
patterns, using a structured dietary history technique.
In women, age at first childbirth was positively associated with colon cancer risk
(odds ratio (OR) age a 26 vs. < 26 = 1.7, 95% confidence interval (CI) = 0.9-3.3).
Women with three or more children were at reduced risk compared with women
with one or two children (OR = 0.6, 95% CI = 0.3-1.1). When women had had
their first child after the age of 26 years, parity was observed to be important (for
1-2 children vs. a 3 children OR = 2.8, 95% CI = 1.1-7.0). For men, opposite but
non-significant associations were found. Adjustment for dietary patterns and other
risk factors did not change the estimates markedly.
Of the hormonal factors, late age at menarche decreased risk (OR = 0.5,
95% CI = 0.3-0.9) while late age at natural menopause slightly increased risk.
Our study provides additional support for the role of reproductive status in the
aetiology of female colon cancer independently of dietary factors.
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Introduction ;
Based on gender differences in colon cancer incidence and tumor site distribution, it
has been postulated that hormonal and reproductive factors play a role in the
aetiology of this cancer.' These gender differences in risk, however, might also be
attributed to reproductive factors influencing behavioural factors, such as diet and
physical activity.*
McMichael and Potter' proposed the 'hormonal hypothesis', postulating that
endogenous oestrogen affects hepatic cholesterol metabolism and increases bile acid
production. High concentrations of secondary bile acids in the colonie lumen are
thought to enhance colon carcinogenesis.' Pregnancy induces a long-term shift in
oestrogen profile and reduces bile acid formation. Progestins and exogenous
oestrogen at high doses also decrease bile acid synthesis.' Under this hypothesis,
reproductive events could be associated with colon cancer risk among women but
not among men.
In order to evaluate this hypothesis, many analytical epidemiological studies have
been conducted and reviewed recently.*'*' Only four of these studied the association
with reproductive factors in both sexes separately.*^ In two of these studies, the
number of children a subject had appeared to decrease colorectal cancer risk in men
as well as in women/** which suggests that life-style factors associated with parity
might be important, such as higher physical activity in larger families and altered
dietary patterns.
In most studies that investigated reproductive factors, total energy intake and the
intake of nutrients relevant to colon cancer were not adjusted for adequately. We
studied the relationship between reproductive factors in women and men and
hormonal factors in women, taking into account dietary factors and other risk
factors of colon cancer.
Subjects and methods
A case-control study of colon cancer was conducted in the Netherlands between
1989 and 1993. Men and women of West European origin, up to the age of 75 at
diagnosis, who resided in the central or eastern part of the Netherlands, spoke
Dutch and did not have a history of cancer, ulcerative colitis or Crohn's disease
were eligible for this study.
Cases
Cases were defined as newly diagnosed and histologically confirmed patients with
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adenocarcinomas of the colon (ICD 153). They were recruited as soon as possible
after diagnosis by their medical specialists in 14 regional hospitals. The cancer
registries of the central and eastern parts of the Netherlands were used as a check
on completeness and provided additional clinical and pathological information. For
28 participants, the cancer registry defined the location of the tumor as rectosigmoid
while according to the surgeon the tumor was located in the colon. Analyses were
conducted including and excluding these cases.
Of all eligible cases diagnosed in the 14 cooperating hospitals, 47% were invited
by the surgeon to participate. Non-invitation was mainly due to administrative and
organizational reasons. Comparison with cancer registry data showed that cases
invited did not differ importantly from those not invited with respect to age, sex,
urbanization grade and site distribution. However, uninvited cases did have a worse
prognosis according to Dukes' status and underwent radiotherapy and chemotherapy
more frequently. Of those invited, 60% agreed to be interviewed. Except for Dukes'
status, the distributions of age, gender, tumor site and therapies of the interviewed
cases was comparable to the distribution among all eligible cases. A short
questionnaire, which included questions on the most relevant dietary and life style
factors, was send to the participants as well as the invited non-participants. All
participants and 23% of these non-participants completed this questionnaire and
returned it. No important differences were observed between participants and non-
participants. Because of the low response among non-participants, these data were
not incorporated into full analysis. Although the number of participants would have
been larger, it would also have been less precise.
The average interval between diagnosis and interview was three months.
Confro/s
Frequency matched population controls, matched for age (on 5-year intervals),
gender, region and degree of urbanization as the cases, were recruited randomly by
the general practitioners of the participating cases. For each case, the general
practitioner received a standardized form with three three-letter strings, randomly
obtained from the local telephone directory to initiate the search for controls in his
or her own database; for each string, the first subject who matched the eligibility
criteria was sent a standard letter of invitation, including a reply form to the
investigator. Of the 520 controls invited, 57% agreed to participate in the interview.
Participation was higher among younger people and those living in urban areas.
Dietary and life style patterns did not differ significantly between those who
participated in the interview and those who refused to participate but completed the
non-response questionnaire (42% of non-participants).
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A total of seven trained dieticians conducted personal interviews in the participant's
home. In order to contain comparable information of cases and controls, each
interviewer visited a similar number of cases and controls from the same age,
gender, region and urbanization grade. The structured interview included questions
on sociodemographic indicators (e.g. age, education, occupation, urbanization
grade), medical history (e.g. cholecystectomy), family history of colon cancer,
reproductive factors (number of children and age at first birth). Female participants
were asked about the type and duration of use of oral contraceptives (OC) and use
of oestrogen-replacement therapy, ages at menarche and menopause, and type of
menopause (natural or surgical). Occupation was used as a measure of socioecono-
mic status (SES); socioeconomic status of married women (including divorcees and
widows), was based on their husband's (or former/late husband's) occupation.
Data on dietary habits were collected, using a structured dietary history
questionnaire'" referring to the previous full year (in cases before symptoms
occurred). Interviewing cases and controls was balanced over seasons to account for
seasonal fluctuations on food patterns. Intake of carbohydrates, fat, fiber and alcohol
were adjusted for energy intake by regression analysis" for men and women
separately.
Data
Odds ratios (OR) as estimators of relative risks and approximate 95 % confidence
intervals (95% CI) were calculated by unconditional maximum likelihood estimation
using BMDP software.'^ To control simultaneously for the potential confounding
effects of age, urbanization grade, energy intake, energy-adjusted intake of fat,
carbohydrates, dietary fiber and vitamin C, socioeconomic level, cholecystectomy,
and family history of colorectal cancer, multiple logistic regression models were
used.
Because of the low numbers of childless cases (7 women and 11 men), subjects
with one or two children were used as reference. Mean age at birth of first birth
(women 26 years; men 28 years) was used to divide into the low and high age at
first birth categories.
Exclusion of potential rectosigmoid cases did not change the results appreciably
(data not shown).
Results
Table 6.1 gives the distribution of risk factors among cases and controls, for men
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and women separately. Cholecystectomy and positive family history were more
prevalent among cases, but due to the stratification by sex, this was of borderline
significance in either men or women (0.05 < p < 0.1). No other statistic significant
differences were observed. i
Table 6.1 Mean and standard deviation (or standard error*) of some characteristics in 232
people with colon cancer cases and 259 controls subjects.
Age (years)
Urbanization grade (% urban)
/tepra/ucf/ve /ac/ors
Number of children
Age at first birth among
parous (years)
Wormo/ie-re/aferf /ac/ors
Age at mcnarchc (years)
Age at menopause (years)
OC use (%)
Cholecystectomy (%)
Family history of
colon cancer (%)
Body mass index (kg/m*)
Defecation frequency
(% more than once/day)
Socioeconomic level
(% blue collar)'
women
cases
n= 102
61.3 ± 10.4
45.1 ±4.9
2.7 ± 1.6
26.3 ± 4.5
13.5 ± 1.8
48.9 ± 5.2
47.9 ±5.1
16.2 ± 3.7
21.1 ±4.2
25.6 ± 4.9
21.0 ±4.1
50.0 ± 5.1
controls
n= 123
61.2 ± 10.5
50.4 ± 4.5
2.7 ± 1.8
25.9 ± 3.9
13.7 ± 1.5
48.5 ± 5.2
47.9 ± 4.5
8.1 ±2.5*
13.6 ± 3.2
25.6 ± 4.3
14.6 ± 3.2
42.9 ± 4.5
cases
n= 130
62.7 ±10.1
51.5 ±4.3
2.8 ± 1.7
27.8 ± 4.8
-
-
-
6.2 ±2.1
17.5 ±3.9
26.2 ± 3.7
30.7 ± 4.1
44.9 ± 4.4
men
controls
n = 136
62.3 ± 9.4
55.1 ± 4.4
2.6 ± 1.8
28.7 ± 4.4
-
-
-
3.8 ± 1.7
9.5 ± 2.6*
26.3 ± 3.3
36.0 + 4.1
38.2 ± 4.2
• p = 0.07.
* Instead of SD, SE = v(p(l-p)/n) is given for proportions.
With respect to reproductive- and hormonal-related factors, female controls,
compared with cases, tended to have lower age at first birth. Although differences
were not significant, defecation frequency was higher among female cases, but
lower among male cases than in controls. A higher proportion of female and male
cases seemed to have a lower socioeconomic level.
With respect to dietary variables, higher energy intake was found among both
female and male cases (Table 6.2). After adjustment for energy intake, cases tended
to consume more fat and less carbohydrates, for men these associations did not
reach statistical significance. Also, energy-adjusted dietary fiber intake and vitamin
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C intake were slightly higher in male cases, and significantly higher in female
cases. The proportion of alcohol consumers was similar, but among those who
consume alcohol mean alcohol intake tended to be higher in cases for both men and
women. • • > • ; •
Table 6.2 Average daily intake (mean ± SD or SEM*) of energy and nutrientst in 232 people
with colon cancer and 259 controls subjects.
Energy (kJ)
Total fat (g)
Total protein (g)
Total carbohydrates
Dietary fiber (g)
Vitamin C (mg)
Alcohol
% Drinkers*
Alcohol (g)«
* p < 0 . 1 .
** p < 0.05.
* Energy adjusted
' SE \(p(l-p)/n).
* Among alcohol
cases
n = 102
8,785 ± 256
86.0 ± 14.0
74.6 ± 12.8
(g) 213.5 ± 42.0
24.2 ± 6.6
108.5 ±51.5
72.5 ± 4.4
11.5 ± 15.3
by regression for
consumers.
women
controls
n = 123
7,841 ± 2,129**
82.5 ± 14.4'
74.9 ± 11.9
224.6 ± 36.7**
26.6 ± 6.7**
129.6 ±58.6**
68.3 ± 4.2
9.4 ± 10.4
cases
n = 130
11,727 ±312
117.7 ±23.0
93.3 ± 14.7
272.1 ±56.1
30.3 ± 8.9
107.6 ± 53.4
86.9 ± 3.0
27.2 ± 29.0
men and women separately.
men
controls
n= 136
10,737 ±2,711**
116.9 ± 20.8
91.5 ± 12.9
281.1 ±49.2
31.1 ±9.0
112.3 ±48.2
90.5 ± 2.5
22.9 ± 20.6
Table 6.3 presents ORs for reproductive factors, unadjusted and adjusted for
medical and dietary factors. After adjustment ORs became stronger, but this did not
change the results dramatically. For women, risk was inversely associated with
number of children (OR = 0.56) and positively associated with age at first birth
(OR = 1.69). For men, associations with both variables were in the opposite
direction.
When both reproductive variables were studied simultaneously, increased risk
was essentially limited to women with few children, who had their first child after
the age of 26 years (OR = 2.79) (Table 6.4). Additional adjustment for use of oral
contraceptives attenuated the OR slightly (OR age at first birth a 26, number of
children 1-2 = 2.48, 95% CI = 0.96-6.44). For men, a decreased risk was observed
in the corresponding exposure category.
Table 6 3 Reproductive factors among men and women and colon cancer risk.
Variables
Number of children
1-2
23
Age at first birth(years)
<26«
* 2 6
Cases*
(n)
44
49
38
54
Controls
(n)
41
64
55
50
Women
Odds Ratios (959i
Age-adjusted
1.00'
0.68(0.37-1.22)
1.00'
1.56(0.88-2.75)
t> CI)
Multivariate'
1.00'
0.56(0.28-1.11)
1.00'
1.69(0.87-3.27)
Cases*
(n)
46
72
60
58
Controls
(n)
59
59
51
67
Men
Odds Ratios (95%
Age-adjusted
1.00'
1.57 (0.93-2.64)
1.00'
0.73 (0.44-1.24)
CI)
Multivariate*
1.00'
1.49 (0.84-2.64)
1.00'
0.69 (0.39-1.23)
Adjusted for age, urbanization grade, energy intake, energy-adjusted intake of fat, carbohydrates, dietary fiber and vitamin C, cholecystectomy, family
history of colon cancer and socio-economic level.
Reference category.
For men < 28 vs. 2 28.
Missing data on both variables in 2 cases, for 1 case age at first birth was unknown.
Missing data on both variables in 1 case.
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Hormonal factors (for women) are presented in Table 6.5. Risk was significantly
lower for a menarche at age 14 than for an earlier menarche (OR = 0.51, 95%
CI = 0.28-0.94). Women who had a natural menopause after the age of 50 had a
slightly increased risk relative to those with an earlier natural menopause. Artificial
menopause and use of oral contraceptives were not associated with colon cancer.
Additional adjustment for parity did not change the association with use of oral
contraceptives importantly (OR = 1.10, 95% CI = 0.49-2.48).
Table 6.4 Number of children in different age categories at first birth and colon cancer risk
(232 cases, 259 controls).
Women
Age at first birth (yr)
< 26 a 26
Men
Age at first birth (yr)
< 28 a 28
1-2 1.35(0.50-3.68)
1.00*
2.79(1.10-7.03)
1.33 (0.55-3.20)
0.81 (0.33-2.01)
1.00*
0.55 (0.27-1.13)
0.82(0.38-1.79)
Odds ratios and (in parentheses) 95% confidence intervals adjusted for age, urbanization grade,
energy intake, energy-adjusted intake of fat, carbohydrates, dietary fiber and vitamin C,
cholecystectomy, family history of colon cancer and socioeconomic level.
* Reference category.
Table 6.5 Hormonal factors among women with colon cancer (n = 102) and control subjects
(n = 123).
Variables
Age at menarche (years)
s 13
a 14
Menopause
natural, at <
natural, at :
artificial
c 50 years
: 50 years
Oral contraceptive use
no
yes
Cases*
(n)
53
44
18
37
21
50
46
Controls
(n)
52
67
30
36
26
63
58
OR
Age-adjusted
1.00*
0.65 (0.38-1.11)
1.00*
1.73(0.81-3.67)
1.32(0.58-3.03)
1.00*
1.02(0.53-1.93)
(95% Cl)
Multivariate*
1.00'
0.51 (0.28-0.94)
1.00*
1.38(0.58-3.31)
0.95 (0.36-2.47)
1.00*
0.97 (0.46-2.03)
Adjusted for age, urbanization grade, energy intake, energy-adjusted intake of fat,
carbohydrate, dietary fiber and vitamin C, cholecystectomy, family history of colon cancer
and socioeconomic level.
Reference category.
Strata do not add up to the total because of missing data.
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Discussion •
Our results show that associations between reproductive events and colon cancer
risk differ between men and women. The statistically significant association is
restricted to women who have fewer than two children and had their first child after
the age of 26. The results appear not to be strongly confounded by other risk factors
including dietary factors. The results therefore support the notion that colon cancer
in men and women partially differ in aetiology and that sex differences in risk
cannot be attributed to life-style factors only.
The results of a case-control study are potentially influenced by selection and
information bias. Selection bias in cases may occur when illness affects
participation rates. Our study included more cases with Dukes' A and B tumors and
fewer cases with a history of radiotherapy or chemotherapy compared with the
cancer registry database for the study area. Since a more severe prognosis, or
medical treatment influencing appetite, may influence the recall of previous dietary
habits, the exclusion of more severe cases can be seen as an advantage, since this
might benefit the quality of the dietary data. Controls had a participation rate of
57%; a non-response study showed that non-responders did not differ in age, sex,
visits to the general practitioner and type of health insurance as indicators for socio
economic status. Furthermore, the proportion of nulliparous women among controls
in our study (14.6%) corresponded with data from the Netherlands Central Bureau
of Statistics for 62-year old women in 1992 (15.3%). With respect to information
bias, both cases and controls were asked about their children in the same structured
manner by the same interviewer. Subjects and interviewer were not aware of the
hypothesis. Thus, selection and information bias are not considered to be important
determinants of our results.
Four other studies examined the association between parity and colon or
colorectal cancer in both sexesA'' In a cohort study of 11,888 residents of a
retirement community' age-adjusted relative risks (RRs) for men with 1, 2 and 3 or
more children compared with childless men were 1.4, 0.8 and 0.4; for women, the
corresponding RRs showed a similar tendency, i.e. 1.6, 1.1 and 0.5 respectively.
The number of colorectal cancer cases was small (58 men, 68 women) and the
duration of follow-up was limited to 4.5 years. Relative risks were adjusted for age
only and not for other risk factors. The investigators explained their findings by a
non-causal relationship resulting from life style variations associated with large
families. In the Melbourne study,* a case-control study among 370 male and 305
female colorectal cancer cases and 720 controls frequency-matched for age and sex,
having more than one child was found to protect against colorectal cancer in
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women (OR = 0.62 95% CI = 0.39-0.99) and men (OR = 0.55, 95%
CI = 0.37-0.83) after adjustment for age at birth of the first child. For colon cancer,
for men and women, this RR was 0.72 (95% CI = 0.50-1.03) and remained stable
after adjustment for dietary factors (eg. intake of fiber and fat), family history of
colorectal cancer, occupation, and marital status. The investigators suggest the
presence of a life style factor that is associated with the number of children as well
as colorectal cancer. A Norwegian cohort study among 1.1 million men and 1.1
million women'' indicated a decreased risk for caecum and ascending colon cancer
in their young sub-population (27 to 57 years old). Age-adjusted RRs for women
with 1, 2, 3 and 4 children compared to nulliparous women were 0.91, 0.64, 0.53
and 0.58 respectively. The investigators suggest that reduction of exposure to bile
acids is responsible for this downward trend. No clear inverse association with
fatherhood was observed for men, but this did not lead the investigators to exclude
the possible effect of life style, whereas the mothers' life style may be more
strongly correlated with family size. In an Australian case-control study by Potter
and McMichael,'' being unmarried was associated with a non-significant increased
risk of colon cancer in both sexes. However, being married without children was
associated with a significant increase in risk of colon cancer among women only
(OR = 2.0).
Our observations on reproductive factors in women are largely in line with these
previous studies. In men however, we observed opposite associations as compared
to women, while the Melbourne case-control study showed similar associations." Of
the cohort studies mentioned above, one showed similar results for men and
women,' while the other did not.'' Thus, the observed sex differences in colon
cancer aetiology do not seem to be a simple artefact caused by study design as
such, and seem to arise from inconsistent associations among men.
Our findings support the hypothesis that endogenous female sex hormones play a
role in the aetiology of colon cancer. The fact that after adjustment for life style
variables ORs became somewhat stronger points to the same direction. In a recent
review, Potter et al.,^ note that an inverse association between reproductive events
and female colon cancer risk was found in the majority of case-control studies, but
not in cohort studies. It has been suggested that higher parity is associated with
reduced risk in older women only,' but this hypothesis could not be explored in our
study for reasons of statistical power. Cohort studies with a longer follow-up period
should especially explore this interesting observation.
Increased physical activity may still provide a possible explanation for the
observed lower risk in larger families. Unfortunately, no well-designed and
validated questionnaire on physical activity usable in a case-control design was
available when this study was conducted. However, it is not very likely that
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physical activity increases strongly with number of children. Nor can physical
activity explain the importance of number of children in group older at the time of
their first child's birth.
The lower risk in men at older age with fewer than three children as compared to
younger men with three or more children might be explained by socio-economic
level, which is related to reproductive as well as other factors. However, adjustment
for socioeconomic level using different classification systems did not change the
results.
Other indicators of a long-lasting or high gastrointestinal exposure to oestrogens
are an early age at menarche, late menopause and use of oral contraceptives. Except
for age at menarche, no significant associations were observed. An inverse
association between age at menarche and colon cancer risk was observed in another
European study;'^ five other studies'*'''•*''* did not find such an association.
Franceschi et a l / found a similar (non-significant) protection against colon cancer
for premenopausal women, but no difference between natural and artificial
menopause, whereas Wu et al.' found an increased risk associated with surgical
menopause (RR = 1.7, 95% CI = 1.0-2.9). Late age at menopause was found to be
weakly protective in some'*'''' but not in others.'*"''* Use of oral contraceptives
showed no relation with colon cancer risk in our study and other studies.' '""•"
The observed differences in associations between reproductive events and colon
cancer risk for men and women support a role of endogenous female sex hormones
in the aetiology of colon cancer independently of dietary factors. The mechanisms
of these hormonal influences need to be explored further.
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Chapter 7
Vegetable and animal products as determinants of colon
. cancer risk in Dutch men and women
Ellen Kampman, Dorette Verhoeven, Lisette Sloots, Pieter van 't Veer. 5ubmi/(e</ /or
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Abstract
To examine the relationship between colon cancer and vegetable or animal products,
we analyzed data from a Dutch case-control study. Dietary patterns were assessed
for 232 colon cancer cases and 259 population controls.
In multivariate analyses, the consumption of vegetables was significantly
associated with reduced colon cancer risk (Odds Ratio highest vs. lowest quartile of
consumption (OR) = 0.4, 95% Confidence Interval (CI) = 0.2-0.7, p-trend =
0.0004). Consumption of fresh red meat was positively associated with risk in
women (OR = 2.4, 95% CI = 1.0-5.7, p-trend = 0.04), especially for those with a
relatively low consumption of vegetables and fruits (OR = 3.1). For men, no
association with fresh red meat consumption was found (OR = 0.9). No clear
associations were found for other products of vegetable or animal origin.
The results of this Dutch case-control study support the preventive potential of
a high vegetable-diet in colon cancer risk. This study suggests this may be
important for women consuming a diet high in red meat.
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Introduction
Colon cancer is one of the most prominent types of cancer in the Netherlands, as in
many other Westernized countries. In Dutch men, colon cancer incidence ranks
third (7%), behind lung cancer (24%) and cancer of the prostate (14%). For Dutch
women, cancer of the colon is the second most common type (10%), after breast
cancer (31%).'
Dietary patterns are considered to contribute importantly to the etiology of
colon cancer. Research focused primarely on two nutrient hypotheses: dietary fiber
is protective, while fat intake increases the risk of colon cancer. Results have been
both affirmative and contradictory for nutrients and food groups.
Nowadays, the dietary fiber hypothesis is mostly interpreted as an effect of
vegetables and/or fruits, with a variety of nutrients and bioactive substances relevant
to the prevention of cancer of the colon as well as many other cancer sites.
Although several epidemiological studies addressed the association between colon
cancer risk and the consumption of vegetables and fruits as reviewed by Steinmetz
and Potter^ and Block et al./ none of these studies were conducted in the
Netherlands. Most previous studies in Westernized countries support a protective
effect for vegetables: about two-third of the case-control studies observed an inverse
association with colon cancer risk for at least one vegetable and/or fruit food
group/*"'* while others reported no association or a positive o n e . " "
Red meat consumption is one of the major sources of saturated fat in a
westernized diet. In contrast to the consumption of vegetables, red meat
consumption as related to colon cancer risk has been studied in the Netherlands
Cohort Study on diet and cancer which showed no important association between
red meat consumption and colon cancer risk.** Although supported by other
studies, ' '"" '" '" these findings contradict results of several studies showing a
significant positive association with red meat consumption.'*"""'*"*' Although
differences in dietary methodology and subject recruitment might partially account
for such inconsistencies, it may be that meat consumption is not important in itself,
but only relative to protective factors provided by vegetables and fruits.** Recently,
Steinmetz and Potter" studied the ratio of the consumption of red meat to that of
vegetables and fruits. Although not significantly so, this ratio was higher for cases
than for controls both in men and women." A similar approach was used in the
Nurses' Health Study for the ratio of red meat to fish and chicken.*'
Moreover, there are many indications that the association between diet and colon
cancer might be different for men and women. However, previous studies reporting
gender-stratified analyses have produced inconsistent findings.*''
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In a case-control study, we examined the role of vegetables, fruits, red meat and
their ratio as related to colon cancer in Dutch men and women. In addition, we
explored associations and potential gender interactions for other food groups of
vegetable and animal origin, which have been linked to the risk of colon cancer,
such as potatoes,** dairy products,'' eggs," fish and poultry.** Since the numerous
components of foods might, through interaction, produce effects which are different
from those of the exposure to a single nutrient and interpretation in terms of
preventive potentials is easier, we focused especially on the consumption of food
groups.
Subjects and methods
The population based case-control study was conducted in the Netherlands between
1989 and 1993. Cases were defined as newly diagnosed male and female patients
with adenocarcinoma of the colon (ICD-0 153). They were recruited from regional
hospitals from east and central Netherlands. The cancer registries of these areas
were used as a check on completeness and provided additional clinical and
pathological information. Cases were Western-European with the Dutch nationality,
who were at time of diagnosis up to 75 years old and did not have previous cancer,
polyposis coli, ulcerative colitis or Crohn's disease. For 28 cases, the cancer registry
defined the location of the tumor as rectosigmoid in contrast with the surgeon who
located the tumor in the colon. Analyses were conducted including as well as
excluding these cases.
Of all eligible cases diagnosed in the cooperating hospitals, 47% was invited to
participate. Non-invitation was mainly due to technical and administrative reasons.
Cases invited did not differ importantly from those not invited in age, gender,
urbanization-level and site distribution. Cases who were not invited did have a
worse prognosis according to Dukes' status and more frequently underwent
radiotherapy and chemotherapy. Of those invited, 60% agreed to be interviewed.
Except for Dukes' status, the distributions of age, gender, tumor site and therapies
of the interviewed cases was comparable to the distribution among all eligible cases.
In order to explore potential selection bias, participants and non-participants were
asked to fill out a short questionnaire on life-style habits and the consumption
frequency of dairy products, bread and meat. All participating cases and 23% of the
non-participating cases filled out the questionnaire and returned it. Cases
participating in the interview did not differ significantly in the consumption of food
groups of major interest from those non-participants who filled out the short ques-
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The population controls were recruited randomly by genera! practitioners of
participating cases, using the same eligibility criteria as for the cases. They were
frequency matched on age, sex and degree of urbanization to the cases. Of the 520
controls invited, 57% agreed to participate in the interview. Participation was higher
among younger people and those living in urban areas. Meat intake, other dietary
and life-style patterns did not differ importantly between those who participated in
the interview and those who refused to participate but completed the non-response
questionnaire (42% of the non-participants).
Cases and controls were interviewed on dietary habits and life-style factors in their
own homes by qualified dietitians. For cases, the interval between diagnosis and
interview was three to six months. Each dietitian interviewed a similar number of
cases and controls in a geographical area. The dietary part of the questionnaire
requested information on the frequency of consumption during 1 year prior to
interview (for cases before diagnosis or complaints) and consisted of a detailed
structured dietary history questionnaire, covering the complete dietary pattern. The
frequency of consumption per month, number of months in which the item was
consumed, the number of portions per consumption and the size of the portions of
289 food items from 19 food groups were asked for. To be able to estimate portion
sizes, frequently used household utensils and cups were weighed.
To minimize errors, the dietary history questionnaire was entered into the
computer using a specially designed computer program which included range-
checks and cross-checks. Checks on the internal consistency of the frequency of
consumption of various meal components with the total meal pattern were
conducted. Frequencies of individual items were corrected automatically in order to
agree with the frequencies of the total food group. Average daily intake of nutrients
was calculated using the Dutch National Food Table.*' Intake of nutrients was
adjusted for energy intake by regression analysis for men and women separately."
In addition to diet, subjects were asked about socio-demographic characteristics
(e.g. age, urbanization-level, education and occupation), menstrual and reproductive
history for women, positive family history of colon cancer, personal medical
history, smoking habits and past use of medications. To address stability of food
habits, changes in habits as a result of gastro-intestinal complaints were asked for.
Data ana/ys/s
Differences in demographic, predisposing, dietary and life-style factors were compa-
red between cases and controls. The individual food items in the questionnaire were
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categorized into major food groups (e.g. vegetables, fruit, red meat (including fresh
red meat) and poultry) which intake was expressed in grams per day. Ratios were
calculated for red meat to poultry and fish and for red meat to vegetables and fruits.
Calculating ratios, non-users were excluded from the analyses (4 non-users of red
meat and 26 non-users of fish or poultry; each participant consumed vegetables or
fruits). Including non-users did not change the results importantly (data not shown).
Nutrient intake, food group consumption and the ratios were divided into
quartiles according to the distribution in the control group. Odds ratios (OR) for
colon cancer as estimates of relative risks, together with their approximate 95%
confidence intervals (95% CI), were calculated by maximum likelihood estimation
using BMDP software, taking the lowest quartile of exposure as the reference. To
account simultaneously for the potential confounding effect of age, gender,
urbanization-level, energy intake, vitamin C intake (only with nutrient intake),
family history of colon cancer, cholecystectomy, socio-economic status, body mass
index, smoking habits and alcohol intake, multiple logistic regression models were
used. Decisions on which covariates to include in the final models were based on 1)
evidence from epidemiological literature, 2) biological plausibility, 3) whether the
regression coefficient of the primary independent variable changed a 10% after
addition of the potentially confounding variable and 4) whether the covariate
entered the model at the 0.10 level of significance.
Chi-square tests for trend were conducted using the median of each quartile as a
continuous variable. Chi-square tests for gender interaction were conducted.
Additionally, odds ratios of those food groups for which an interaction with gender
was observed were calculated for men and women separately, with the quartiles
based on the distribution of the intake of male and female controls, respectively.
Results
Mean age was similar among cases and controls (Table 7.1). The case group
included more men, less current smokers, less people living in urban areas and a
higher proportion of people with lower socio-economic status.
Family history of colon cancer and cholecystectomy was more frequent among
cases. The intake of energy, energy-adjusted intake of total fat and total protein was
higher among cases, while the energy-adjusted intake of total carbohydrates, dietary
fiber, vitamin C and alcohol was less. Total supplement use and use of specific
calcium and vitamin D supplements tended to be lower in cases. Cases and controls
did not differ in body mass index.
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Table 7.1 Mean and standard deviation of some characteristics in 232 colon cancer cases and
259 controls.
Characteristics
£>emograp/uc /actors
Age (years)
Sex (%male)*
Urbanization-level (% urban)*
Socio economic status (% blue collar)"
Predisposing /actors
Family history of colorectal
cancer (%)*
Cholecystectomy (%)*
Piefary /actors*
Total energy intake (kj)
Total fat (g)
Total carbohydrates (g)
Total protein (g)
Dietary fiber (g)
Vitamin C (g)
Z,i/e-sfy/e /actors
Body mass index (kg/m')
Current smokers (%)*
Alcohol (g)'
Supplement use
Total (%)'
Calcium and or vitamin D (%)*
Cases (n = 232)
mean ± SD
62 ± 10
56 ± 3
48 ± 3
4 6 ± 9
18 ± 3
10 ± 7
10,433 ± 3,234
104 ±25
246 ±58
85 ± 17
28 ± 9
105 ± 53
26 ± 4
29 ± 3
11 ±25
34 ± 3
11 ± 2
Controls (n = 259)
mean ± SD
62 ± 10
53 ± 3
53 ± 5
4 0 ± 3
11 ± 2
5 ± 6
9,362 ± 2,844*
101 ± 25
254 ± 52
84 ± 15
29 ± 8
118 ±54*
26 ± 4
33 ± 3
14 ± 18
37 ± 3
19 ±2*
' adjusted for total energy intake by regression analysis, separately for men and women.
* p < 0.05.
Table 7.2a presents odds ratios of colon cancer for quartiles of intakes of sever-
al food groups. Considering food groups of vegetable origin, a significant inverse
association with vegetable consumption was found after adjustment for total energy
and for variables for which frequency matching occurred. For other food groups of
vegetable origin no significant associations were found: OR ranged from 0.67 for
potatoes to 1.16 for cereal products (Table 7.2a). For the consumption of legumes
no important associations were found as well (OR = 1.08; 95% CI = 0.67-1.76).
However, in this population legumes were consumed too infrequent to draw firm
conclusions.
Table 7.2a. Vegetable and animal products as related to the risk of colon cancer by quartiles of vegetable and animal products (both genders combined).
Variable 01 Q2 Q3 04 X t^rend (p-value) x*8"ider interactions
(p-value)
VEGETABLE PRODUCTS
Vegetables (g/day) < 142 142-191 192-247 > 247
cases/controls 81/65 68/65 48/65 35/64
OR(95%CI)« 1.00 0.82(0.50-132) 0.57(0.34-0.95) 0.40(0.23-0.69) 132(0.22)
OR(95%CI)' 1.00 0.73(0.45-1.21) 0.53(0.32-0.89) 0.40(0.23-0.69) 1238(0.0004)
Fruits (g/day) < 125 125-198 199-288 > 288
cases/controls 62/65 63/65 51/65 56/64
OR(95% CI)« 1.00 0.95(0.57-1.58) 0.78(0.46-1.32) 0.76(0.45-1.29)
OR(95% CI)' 1.00 0.97(0.58-1.63) 0.79(0.46-1.35) 0.82(0.84-1.41) 0.80 (037)
4.12 (0.04)
Potatoes (g/day) < 79 79-115 116-171 > 171
cases/controls 55/67 62/64 69/65 46/63
OR(95% CI)« 1.00 1.23(0.74-2.07) 1.16(0.69-1.95) 0.62(0.34-1.12)
OR(95% CI)' 1.00 1.23(0.73-2.08) 1.24(0.73-2.11) 0.67(0.37-1.22) 1.77 (0.18)
0.13 (0.72)
Cereal products (g/day) < 121 121-159 160-200 > 200
cases/controls 56/66 55/64 45/68 76/61
OR(95% CI)» 1.00 0.96(0.57-1.62) 0.60(0.35-1.05) 0.99(0.55-1.77)
OR(95% CI)' 1.00 1.08(0.63-1.85) 0.69(0.39-1.21) 1.16(0.63-2.14) 0.08(0.77)
ANIMAL PRODUCTS
Red meat (g/day) < 52 52-72 73-94 > 94
cases/controls 55/67 46/64 59/67 72/61
OR(95% CI)' 1.00 0.84(0.49-1.43) 0.97(0.58-1.63) 1.18(0.70-2.00)
OR(95%CI)' 1.00 0.80(0.47-1.38) 0.91(0.54-1.55) 1.11(0.65-1.90) 030(038)
Poultry (g/day) < 5 5-10 11-21 > 21
cases/controls 67/77 53/53 66/71 46/58
OR(95% CI)' 1.00 1.08(0.65-1.82) 1.08(0.67-1.74) 0.86(0.51-1.45)
OR(95% CI)' 1.00 100(0.59-1.70) 1.04(0.64-1.70) 0.79(0.46-1.35) 0.71(0.40)
0.62 (0.43)
5.45 (0.02)
0.70 (0.40)
2
Fish (g/day)
cases/controls
OR(95% CI)*
OR(95% CI)'
Dairy products (g/day)
cases/controls
OR(95% CI)«
OR(95% CI)'
Eggs (g/day)
cases/controls
OR(95% CI)'
OR(95% CI)'
RED MEAT/POULTRY + FISH
ratio
cases/controls*
OR(95% CI)'
OR(95% CI)'
< 5
64/70
1.00
1.00
< 270
55/65
1.00
1.00
< 8
49/65
1.00
1.00
< 1.33
48/61
1.00
1.00
5-12
41/62
0.72(0.42-1.22)
0.73 (0.42-1.24)
270-404
51/66
0.84(0.49-1.42)
0.88(0.52-1.51)
8-12
46/66
0.86(0.50-1.48)
0.86(0.50-1.49)
1.33-2.52
61/61
1.14 (0.67-1.95)
1.05(0.61-1.81)
13-24
49/63
0.85 (0.51-1.43)
0.85 (0.50-1.44)
405-588
44/64
0.71 (0.41-1.21)
0.77(0.44-1.34)
13-19
69/69
1.19(0.71-2.00)
1.22 (0.72-2.06)
2.52-4.73
57/60
1.18(0.69-2.02)
1.22(0.71-2.11)
>24
78/64
1.15 (0.70-1.89)
1.13 (0.68-1.87)
> 588
82/64
1.13 (0.67-1.89)
1.27 (0.75-2.17)
> 19
68/59
1.22(0.71-2.08)
1.17 (0.68-2.01)
> 4.73
51/62
1.07(0.62-1.86)
1.05 (0.60-1.84)
0.84 (0.36)
1.4S (0.23)
0.79 (0.38)
0.36 (0.55)
2.00 (0.16)
0.31 (0.58)
0.01 (0.92)
1.88 (0.17)
RED MEAT/VEGETABLES + FRUITS
ratio
cases/controls*
OR(95% CI)'
OR(95% CI)'
<0.11
41/64
1.00
1.00
0.11-0.18
53/63
1.33 (0.77-2.31)
1.26(0.72-2.22)
0.18-0.27
60/65
1.47 (0.85-2.54)
1.45 (0.83-2.52)
>0.27
76/65
1.82(1.06-3.13)
1.76(1.01-3.07) 4.00 (0.05)
16.23 (0.0001)
§ adjusted for age, gender, urbanization-level and total energy intake.
1 adjusted for age, gender, urbanization-level, total energy intake, alcohol intake, cholecystectomy and family history of colorectal cancer.
* non-users of food groups included in the denominator and/or nominator were excluded from these analyses.
Table 7.2b. Total energy intake and the intake of energy-adjusted nutrients as related the risk of colon cancer (both genders combined).
Variable Ql Q2 Q3 Q4 x* trend (p- ^gender inter-
value) actions (p-value)
0.48 (0.49)
Energy intake (Kj)
cases/controls
OR(95% CI)'
OR(95% CI)'
Vitamin C*
cases/controls
OR(95% CI)«
OR(95% CI)'
P-Carotene'
cases/controls
OR(95% CI)*
OR(95% CI)'
Dietary fiber*
cases/controls
OR(95% CI)'
OR(95% CI)'
< 7,476
39/65
1.00
1.00
<79.0
73/65
1.00
1.00
< 1.8
81/63
1.00
1.00
< 23.1
82/65
1.00
1.00
7,476-8,857
46/65
1.36(0.76-2.41)
1.36(0.76-2.45)
79.0-110.8
73/65
1.04(0.64-1.69)
1.07(0.65-1.76)
1.8-2.4
50/67
0.64 (0.39-1.07)
0.64 (0.38-1.06)
23.1-27.8
49/65
0.58 (0.35-0.97)
0.57 (0.34-0.96)
8,858-11,097
57/65
1.74(0.98-3.08)
1.82 (1.01-3.30)
110.8-146.6
49/65
0.66(0.40-1.11)
0.70(0.42-1.19)
2.4-3.4
53/65
0.69 (0.42-1.15)
0.70 (0.42-1.16)
27.8-33.4
49/65
0.58 (0.34-0.97)
0.63(0.37-1.06)
> 11,097
90/64
3.17(1.70-5.91)
3.47(1.83-6.58)
> 146.6
37/64
0.51 (0.30-0.88)
0.53(0.31-0.92)
>3.4
48/64
0.60 (0.36-1.00)
0.61 (0.36-1.03)
> 33.4
52/64
0.56 (0.33-0.95)
0.62(0.36-1.08)
17.57 (0.0000)
6.91 (0.009)
2.91 (0.09)
Z47 (0.12)
2J3 (0.11)
0.32 (0.57)
3.54 (0.06)
Animal protein'
cases/controls
OR(95% CI)'
OR(95% CI)'
Saturated fat'
cases/controls
OR(95% CI)«
OR(95% CI)'
Cholesterol'
cases/controls
OR(95% CI)«
OR(95% CI)'
<48.2
54/65
1.00
1.00
< 33.4
42/64
1.00
1.00
< 226.2
45/65
1.00
1.00
48.2-56.5
45/65
0.87(0.50-1.50)
0.85 (0.48-1.49)
33.4-40.7
64/66
1.71 (0.99-2.95)
1.53(0.87-2.69)
226.2-286.0
59/65
1.58(0.92-2.73)
1.43(0.82-2.50)
56.5-65.4
66/65
1.40 (0.82-2.40)
1.39(0.80-2.41)
40.7-49.5
64/65
1.80 (0.96-3.38)
1.55 (0.80-3.01)
286.0-347.2
60/65
1.71 (0.97-3.03)
1.54 (0.86-2.78)
>65.4
67/64
1.25 (0.72-2.17)
1.32 (0.75-2.33)
>49.5
62/64
1.63(0.82-3.23)
1.37(0.66-2.85)
> 347.2
68/64
1.73(0.95-3.14)
1.48 (0.80-2.76)
1.88 (0.17)
0.09 (0.77)
0.08 (0.78)
0.44 (0.51)
1.21 (027)
0.53 (0.47)
• adjusted for age, gender, urbanization-level and total energy intake.
" adjusted for age, gender, urbanization-level, total energy intake, alcohol intake, vitamin C intake (not for P-carotene and dietary fiber),
cholecystectomy, family history of colorectal cancer.
* mg per day, adjusted for total energy intake by regression, separate for men and women.
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Table 7.3 Gender specific associations of fruits, red meat, the ratio of meat to vegetables and
fruit with the risk of colon cancer.
Variable
FRUITS
Me/i g/day
cases/controls
OR(95%CI)«
OR(95%CI)'
Women g/day
cases/controls
OR(95%CI)»
OR(95%CI)'
RED MEAT
Men g/day
cases/controls
OR(95%CI)'
OR(95%C1)'
Women g/day
cases/controls
OR(95%CI)'
OR(95%CI)'
Ql
< 100
36/34
1.00
1.00
< 143
31/31
1.00
1.00
<60
33/34
1.00
1.00
<38
12/31
1.00
1.00
RED MEAT/VEGETABLES
Men ratio
cases/controls
OR(95%CI)»
OR(95%CI)'
Women ratio
cases/controls
OR(95%CI)'
OR(95%C1)'
< 0.14
32/34
1.00
1.00
<0.09
16/33
1.00
1.00
Q2
100-162
25/34
0.73 (0.36-1.49)
0.77 (0.37-1.61)
143-241
30/31
0.86 (0.41-1.80)
0.89 (0.42-1.89)
60-83
35/36
0.82(0.41-1.65)
0.80(0.39-1.61)
38-59
25/33
2.05 (0.86-4.88)
1.82(0.75-4.46)
+ FRUITS
0.14-0.22
33/32
1.09(0.54-2.20)
1.04(0.51-2.13)
0.09-0.13
11/26
0.92 (0.36-2.36)
0.81 (0.30-2.17)
03
162-269
30/34
0.80(0.40-1.61)
0.84 (0.41-1.72)
241-327
24/31
0.77 (0.36-1.69)
0.82 (0.38-1.79)
83-102
24/33
0.62 (0.30-1.30)
0.57 (0.27-1.20)
59-83
36/31
2.82(1.21-6.56)
2.71 (1.15-6.38)
0.22-0.33
24/35
0.79(0.38-1.61)
0.79(0.38-1.64)
0.13-0.20
26/32
1.65(0.73-3.71)
1.53 (0.67-3.51)
Q4
>269
39/34
0.94 (0.48-1.86)
1.00(0.49-2.03)
>327
17/30
0.48(0.21-1.09)
0.54(0.23-1.23)
> 102
38/33
0.96 (0.47-1.92)
0.89 (0.43-1.81)
> 83
29/28
2.40(1.01-5.73)
2.35 (0.97-5.66)
>0.33
40/34
1.28 (0.64-2.56)
1.18 (0.57-2.43)
>0.20
48/31
3.04(1.41-6.56)
3.05 (1.39-6.71)
X t^rend
(p-value)
0.02 (0.88)
2.27 (0.13)
0.25 (0.62)
4.09 (0.04)
0.16 (0.69)
11.64(0.0006)
§ adjusted for age, urbanization-level and total energy intake.
1 adjusted for age, urbanization-level, total energy intake, alcohol intake, family history of colon
cancer and cholecystectomy.
Additional adjustment for other covariates (cholecystectomy, family history and
alcohol intake) did not change the odds ratios appreciably. Social economic status,
any supplement use, body mass index, smoking habits, and total fat intake did not
enter the multivariate model at the 0.10 level of significance, did not appreciably
alter the estimates and were therefore not included in the models.
For intake of animal products, non-significant positive associations were found
for red meat, dairy products and eggs. A non-significant inverse association was
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observed for poultry consumption. The ratio of red meat to poultry and fish
consumption was not importantly associated with risk. The ratio of red meat to
vegetables and fruits, however, was significantly positively related to risk. No
gender interactions were observed, except for the consumption of fruits, red meat
and the ratio of red meat to vegetables and fruits.
Table 7.2b presents odds ratios for colon cancer by quartiles of total energy
intake and by quartiles of energy-adjusted nutrients from vegetable and animal
sources. Energy intake was positively associated with colon cancer. For nutrients
related to vegetable intake (dietary fiber, P-carotene, vitamin C) inverse associations
with risk were found. As a consequence, inclusion of vitamin C in the multivariate
model attenuated the odds ratios for dietary fiber and p-carotene (data not shown).
Nutrients related to meat intake (saturated fat, animal protein, cholesterol) were
found to be positively non-significantly associated with risk.
For the food groups that showed an interaction with gender (Table 7.2a), gender
specific odds ratios are presented in Table 7.3. For both men and women a non-
significant inverse association with consumption of fruits was observed, which was
stronger for women. Among women, but not among men, a significantly increasing
trend was evident for intake of red meat. A similar association was not seen in men.
Adjustment for saturated fat intake did not appreciably modify these results and
saturated fat intake was therefore not included in the model.
When participants (33 cases and 10 controls) who indicated that they had altered
their dietary pattern as a result of gastro-intestinal distress were excluded from the
analyses, results did not change appreciably either.
Discussion
From those products of vegetable and animal origin studied, the consumption of
vegetables was found to be inversely associated with colon cancer risk. In addition,
for women, a non-significant inverse association was found for fruit consumption,
while red meat consumption increased risk.
In each retrospective case-control study, selection and information bias might affect
the internal validity. Selection bias in cases may occur, when degree of illness is
correlated to participation rate. In this study cases with a worse prognosis according
to the Dukes' classification participated less often. Dukes' status was inversely
related to vegetable consumption: cases with Dukes' C and D tumors consumed less
vegetables than those with Dukes' A and B tumors. If more cases with C and D
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tumors would have participated in the study, we might have found stronger inverse
associations for vegetables. Meat consumption was not related to Dukes' status in
this study. Participating and non-participating cases did not differ in meat
consumption either. Since recall of dietary habits can be influenced by a more
severe prognosis or medical treatment influencing appetite, it may be an advantage
to have cases with better prognosis participating in the study. Age, gender and
urbanization-level from interviewed cases did not significantly differ from those
eligible.
In the Netherlands, a vegetable rich diet is related to a healthy life-style in
general and a higher socio-economic status. If selection of more health-conscious
controls occurred, it might explain the results of this study. However, our
population-based control group was comparable to the general population according
to the distribution of socio-economic status.
In order to minimize information, cases and controls were interviewed in the
same season using a structured dietary history questionnaire. Interviewers were
trained by the same experienced dietician, who intensively monitored their inter-
viewing and coding. Each interviewer assessed dietary habits of an similar number
of cases and controls. No differences between interviewers were found.
Recall bias might influence the results especially when cases, as a result of their
disease, report their usual intake before symptoms occurred or the disease was
diagnosed differently from the controls. Differential overreporting could occur if
some cases remember consuming more foods in general by concentrating more
intensively, which is supported by the observed positive association with total
energy intake. However, adjustment for total energy intake could not explain our
findings. Social desirability of eating healthy foods, such as vegetables and fruits,
might influence recall as well. Since the questionnaire was structured, and the
complete dietary pattern and several life-style habits were inquired about, it may be
assumed that participants were unaware of the hypothesis tested. Finally, changes of
habits as a result of gastro-intestinal distress might also be an important reason for
recall bias. However, excluding those who indicated to have changed their dietary
habits because of complaints did not change the results importantly.
In conclusion, selection and information bias do not seem to have distorted the
internal validity of the study seriously.
Food groups o/ vegefafe/e or/gzn
With respect to vegetable consumption, our study confirms the results of the
majority of other case-control studies on colon cancer which observed inverse
associations with at least one vegetable group." However, most studies reported non-
significant decreases in risk of approximately 20 to 40% with higher intakes of
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vegetables. Differences between studies might be a result of different consumption
patterns among the populations studied. The consumption of vegetables in our study
population is relatively high as compared to other studies, and is also high when
compared with the intake among the general Dutch population, which is assessed
using a 2-day record.^ Although checks have been included in the data entry
program to compare the reported total frequency of vegetable consumption with the
reported consumption of individual vegetables, this might just be a consequence of
the lengthy dietary history method used.
Taking power considerations into account and the fact that the examination of a
large number of food items might increase the possibility of chance findings and
therefore introduce over-interpretation, we explored the associations with food
groups and not of individual food items. Previous studies observed inverse
associations between colon cancer risk and green leafy vegetables'* and cruciferous
vegetables.'"' The majority of vegetables consumed in this population were
cruciferous vegetables and green leafy vegetables.
Vegetable consumption was more strongly related to risk than fruits. This is not
in line with the case-control study of Steinmetz and Potter'" conducted in Australia.
In our study an inverse association with fruit consumption was only observed
among women, which is in line with the results for fruits in other'*-'" but not all*
case-control studies.
Potatoes are an important source of vitamin C and polysaccharides. We observed
an inverse association with potato consumption. This is in line with a few other
case-control studies,"' while in some studies an increased risk with potato
consumption was found."•"•'* Nevertheless, as potatoes are often consumed as part
of the main meal, the observed inverse association might be an underestimation of
the true association, because of the associated consumption of meat or the use of
fat-laden condiments.
Food groups o/ awi/wa/ origin
Except for a positive association with red meat consumption in women, for food
groups of animal origin, only non-significant associations were found. None of the
quintile specific OR's nor trends were statistically significant.
A higher consumption of fish or poultry did not importantly decrease colon
cancer risk as suggested by other studies.'*'" Furthermore, the ratio of red meat to
fish and poultry was not associated with risk, which is in line with the findings of
an Australian case-control study," but not with the findings in the Nurses' Health
Study.-"
Consumption of dairy products was weakly positively, but non-significantly
related to risk in this population. The results of epidemiological studies have been
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controversial with respect to consumption of dairy products; some suggest a non-
significant positive association,""'^ while others observe a significant inverse
association.'"'"
The consumption of eggs was not markedly associated with risk in this
population. Although the range of egg consumption was similar, an Australian case-
control study observed an 2.4 fold increase in risk in the uppermost quartile of
consumption." Cholesterol was positively but not significantly related to risk in our
study.
An increased risk with red meat consumption was observed among women. Beef
and pork were the most frequently consumed types of red meat in this population.
Increased risks with higher consumption of red meat have previously been observed
in some studies,'*"'*"* but not in others, including a cohort study in the
Netherlands."''" Red meat is an important source of saturated fat which has been
linked to colon cancer risk in most studies.** Saturated fat was positively but not
significantly associated with risk in our study, Besides its fat content, meat might be
an important source of a variety of heterocyclic amines, formed during cooking
processes. After enzymatic activation, these compounds are found to be potent
mutagens shown to induce colon tumors." Since we did not expect a large
heterogeneity in meat preparation in this older population and the assessment of
cooking method might be unreliable, we did not explore methods of meat
preparation in this study.
This study implies that among women the consumption of red meat relative to
vegetables and fruits might be important. Antioxidants or other substances in
vegetables and fruits might neutralize the potential initiating or promoting factors
which might be present in red meat.'"
Gender
Gender interactions were observed for the consumption of fruits and red meat.
Different findings for men and women might make a chance finding more likely.
Moreover, differences in results between genders could be due to a difference in the
preciseness of the information on food consumption. Women, however, are more
likely to give more precise information on food consumption than men; in this
Dutch population women traditionally have a more active role in food purchasing
and preparation. However, to minimize recall differences between genders in our
study, female spouses were asked to be present at the time of the home interview of
theirmale partner. A second explanation for the gender differences might be related
to the amount consumed. In this study and in the general Dutch population, women
tend to consume more fruits than men. However, women consume less red meat as
well.
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The positive association with red meat intake in women was mainly determined
by the reference group, with an extremely low consumption of red meat. Excluding
this group from the analyses attenuated the odds ratio. It is plausible that the
category with the lowest meat consumption differs in other risk factors as well. This
explanation does not hold, however, since controls with the lowest as compared to
the highest red meat consumption, did not differ importantly for dietary variables
other than animal protein (data not shown). Nevertheless, those with the lowest red
meat consumption tended to have a more health-conscious life-style, e.g they
smoked less, drank less alcohol and used more vitamin supplements. Thirdly, real
gender differences may exist in colon cancer aetiology. This is supported by the fact
that men and women differ in colon physiology, such as bile acid profiles and
colonie pH.^ Moreover, epidemiologic studies have shown different demographic
patterns of colon cancer for men and women."
In summary, the results of this Dutch case-control study provide further support
for a protective role for vegetable consumption in colon cancer risk. With the
exception of fruits and red meat in women, it does not provide evidence for
important reductions or enhancements in risk with other vegetable or animal
products in the Netherlands.
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Chapter 8
Fermented dairy products, calcium and colorectal cancer in
the Netherlands Cohort Study
Ellen Kampman, R. Alexandra Goldbohm, Piet A. van den Brandt, Pieter van 't Veer.
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Abstract ~
Experimental studies suggest that an increased consumption of fermented dairy
products and calcium might decrease the risk of colorectal cancer.
The association between fermented dairy products, dietary calcium and colorectal
cancer risk was investigated in a population with a wide variation in intake of dairy
products. The Netherlands Cohort Study on diet and cancer (NLCS) started in 1986
when 120,852 Dutch men and women, aged 55-69 years, filled out a questionnaire
on dietary patterns and life-style. The present analysis is based on 3.3 years of
follow-up and included 215 incident cases of colon cancer and 111 incident cases of
rectal cancer, excluding cases diagnosed in the first year of follow-up.
After adjustment for potential confounding variables, colorectal cancer risk was
weakly inversely associated with the consumption of fermented milk (Relative Rates
(RR) in the highest category of intake compared to non-users = 0.89, 95%
Confidence Intervals (CI) = 0.60-1.33), unfermented milk (RR = 0.86, 95% CI =
0.57-1.29), and cheese (RR = 0.88, 95% CI = 0.59-1.33). However, category-
specific relative rates, and tests for trends were not statistically significant. For
fermented milk, the inverse association was limited to colon cancer (RR = 0.70,
95% CI = 0.43-1.15, trend p = 0.33).
In crude and multivariate models, total dietary calcium intake (highest vs. lowest
quintile RR = 0.92, 95% CI = 0.64-1.34) and calcium from fermented dairy
products (RR = 1.14, 95% CI = 0.77-1.68) were not significantly associated with
colorectal cancer risk. Calcium from unfermented dairy products was inversely
associated with rectal cancer risk (RR = 0.55, 95% CI = 0.30-1.04, trend p = 0.03).
After 3.3 years of follow-up, these data are not consistent with a substantially
decreased risk of colorectal cancer with increased intake of fermented dairy
products and dietary calcium.
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Introduction
Colorectal cancer is one of the major types of cancer in Western society. In the
Netherlands, yearly about 48 new cases of colorectal cancer (30 colon, 18 rectum)
are diagnosed per 100,000 men and 49 cases per 100,000 women (35 colon, 14
rectum). Colorectal cancer is the third most common cancer in Dutch men and the
second most common cancer in Dutch women.' As its incidence is still rising,
treatment is difficult, and mortality remains high, emphasis should be placed on
preventive measures. Besides dietary recommendations against cancer in general,
such as a higher consumption of vegetables and fruits,^ other relatively simple and
feasible dietary changes might add to the prevention of colorectal cancer.
The possible protective role of fermented dairy products such as yogurt,
buttermilk and cheese, originally proposed by Metchnikoff in the beginning of this
century, has regained attention in the past decade. Establishment of certain
lactobacilli in the gastro-intestinal tract could contribute to the stabilization of the
colonie flora, and exert beneficial effects on the host. In recent experiments, the
activity of carcinogen-producing faecal enzymes was decreased in subjects
supplemented with Lac/ofoac///«s cultures'" and in vitro studies with human
lymphocytes suggest that lactobacilli stimulate the immune system locally, as well
as systemically.^
In addition to these mechanisms mediated by microorganisms, fermented dairy
products contribute substantially to our daily calcium intake. In the Netherlands,
about 70% of calcium intake is of dairy origin, half of which is from fermented
dairy products. It is hypothesized that calcium" or, more recently, that calcium
phosphate"* binds free fatty acids and bile acids, thereby reducing the effective toxic
dose to the colonie epithelial cells and their subsequent proliferative response.
Calcium might also directly influence cell proliferation by inducing cell
differentiation.'"
Although several epidemiological studies have investigated the relationship
between dairy product consumption, calcium intake and colorectal cancer (e.g."'")
or colorectal polyps (e.g."), only few addressed the association with fermented
dairy products.'*'*"'^'''*' In two population-based case-control studies on colon
cancer an inverse association was observed for yogurt (Odds Ratio (OR) = 0.83 for
10 servings per month, 95% Confidence Intervals (CI) = 0.70-0.98)*' and cultured
milk consumption (OR = 0.65, 95% CI = 0.41-1.01),"" adjusted for potential
confounding variables. In two companion American prospective studies, the 1980-
1988 follow-up of the Nurses' Health Study (NHS: 121,700 women) and the 1986-
1990 follow-up of the Health Professionals Follow-Up Study (HPFS: 51,529 men),
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a non-significant inverse association with yogurt consumption and colorectal polyps
was found (RR for more than 4 times a week 1 cup vs. almost never NHS = 0.60,
95% CI = 0.30-1.18; HPFS = 0.66, 95% CI = 0.28-1.46), which diminished in the
HPFS after adjustment for covariates (RR = 0.89)."
Although cheese consumption contributes significantly to saturated fat intake, in
several case-control studies'''"'"' and one prospective study" the consumption of
this product was not strongly associated with colorectal cancer risk (Relative Rates
(RR) 0.9, 0.7, 1.1 and 1.1 respectively).
The studies mentioned above have mainly been conducted in countries in which
the consumption of yogurt or cultured milk is not integrated in traditional food
habits. In countries in which the consumption of fermented milk is high and
heterogeneous, the comparison of risks between high and low consumption
categories would be most powerful. The Dutch have a longstanding tradition of
fermented dairy product consumption (e.g. per capita annual consumption of yogurt
in the Netherlands is 18.9 kg vs. 2.1 kg in the United States)."'' In two case-control
studies conducted in the Netherlands inverse associations between breast cancer^
and cancer of the exocrine pancreas* on the one hand and fermented dairy product
consumption on the other were observed. We studied the association between these
products, calcium and colorectal cancer prospectively in the ongoing Netherlands
Cohort Study (NLCS) on diet and cancer."
Methods
The cohort characteristics and the method for cancer follow-up have been
described."' Briefly, the study was initiated in 1986 when 58,279 men and 62,573
women aged 55 to 69 completed a self-administered baseline questionnaire
inquiring after food habits and potential confounding factors. Following the case-
cohort approach for analysis of the data, a subcohort of 3,500 persons (1,688 men,
1,812 women) was randomly sampled from the baseline cohort and followed up for
vital status to estimate the person time contributed by the entire cohort. No
subcohort members were lost to follow-up. Incident cancer cases occurring in the
cohort were identified by record linkage to cancer registries and a nation-wide
pathology register."* The analysis in this report was restricted to 3.3 years of follow-
up from September 1986 (baseline) to December 1989. The completeness of cancer
follow-up was estimated to be 95%.**
The semi-quantitative food frequency questionnaire included 150 food items
concentrating on habitual food and beverage intake during the preceding year.*' The
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daily amounts of 9 dairy items were estimated from the number of glasses (milk,
chocolate milk, buttermilk), number of cups (yogurt, curds, custards with and
without dietary fiber) or number of sandwiches filled (cheese and low-fat cheese).
In addition, consumption of cheese as a meat substitute with the hot meal was asked
for. ., ..
The questionnaire was validated against a 9-day dietary record.* The sex- and
energy- adjusted Pearson coefficients of correlation for dietary calcium was 0.62.
The Spearman coefficient of correlation for milk and milk products was 0.60 and
for cheese 0.61. To minimize observer bias in coding and interpretation of the data,
questionnaires were key-entered twice and processed blinded with respect to
case/subcohort status.
Data
Subjects who reported a history of cancer other than skin cancer in the baseline
questionnaire were excluded. A total of 3,346 subcohort members (1,630 men,
1,716 women) and 478 incident cases (312 colon, 166 rectum; 258 men, 220
women) remained available for analysis. Furthermore, 7% of these subjects were
excluded because of incomplete or inconsistent dietary data." Therefore, 3,111
subcohort members and 443 colorectal cancer cases (293 colon, 150 rectum), 12 of
which were members of the subcohort, were included in the analysis. As subclinical
symptoms of colorectal cancer may influence dietary habits before diagnosis, data
were analyzed without taking the first year of follow-up into consideration (3,083
subcohort members, 215 colon cancer and 111 rectal cancer cases).
Categories of dairy product intake were based on the subcohort distribution with
non-users taken as the reference. Additional analyses were conducted excluding
non-users and taking the lowest category of intake as the reference. For nutrient
intakes, quintiles based on the subcohort distribution were used in the analysis.
Since subjects tend to skip items they do not consume/' persons with missing data
on a relevant dairy product were treated as non-users. We verified this assumption
by conducting analyses including a variable indicating those with missing data on
one of the specific foods.
In this cohort, the major fermented dairy products were buttermilk (39% of total
consumption in grams), yogurt (39%), fat cheese (16%) and curds (6%). Because of
their low contribution, curds are not taken into account in analyses on products. The
fermented milks (yogurt and buttermilk) which differ from cheese with respect to
their consumption pattern, were treated as one food group. With respect to cheese,
analyses were restricted to full-fat cheese (95% hard cheese) which accounts for
about 90% of cheese consumption in this cohort.
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In this population, the consumption of yogurt and buttermilk was positively,
although not strongly, correlated (r = 0.13).
Mean daily nutrient intake was calculated from mean food intakes using the
computerized Dutch food composition tabled Energy-adjusted nutrient intakes were
based on residuals from the regression of nutrient intake on total energy intake.**
Since, exact amounts of calcium in the various supplements used were not
available, calcium supplement use (alone (91%) or in combination with vitamin D)
is examined as a dichotomous variable (use yes or no). Since less than 1% of the
subcohort uses specific vitamin D supplements, these supplements were not taken
into account in these analyses.
The case-cohort approach was used for data analysis.** Specific programs were
developed to account for the additional variance introduced by estimating the person
time-at-risk for the subcohort instead of for the entire cohort."
Apart from the known risk factors for colorectal cancer (age, family history of
large bowel cancer, history of gallbladder surgery^), the following variables were
evaluated as potential confounders using multivariate models: smoking, level of
education, any vitamin supplement use, intake of energy and energy adjusted intake
of fat and dietary fiber. Cases with missing data on covariates were excluded from
the multivariate analyses.
Vitamin D intake through sun exposure and from foods could not be adequately
assessed and was not taken into account in these analyses.
In addition, analyses were conducted for colon and rectal cancer separately.
Results
Daily intake of yogurt and buttermilk together (median) ranged from 0 g/day in the
lowest to 267 g/day in the highest category of intake. For hard cheese consumption,
the intake ranged from 0 in the lowest to 37 g/day in the highest category. Intake of
calcium ranged from 546 mg in the lowest quintile to 1,344 mg in the highest
quintile; after energy adjustment these medians were 581 and 1,286 mg/day,
respectively.
Table 8.1 shows various characteristics of subcohort members according to high
and low intake of fermented milk and calcium.
Those who never consumed yogurt or buttermilk did not differ largely regarding
age, energy intake and calcium/ phosphate ratio from those in the highest category
of intake. Energy-adjusted intake of fat was higher, while energy-adjusted dietary
fiber intake was lower in the lowest category of fermented milk consumption.
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Table 8.1 Characteristics of subcohort members (n = 3,111) according to high and low intake
of fermented milk" and calcium.
Variables
Age ± SD
Gender (% men)
Dietary factors (mean + SD)
Fermented milk (g/day)
Hard cheese (g/day)
Unfermented milk (g/day)
Calcium (mg/day)*
Energy (kJ/day)
Total fat (g/day)*
Dietary fiber (g/day)*
Calcium/phosphate ratio
Medical and life-style factors
Body mass index (kg/m*)
Gallbladder surgery (%)
Family history of colorectal
cancer (%)
High level of education (%)
Current smokers (%)
Calcium supplement users (%)^
Fermented milk"
Non-users
61.8 + 4.2
60.6
0
17 ± 18
114 + 162
814 ±281
8,102 ± 2,282
86+ 17
26 + 7
0.6 ± 0.1
25.0 ± 3.2
7.6
5.0
11.4
42.1
1.8
Highest
category of
intake
61.5 ±4.2
39.2
303 ± 116
21 ± 19
91 ± 134
1,146 ± 272
7,967 ±2,100
79+ 16
29 + 7
0.7 ± 0.1
25.3 + 3.2
11.7
5.7
15.4
21.6
5.5
Calcium
Lowest
quintile of
intake
61.5 ±4.1
49.0
34 ±51
8 + 8
28 + 49
633 ± 135
6,738 ± 1,790
85 ± 15
26 ± 6
0.5 ±0.1
25.1 +3.3
10.1
5.1
10.0
35.6
2.2
Highest
quintile of
intake
61.2 ± 4.2
49.0
165 ± 163
33 ±24
233 ± 204
1,300 ±248
9,356 ± 2,311
82 ± 18
28 + 8
0.8 ± 0.1
24.9 ± 2.9
9.4
5.5
13.3
27.9
4.8
" Buttermilk and yogurt.
* Adjusted for total energy intake by regression analysis.
' Includes only calcium (91%) or calcium in combination with vitamin D or magnesium.
Women consumed yogurt and buttermilk more frequently than men (Table 8.1;
median daily intake among users: women 96 g, men 79 g), whereas cheese
consumption was similar for both genders (median daily intake among users 19 g).
Body mass index and a positive family history for colorectal cancer did not differ
appreciably between the two categories of consumption. Among the highest
category of consumption, a history of gallbladder surgery was reported more
frequently, and educational level was higher. The non-user group included more
current smokers. Calcium supplements were used more frequently by those with the
highest consumption.
Hard cheese consumption was positively associated with energy intake and
educational level (data not shown).
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Table 8.2 Relative rates of colorectal
Average daily
intake (g)
Fermented milk
non-users
<30
30-90
90-180
> 180
Hard cheese
non-users
< 15
15-30
>30
Unfcrmented milk'
non-users
< 120
120-240
> 240
Subcohort
members
719
561
569
732
502
394
1,173
860
656
1,126
819
785
353
Cases
85
49
67
76
49
48
104
107
67
130
77
83
36
cancer according to
Relative rates (95%
Age-, gender-
adjusted
1.00
0.82 (0.56-1.20)
1.07(0.76-1.52)
0.91 (0.65-1.28)
0.90 (0.61-1.32)
1.00
0.69 (0.48-0.99)
0.90(0.62-1.30)
0.82(0.55-1.21)
1.00
0.79 (0.58-1.07)
0.90 (0.66-1.21)
0.85 (0.57-1.26)
consumption of dairy
CI)
Multivariate^
1.00
0.83(0.56-1.21)
1.10(0.77-1.56)
0.93(0.66-1.31)
0.89(0.60-1.33)
1.00
0.67 (0.47-0.97)
0.94(0.65-1.37)
0.88 (0.59-1.33)
1.00
0.81 (0.59-1.09)
0.90(0.67-1.22)
0.86 (0.57-1.29)
products."
X* for
trend*
(p-value)
0.10 (0.75)
0.32 (0.57)
0.70 (0.40)
Excluding first year of follow-up.
Multivariate model.
Adjusted for age, gender, family history of colorectal cancer, intake of energy, energy-
adjusted intake of fat and dietary Tiber, Body mass index, history of gallbladder surgery.
Buttermilk and yogurt.
Whole milk and skim/low-fat milk.
Calcium intake was positively associated with energy intake, but no important
associations of calcium were observed with age, gender, energy-adjusted intake of
fat and dietary fiber, body mass index, family history of colorectal cancer, history
of gallbladder surgery, educational level and smoking status (Table 8.1). The
calcium/phosphate ratio was higher and calcium supplements (alone or in
combination with vitamin D) were more frequently used among those with the
highest dietary calcium intake. Previous publications provide differences between
cases and subcohort members for several non-dairy variables.*^
Table 8.2 shows the relative rates (RR) of colorectal cancer according to dairy
product consumption. After adjustment for age and gender, consumption levels for
fermented milk, cheese and unfermented milk were weakly inversely related to
colorectal cancer risk. However, for fermented and unfermented milk, none of the
category-specific relative rates nor trends were statistically significant. For yogurt
and buttermilk separately similar non-significantly decreased risks were observed:
RR for highest vs. lowest intake was 0.89 (95% CI = 0.65-1.21) for yogurt and 0.94
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(95% CI = 0.68-1.30) for buttermilk. The associations with fermented dairy
products tended to be most pronounced in women: RR for highest vs. lowest intake
was 0.81 (95% CI = 0.46-1.44) for fermented milk and 0.61 (95% CI = 0.34-1.09)
for hard cheese.
Adjustment for other potentially confounding variables in multivariate analysis
did not change the results appreciably (Table 8.2). Education level, supplement use
and smoking status were not included in the models since they did not affect the
estimates. Additional adjustment for total calcium intake or inclusion of cases
diagnosed during the first year of follow-up did not change the results either (data
not shown).
The inverse association with fermented milk was restricted to colon cancer
(multivariate RR for highest vs. lowest intake: colon = 0.70, 95% CI = 0.43-1.15,
X* trend = 0.23; rectum = 1.38, 95% CI = 0.74-2.57, x* trend = 0.25).
Former analyses assume that those who skipped relevant dairy items in the
questionnaire were non-users. When analyses were repeated, including an indicator
variable for these subjects, RR estimates for fermented milk, cheese and
unfermented milk did not change appreciably (RRs 0.90, 0.85 and 0.95
respectively). Excluding non-users from the analyses and choosing the lowest
category of consumption as the reference altered the RRs slightly (RRs 0.96, 1.21
and 1.10 respectively).
Table 8.3 presents the observed relative rates for energy-adjusted dietary calcium
intake and calcium from different dietary sources. After adjustment for age and sex
and in multivariate models, total dietary calcium and calcium from fermented dairy
products were not strongly associated with colorectal cancer risk, while calcium
from unfermented dairy products tended to be inversely and calcium from non-dairy
products positively associated. The non-significant inverse association with calcium
from unfermented milk and the positive association with non-dairy calcium were
most pronounced for rectal cancer (RR highest vs. lowest quintile for unfermented
dairy calcium = 0.55, 95% CI = 0.30-1.04, x* fend = 4.57; RR for non-dairy
calcium - 2.32; 95% CI = 1.02-5.28, x* trend = 5.67).
Calcium supplement use was not associated with risk (multivariate RR of users vs.
non-users = 0.95, 95% CI = 0.50-1.78).
When analyses were conducted in terms of the calcium/phosphate ratio (RR per
difference of 0.1 =0.94, 95% CI = 0.85-1.04) or stratified according to gender,
results remained similar (data not shown).
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Table 8.3 Relative rates
Nutrient
Total dietary calcium''
number of cases
number in subcohort
median intake in subcohort,
mg/day
age- and gender-adjusted RR
multivariate RR'
(95% CI)
Calcium from non-dairy
products
number of cases
number in subcohort
median intake in subcohort,
mg/day
age- and gender-adjusted RR
multivariate RR'
(95% CI)
Calcium from fermented
dairy products''
number of cases
number in subcohort
median intake in subcohort,
mg/day
age- and gender-adjusted RR
multivariate RR'
(95% CI)
Calcium from unfermented
dairy products
number of cases
number in subcohort
median intake in subcohort,
mg/day
age- and gender-adjusted RR
multivariate RR^
(95% CI)
of colorectal cancer
Ql
98
623
596
1.00
1.00
91
621
238
1.00
1.00
81
625
64
1.00
1.00
110
622
45
1.00
1.00
for quintiles of dietary c
Level of consumption
Q2
89
619
768
0.83
0.84
(0.58-1.22)
82
625
284
1.14
1.27
(0.83-1.92)
87
620
181
0.96
1.01
(0.69-1.48)
85
625
150
0.78
0.78
(0.54-1.11)
Q3
87
622
Q4
81
627
893 1,032 1
0.96
0.96
(0.67-1.39)
95
622
318
1.51
1.82
(1.21-2,74)
94
621
287
1.20
1.29
(0.89-1.88)
78
616
238
0.70
0.69
(0.48-1.01)
0.92
0.93
(0.64-1.36)
93
621
356
1.28
1.64
(1.05-2.56)
95
628
394
1.10
1.18
(0.80-1.72)
93
624
345
0.81
0.79
(0.55-1.14)
]
:alcium intake." j
Q5
88
620
,288
0.93
0.92
(0.64-1.34)
82
622
417
1.25
1.77
(1.08-2.90)
86
617
634
1.07
1.14
(0.77-1.68)
77
624
540
0.72
0.71
(0.48-1.05)
X* for trend 5
(p-value) ;
0.03 (0.87)
0.02 (0.89)
1.77 (0.18)
6.56(0.01)
0.41 (0.52)
0.98 (0.32)
2.65 (0.10)
2.60(0.11)
Excluding first year of follow-up.
Adjusted for total energy intake by regression analysis. Total dietary calcium does not include
calcium supplements.
Adjusted for age, gender, family history of colorectal cancer, intake of energy, energy-adjusted
intake of fat and dietary fiber, body mass index, history of gallbladder surgery.
Yogurt, buttermilk, cheese, curds.
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Discussion
These data do not support a protective role of fermented dairy products or calcium
in colorectal cancer risk. Although risks of colon and rectal cancer were inversely
associated with fermented milk consumption and calcium intake from unfermented
dairy products respectively, none of the relative rates were significantly different
from unity.
A potential drawback of this study is the short follow-up period, i.e. 3.3 years.
Especially when gastro-intestinal complaints in the time span before diagnosis
would have changed dairy product intake, this could have altered the associations.
However, the similarity of results observed in the data with and without cases
diagnosed within the first year of follow-up does not support this possibility. Our
questionnaire inquired after dietary patterns in the preceding year and might not be
representative over a longer period of time. However, this is a population of elderly
people, who are usually considered to have stable food patterns. This stability is
confirmed by a repeatability study, in which the food frequency questionnaire was
readministered in five consecutive years after baseline assessment. It indicated fairly
stable nutrient intakes over time (unpublished data). Furthermore, the consumption
of these sour fermented milk products is strongly related to preference, which
makes it reasonable to assume that the intake of these products does not change
dramatically over the years.
The absence of an observed association is not likely to be explained by
insufficient contrast in the population. In our cohort, the intake of yogurt and
buttermilk varied from zero in the lowest category to a median of 267 g/day in the
highest one according to the questionnaire data; and for cheese from zero in the
lowest to 37 g/day in the highest category. Despite a lower per capita intake** and
presumably a smaller range of intake in the United States, in two American colon
cancer case-control studies'**' a significant protective effect was found for cultured
milk and yogurt. However, no important associations between fermented dairy
products and colorectal polyps were found in the Nurses' Health Study and the
Health Professionals Follow-up Study, two American prospective studies." In a
Dutch breast cancer case-control study (133 cases, 289 population controls), women
with a daily intake of 225 g of fermented milk had a 45% lower risk (OR = 0.55,
95% CI = 0.24-1.27) than non-users." An odds ratio of 0.49 (95% CI = 0.14-1.76)
was found for those women who consumed 20 to 40 g of cheese per day compared
to non-users.^ In a Dutch case-control study on pancreatic cancer, an inverse
association with fermented milk products (highest vs. lowest quintile of intake
OR = 0.37, p < 0.05) and cheese (OR = 0.44, p > 0.1) was observed.*
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The apparent contradiction of results from epidemiological studies and
experimental studies examining lactobacilli is intriguing,^ but might be explained
by differences in bacterial strains. In most experiments Lflctoftac///u5 acufop/n/us is
used, which passes the stomach and survives the gastro-intestinal tract, whereas L.
ftu/gar/cus, Sfrep/ococcus //ler/nop/i'/ws, S. /act/5 and 5. frewior, which are most
frequently used in yogurt and buttermilk, are less resistant to acidic conditions in
the stomach.**
Compared to fermented dairy products, the association between calcium
consumption and colorectal cancer risk has been studied more often in
epidemiology. However, results are not consistent: some studies found an inverse
association," ^ " ^ while others found only a weak non-significant inverse
association""'*' or no association at all."* Until now, only a few prospective studies,
using a validated food frequency questionnaire, investigated the association between
calcium intake and colon cancer' or colorectal adenomas." In the Iowa Women's
Health Study," after 4 years of follow-up, higher intakes of total calcium (including
supplements) and milk products were associated with a 20-30% reduction in colon
cancer risk. However, the multivariate adjusted estimates and the x^ for trend were
not statistically significant and dietary calcium was not associated with risk
(RR = 0.95; 95% CI = 0.57-1.61). In the NHS and HPFS no associations with total
or dietary calcium and colorectal polyps were observed (RR for highest vs. lowest
intake of total calcium: NHS = 1.17, 95% CI = 0.81-1.69; HPFS = 1.13,
95% CI = 0.76-1.66)."
Our results apply to an elderly population. Since calcium metabolism in pre- and
postmenopausal women might be different, our results might not be applicable to a
younger generation. However, in the Nurses' Health Study, which covers a younger
age group, no association between the occurrence of colorectal adenomas and
calcium intake was observed."
Median calcium intake ranged from 546 mg per day in the lowest quintile to
1344 mg per day in the highest quintile. According to Newmark et al.'s
calculations/ a daily intake of 1,500 mg calcium is necessary for individuals with a
high-fat (150 g/day), high-phosphate (1,500 mg/day) diet to neutralize the fatty acid
and bile acid concentrations in the bowel. This implies that a substantial proportion
of participants in our study should have been consuming an adequate amount of
calcium to experience the biological effects, especially since fat intake was lower
than used in the calculations of Newmark et al."
The differences in relative risk observed for calcium from different dietary
sources might be a chance finding. The range of calcium intake from non-dairy
products is about one third of that from dairy products, resulting in less stable
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estimates. Furthermore, the non-dairy group is a mixture of different food items,
such as vegetables, coffee and tea, which makes these findings difficult to interpret.
Exposure to sunlight, the most important source of vitamin D, was not taken into
account, since no validated method of sunlight exposure assessment using a self-
administered questionnaire was available. Since our national nutrient database did
not include vitamin D and supplements only including vitamin D are rarely used in
this cohort, vitamin D intake could not be studied. In contrast to the United States,
Dutch dairy products are not supplemented with vitamin D.
In summary, the consumption of fermented dairy products and the intake of
dietary calcium are not significantly associated with colorectal cancer risk in this
elderly population with a relatively wide variation in dairy product consumption.
Although a weak non-significant inverse association with colon cancer was
observed, the protective effect of fermented dairy products as seen in experimental
studies could not be confirmed in this prospective study with a follow-up period of
3.3 years.
Although similar results were found when analyses were conducted with and
without cases diagnosed during the first year of follow-up, a longer follow-up time
is needed to be certain that no changes in dairy product consumption occurred as a
result of subclinical disease. Moreover, it remains worthwhile to study gender
differences and differences between various sites within the large bowel.
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Integration of results and epidemiological considerations
• • • • s * * ,
Integration of results
In this thesis the results of four epidemiological studies are described in which the
associations between fermented dairy products, calcium and colorectal adenomas or
colorectal cancer were examined. The main results and characteristics of these
studies are summarized in Figure 9.1 and Table 9.1 respectively.
relative risk, 95% confidence interval
highest versus lowest category of intake
NHS1 NHS2 HPFS NLCS NLCC
fermented dairy products
NHS1 NHS2 HPFS NLCS NLCC
dietary calcium
Figure 9.1 Fermented dairy products, calcium and colorectal cancer risk in the four
epidemiological studies described in this thesis (NHS1 = Nurses' Health Study
1984-1988; NHS2 = Nurses' Health Study 1980-1988 and Health Professionals
Follow-up Study; NLCS = Netherlands Cohort Study; NLCC = Netherlands Case-
Control study).
For fermented dairy products non-significant inverse associations were observed in
the two follow-up periods of the Nurses' Health Study (Chapter 3) for colorectal
adenomas and in the Netherlands Cohort Study (Chapter 8) for colorectal cancer,
while in the Health Professionals Follow-up Study (Chapter 3) and the Netherlands
Case-Control Study (NLCC) non-significant positive associations were observed
(Figure 9.1). Dietary calcium was non-significantly inversely related to risk in the
Netherlands Cohort Study, while no association was found in the Health
Professionals Follow-up Study, a non-significant positive association was observed
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in both follow-up periods of the Nurses' Health Study and a significant increased
risk with increasing calcium intake was found in the Netherlands Case-Control
Study.
The overall inverse variance weighted estimate of relative risk in these four
studies, excluding Nurses' Health Study 2, was 0.91 (95% CI = 0.74-1.12) for the
highest vs. the lowest category of fermented dairy product consumption and 1.10
(95% CI = 0.90-1.35) for the highest vs. lowest category of dietary calcium intake.
Overall, the suggested protective effect of fermented dairy products and dietary
calcium on colorectal adenomas or cancer risk is not supported by the results of
these studies. :
These null findings might reflect the underlying association, but might also result
from a failure to observe a truly existing inverse association. Such a failure might
be attributed to the end-point under study, the methodology of exposure assessment,
/toe varia/ww? of exposure m tfre stuc/y population and (he biofogicaf relevance,
confounding or effect modification or a lack of statistical power.' The purpose of
this chapter is to discuss these possible explanations for our null findings (see
'Epidemiological considerations'). In addition, the external validity of these studies
is evaluated by comparing our findings with the results of other analytical
epidemiologic studies and human experimental research (see 'Integration with the
literature').
The studies described in this thesis represent three different end-points (distal
adenomas, colon and rectal cancer), three different epidemiological study designs
(cohort, case-subcohort, case-control), two different methods of exposure assessment
(semi-quantitative food frequency and dietary history) and, since these studies were
conducted in different populations (US and the Netherlands), different ranges of
fermented dairy product intake (Table 9.1). The studies can be compared to a
reasonable degree with respect to definition of exposure and adjustment for
potential confounding variables. The advantages and disadvantages of these studies
are described in more detail in the corresponding chapters (Chapter 3 to 8).
Epidemiological considerations
As discussed in Chapter 2, colorectal carcinogenesis is a process of several stages in
which adenomatous polyp formation precedes the formation of the malignant tumor.
The mechanisms by which fermented dairy products and calcium might reduce
colorectal cancer risk could involve earlier stages as well as later stages in the
polyp-cancer sequence and may differentially affect the various sites of the
colorectal tract (Chapter 2).
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Adenomatous polyps can serve as an intermediate end-point for the study of
determinants of colorectal cancer, which shortens the period between dietary
assessment and the onset of the disease. If diet affects polyp formation, stronger
associations with fermented dairy products and calcium might be found when
studying these precursor lesions. a<t
Table 9.1 Characteristics of the four studies described in this thesis.
Nurses' Nurses' Health Netherlands Netherlands
Health Study Health Study Professionals Cohort Study Case-Control
1 2 Follow-up Study
Study
Type of study
Population
End-point
cohort
US,
endoscopied
nurses
(women)
cohort
US,
endoscopied
nurses
(women)
cohort cohort
US, Netherlands,
endoscopied general
health population
professionals
(men)
distal colon, distal colon, distal colon, colon, rectum,
rectum, rectum, rectum, carcinoma
adenoma adenoma adenoma
case-control
Central and East
Netherlands,
general
population °
colon carcinoma
Years of
follow-up
Number of cases/
controls or
cohort
Dietary method'
Median (per day)
highest quintile
or quartile of
intake"
Adjusted for
4
283/6,988
sqffq
i = 121
ferm.dairy':
129 g
calcium:
1,550 mg
age, energy.
bmi,alcohol,
folate, sat.fat,
fiber,
fam.history
endoscopies
8
350/8,575
sqffq
i = 61
ferm.dairy':
134 g
calcium:
1,160 mg
see NHS1
4
331/9,159
sqffq
i= 131
ferm.dairy':
111 g
calcium:
1,500 mg
see NHS1
3.3
326/3,083
sqffq
i = 150
ferm.dairy'':
267 g
calcium:
1,288 mg
age, gender, fat
energy, fiber,
bmi, fam.history
cholecystectomy
-
232/259
dietary history
i = 289
ferm.dairy':
335 g
calcium:
1,712 mg
age, gender,
energy, fat,
fiber,
fam.history,
cholecystectomy,
alcohol, vit.C
' sqffq, semi-quantitative food frequency questionnaire.
* among controls or (sub)cohort.
' yogurt, sour cream, cream cheese, cottage cheese, hard cheese.
•* yogurt, buttermilk.
' yogurt, buttermilk, sour cream, curds, kefir, other fermented milk drinks.
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Since we assessed the association between these exposures and the risk of both
adenomas as well as cancer, it is unlikely that an important effect was missed just
because of an irrelevant time window in colorectal cancer aetiology. Despite these
biological and methodological considerations, no differences in associations with
fermented dairy products and calcium were observed for colorectal adenomas and
colorectal cancer: for both end-points no important associations were found.
Based on experimental and epidemiological studies suggesting partially different
aetiologies for cancer of the colon and rectum, we examined the association with
risk for these different subsites separately. Slight differences were observed between
colon and rectum cancer in the Netherlands Cohort Study: fermented dairy product
consumption was more strongly associated with colon cancer risk, while the intake
of calcium from unfermented dairy products was inversely associated with rectal
cancer.
C«icer of flfor prvwmroi' ami errerai' sites or" trie coi'on might 6e explained by
different aetiological factors as well. However, since sigmoidoscopy or endoscopy
usually do not reach the proximal site of the colon, this site was not taken into
account in studying adenoma risk. Because of power considerations, we did also not
explore differences between subsites in the studies on colon cancer.
Thus, the null findings of these studies are not likely to be explained by the
choice of the end-point under study. However, the potential differences between
colon and rectal cancer, and among different subsites within the colon, need further
study. A longer duration of follow-up of the Netherlands Cohort Study will provide
opportunities to explore these differences in more detail and to study different
subsites within the colon. These additional analyses will be conducted after 5 years
of follow-up supported by a grant from the Netherlands Digestive Diseases
Foundation.
o/
The main hypothesis in this thesis was studied in three prospective studies and one
retrospective study. Prospective studies are less prone to potential sources of
methodological bias in exposure assessment, such as recall and selection bias,
associated with retrospective case-control investigations. Because in prospective
studies exposure information is collected before diagnosis, illness is not very likely
to affect recall of previous habits. In Chapter 5 it is discussed that recall bias might
be especially important in a case-control study when cases, as a result of their
disease, report their usual intake before complaints started or diagnosis occurred
differently from the control group. This problem is becoming increasingly relevant
because of the widespread publicity about diet and cancer. However, since dairy
products have a good image in the Netherlands, it is thought to be unlikely that
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cases, whether or not intentionally, have overestimated their calcium intake to
'explain' their illness. Furthermore, dietary patterns might have been adapted to
gastro-intestinal distress or food aversions associated with therapy. Since current
dietary patterns influence the recall of past diet,' such changes might bias the results
importantly. In our case-control study, none of those who replied to suffer from
gastro-intestinal distress reported to have changed their consumption of dairy
products (Chapter 2).
The second cause of a lack of internal consistency in a case-control study could
be biased sampling of cases and controls, especially when participation rates are
low. In our case-control study 60% of the invited cases 57% of the controls were
willing to be interviewed. In Chapter 4 it is argued that the possible selection of
cases and controls due to non-response will strengthen an inverse association.
However, those who completed the non-response questionnaire may not be
representative of the total of non-responders (Chapter 4). The fact that more cases
with a relatively good prognosis have been included in the case-control study is not
likely to have influenced the results considerably, since consumption of fermented
dairy products and intake of calcium were not related to Dukes' status (Chapters 4
and 5). Furthermore, recruitment of controls by the general practitioner of the cases
made the control group more comparable to the general population with respect to
socio-economic level than a control group recruited via municipal registries. This
might explain differences with previous Dutch case-control studies on breast and
pancreas cancers respectively""' (Chapters 4 and 5).
A methodological bias which might be important both in retrospective and in
prospective designs, is that the method of dietary assessment is not sufficiently
precise to measure differences that truly exist.' Evaluations of the validity and
reproducibility of the semi-quantitative food frequency questionnaires used in the
American and the Dutch prospective studies indicated that these questionnaires
provided useful information about the consumption of dairy products and calcium
(Chapters 3 and 8). The dietary history questionnaire in the case-control study was
an extended version of a previously used validated questionnaire (Chapter 4). The
median intake of calcium among controls in the case-control study was higher than
in the Netherlands Cohort Study and higher than the estimated mean intake in the
general Dutch population as assessed by a two-day dietary record/ This might be a
consequence of the extensive number of questions addressing dairy products. In the
American studies the questionnaires used in the four-year follow-up included 11
dairy items, in the Netherlands Cohort Study 9 dairy items were asked for, while in
the case-control study the consumption of all common dairy items used during
different meals was assessed with a maximum of about 25 products. Furthermore,
the questionnaire used in the case-control study was a fully quantitative
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questionnaire. Sizes of major cups and utensils were measured. The questionnaire
used in the case-control study was interview-based and not self-administered. This
is believed to contribute to a higher degree of internal consistency in the reported
food pattern, resulting in more precise estimates of consumption.'
With respect to the time window of dietary assessment, it is clear that the
American studies covered a period preceding tumor formation. Nevertheless, when
the onset of the disease occurred during childhood, we may have missed a truly
existing association. It seems however unrealistic to assume that valid information
could have been gathered since studies conducted to date suggest that diet may be
recalled with acceptable levels of misclassification up to approximately 10 years.'
Moreover, the fact that colorectal cancer rates rise consistently with migration and
westernization'' suggest that dietary factors might be especially important in adult
life.
Thus, although some degree of recall bias and selection bias can never be
completely ruled out in a retrospective study, the errors associated with assessment
of fermented dairy product consumption and calcium intake in these studies are not
likely to be influenced by methodological biases.
Vianaf J'O/J o/ exposure awd Wo/o#ica/ re/eva/ice
To observe a possible statistically significant inverse association between fermented
dairy products, calcium and colorectal cancer, sufficient variation in consumption
levels for fermented dairy products and calcium in the study population is required.
Moreover, it must be considered whether the absolute level of intake is of biological
relevance and whether negative confounding exists.
The consumption of fermented milk, such as yogurt and buttermilk, is strongly
related to taste: the fact that the sour taste is liked or disliked contributes to
variation in consumption level. Since fermented dairy products are integrated in the
traditional Dutch food pattern and the per capita consumption of these products is
much higheer than in the US (Chapter 2), it might be worth-while to study this
subject in the Netherlands. Although consumption of fermented dairy products
indeed differed between the Dutch and the American studies (Table 9.1), the intake
of calcium did not differ appreciably between populations in the prospective studies
(Table 9.1). However, despite the higher and more heterogeneous consumption of
fermented dairy products in the Netherlands, the estimates of the four studies did
not differ appreciably.
It is questionable whether the consumption of fermented dairy products or the
intake of calcium was high enough to exert a biological effect. Our écologie study
(Chapter 2, Figure 2.2) suggested that the range of consumption of fermented milk
in the Netherlands Case-Control Study (about 330 g/day) is sufficiently large to be
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able to observe a relative risk less than 0.5. Moreover, the level of consumption of
fermented dairy products in the Dutch studies was comparable to that in a previous
study on breast cancer in which a protective effect was observed. However, based
on the results of experimental studies, it may be inferred that still a higher and more
frequent consumption is necessary to influence the colonie flora (see 'Experimental
studies'). With respect to dietary calcium the range in intake in our studies should
have been high enough to show a decrease in risk as calculated by Garland's^ and
Newmark's" groups. They estimated an intake of 1,200-1,500 mg calcium per day
to be sufficient to neutralize bile acids and free fatty acids in the colonie lumen
with an intake of about 150 g fat and 1,500 mg phosphate per day. The mean intake
of fat in our studies was about 80 to 90 g per day, whereas the mean intakes of
phosphate and calcium ranged from 1,200 to 1,700 mg in the highest categories.
This implies that a substantial proportion of participants in our studies should have
been consuming an adequate amount of calcium to experience the biological effects.
On the other hand, if calcium influences cell proliferation directly, which is the
second hypothesized mechanism as described in Chapter 2, the intracellular
concentration might be more important than the intraluminal calcium content. In
this respect, vitamin D status might be of major importance. However, in the
American cohorts, vitamin D intake did not influence the results on colorectal
polyps (Chapter 3; and see 'Effect modification'). In the Dutch studies vitamin D
exposure was not assessed (Chapters 5 and 8).
The biological relevance might also depend on the specific strains of bacteria
used for the fermentation process. The bacterial strains used to culture milk might
differ among countries, states and products. In the Netherlands, Lacfofeac/7/us
ftn/garicMs, Srre/j/ococcus r/iermop/n/MS, S. /ac/z's and S. tremor are mainly used to
produce yogurt and buttermilk. These strains are used in some parts of the US as
well, but in other parts Lacfofcari//«s ac/</op/t{7u5 is more frequently used for
fermentation. Since several strains might not survive the gastro-intestinal tract and
possibly only viable bacteria exert an effect on the bowel flora (see 'Experimental
studies'), the differences in findings among epidemiological studies might be
explained by differences in fermented dairy products studied. However, in a Dutch
case-control study on breast cancer, an inverse association was observed for yogurt,
buttermilk and cheese, whereas cheese mainly contains unviable bacteria. In the
four studies no differences among the different fermented dairy products were
found.
Considering the population-specific confounding variables, it was expected that,
since the consumption of fermented milk is rare sparse in the US, the consumption
of these products might be related to other health conscious habits. However, in the
two Dutch studies the use of fermented dairy products was also clearly related to
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health consciousness (e.g. less smoking, less alcohol use, more supplement use, a
higher consumption of vegetables). Adjustment for these potential confounding
variables did not influence the estimates importantly, however.
In conclusion, variation in intake, absolute consumption levels for fermented
dairy products and calcium or confounding are not likely to explain the null
findings of our studies. However, these results do not exclude the possibility that
inverse associations might still be found with higher doses of dairy products, or
with products cultured with other bacterial strains.
Interaction with other dietary variables might have influenced the results. As
described in Chapter 2, especially a high dietary phosphate/calcium ratio or the
vitamin D status might modify the associations between calcium and colorectal
cancer risk. Furthermore, if calcium exerts an effect on colorectal carcinogenesis by
binding bile acids and free fatty acids, whose concentrations in the colonie lumen
raise with higher saturated fat intake, the observed association may depend on the
fat content of the diet. Finally, dietary fiber might modify the effect by binding
calcium. The possible effect modifications were studied in the American studies by
assessing the association with calcium at different levels of phosphate, vitamin D,
saturated fat and dietary fiber intake. It appeared that the associations between
calcium and colorectal polyp risk did not differ at different levels of intake of these
dietary variables. Moreover, a high phosphorus intake relative to the intake of
calcium was evaluated in all four studies. The ratio was not associated with
adenoma or carcinoma risk.
Apart from mechanistic interactions, sex and/or age may be potential effect
modifiers. Incidence rates differ between men and women over categories of age
(Chapters 2 and 6). The four studies differ in gender and age distribution: at
baseline the Nurses' Health Study included women only, who were mainly
premenopausal, while the Health Professionals Follow-up Study included only men,
aged between 40 and 75. The two Dutch studies both included men and women: the
Netherlands Cohort Study included middle-aged men and women, while in the
Netherlands Case-Control Study men and women younger than 76 years at
diagnosis were included (mean age about 61). Differences were observed between
genders: consumption of yogurt and buttermilk was significantly higher among
women. Moreover, the association between consumption of fermented dairy
products and colorectal adenoma or cancer risk differed between genders: among
women (non-significant) inverse associations were found, while for men these
associations tended to be positive. For dietary calcium differences between genders
were not consistently found (Figure 9.2).
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In the Netherlands Case-Control Study a significant difference between men and
women was observed for fermented dairy products. Additionally, gender interactions
were observed for fruit and meat consumption (Chapter 7) and different associations
with parity and age at first child birth were found for men and women (Chapter 6).
relative risk, 95% confidence interval
highest versus lowest category of intake
US NLCS NLCC
fermented dairy products
NLCS NLCC
dietary calcium
I men 0 women
Figure 9.2 Gender-specific associations between colorectal cancer and fermented dairy
products and dietary calcium (US = Nurses' Health Study 1 and Health
Professionals Follow-up Study; NLCS = Netherlands Cohort Study;
NLCC = Netherlands Case-Control study).
Differences in the strength of associations between men and women might be
attributed to differences in internal validity of the studies for both sexes or by actual
biological differences. Considering the internal validity of the studies, men might
report their diet less accurately than women, which might attenuate the relative
risks. However, in a review of dietary recall methods by Friedenreich et al., it was
concluded that men and women recall their previous diet with a similar accuracy.'
Furthermore, in the Netherlands Case-Control study this difference in reporting
should be minimal since women, who normally cook the main meal in this older
age group, were present during their husbands' interview. Moreover, the Dutch
National Food Consumption Survey data support the finding that the consumption
of fermented dairy products is higher among women.'
Finally, biological explanations might be proposed as well. As described in
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Chapters 2 and 6, it has been suggested that the causes of colorectal cancer differ
between the genders. Therefore, it might also be expected that the most effective
agents for reducing the risk would also differ between the genders. Since colon
physiology differs between genders (Chapter 2), the survival and colonization of
lactobacilli strains in the gastro-intestinal tract might differ. If hormonal factors
would be important in the adherence of lactobacilli and in calcium metabolism,
differences might be expected between pre- and postmenopausal women. However,
the association with fermented dairy products did not differ between the Nurses'
Health Study and the Netherlands Cohort Study.
Overall, differences among men and women in the strength of associations with
fermented milk intake should be explored further in epidemiological as well as
experimental studies.
Power
An association may be missed because of low statistical power due to an inadequate
size of the study population. A low statistical power may have been important in
the smallest of the four studies with, as a consequence, the largest confidence
intervals: the Netherlands Case-Control Study. A priori power calculations are
presented for this study in Chapter 4. In the final analyses of the case-control study,
232 cases and 259 controls were included (Chapters 5-7). According to our
calculations, with a variation in intake between the highest and lowest quartile of
about 800 mg calcium per day, an odds ratio of 0.5 could have been detected with a
power of approximately 80% (a = 0.05).
The number of cases in the case-control study was almost similar to the number
of cases in the prospective studies, while the 'sample' from the source population
was 10 to 30 times smaller. Nevertheless, the standard errors of the prospective
studies are only half of those in the case-control study. This illustrates the efficiency
of a case-control design.
Considering the findings of the prospective studies, it does not seem likely that
the failure to observe an inverse association between calcium and colon cancer risk
is a result of inadequate statistical power.
Integration with the literature
To study the external validity, the results of these four studies are compared with
the epidemiological literature reviewed in Chapter 2 according to the aspects
discussed above. In general, it can be stated that, apart from our own studies, hardly
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any of the epidemiological studies conducted have focused specifically on the
consumption of milk products or calcium intake. Therefore, these studies may not
have fully addressed all the confounding and interaction issues. Moreover, the
possibility of reporting and publication biases should be taken in mind.
Additionally, the epidemiological findings are compared with the experimental
evidence as summarized in Chapter 2.
Fermented dairy products
None of the case-control studies on colorectal polyps and none of the prospective
studies on colorectal cancer reported to date have addressed the consumption of
fermented milk. Only three case-control studies have addressed the consumption of
yogurt or buttermilk: two studies on colon cancer conducted in the US by Young
and Wolf'" and Peters et al.," and one Japanese study on colon and rectal cancer by
Tajima and Tominaga.'^ In the American studies, a significant inverse association
was observed, while the Japanese study found a significant positive association with
yogurt consumption for colon as well as rectal cancer. The differences observed
between our findings and these studies may be related to differences in source
populations, methods of dietary assessment and dietary methodology used.
The study by Peters at al., which is the largest of the case-control studies on
colon cancer to date (746 cases, 746 controls), was conducted in Los Angeles
county, while Young and Wolf conducted their study in Wisconsin. The difference
with our findings might be explained by a difference in bacterial strains used to
culture milk across the areas covered by the studies. Analyses in the Nurses' Health
Study and the Health Professionals Follow-up Study, covering 11 different US
states, were not stratified by state.
The dietary methodology used in the study by Peters et al. is a mixture of the
methodologies used in our American studies and our Dutch case-control study: the
questionnaire Peters et al. used was an interview-based, slightly expanded version of
the semi-quantitative questionnaire used in the Nurses' Health Study and the Health
Professionals Follow-up Study (Chapter 3), quantifying portion sizes. In the other
case-control study, by Young and Wolf, dietary habits during different age stages
were asked for. The inverse association was only observed among those over 34
(OR = 0.7, 95% CI = 0.4-1.0) and not at younger ages in which odds ratios of 0.9
(between 18 and 35 years) and 1.0 (under age 18) were observed,'" which might
point to chance, a late stage effect or a hormonal effect. With respect to the third
study, conducted in Japan, it is not possible to compare our findings, since their
methodology is described only briefly and the source population is very different.
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Our findings for cheese consumption are not in line with one of the two
prospective studies and three of the six case-control studies addressing hard cheese
consumption in which positive associations for colorectal cancer were found
(Chapter 2). Significant positive associations were observed for rectal cancer only.
In most of the studies addressing cheese consumption, the analyses were not
adjusted for fat intake. Our null findings for cheese are especially interesting since
cheese is a high-fat food item and an increased risk with dietary fat was observed in
the Nurses' Health Study, the Health Professionals Follow-up Study and the
Netherlands Case-Control Study.
The prospective study by Phillips et al.'^ found a significant positive association
with cheese consumption for men, while a non-significant inverse association was
found for women. Although this might support a hormonal effect of lactobacilli, it
might also point to other habits related to cheese intake. Since none of the other
studies on fermented dairy products report results of analyses stratified by gender
firm conclusion cannot be drawn.
The results of the Netherlands Cohort Study and the Netherlands Case-Control
Study are not in line with the results of previous case-control studies on breast
cancer and pancreatic cancer conducted in the Netherlands/ Both studies observed
an inverse association with consumption of fermented dairy products. Although the
aetiology of colon cancer differs from that of breast cancer and pancreatic cancer,
the inverse associations reported from these studies might be explained by the
choice of the control group. Consumption of fermented dairy products is
significantly higher in those with a higher socio-economic status. If the population-
based control groups used in those studies included a higher proportion of more
health-conscious, more educated and well-to-do persons, these studies could
erroneously observe an inverse association with fermented dairy products. As
described in Chapter 4, the socio-economic status distribution of the control group
used in our case-control study was comparable to that of the general Dutch
population. The additional control group we recruited via municipal registries, like
in the other case-control studies, indeed included more persons with a higher socio-
economic status.
Overall, the epidemiological evidence on fermented dairy products is too sparse
to allow firm conclusions to be drawn. The available evidence, however, does not
provide strong evidence for a clear preventive potential.
Like epidemiological studies, experimental data on fermented dairy products or
lactic acid bacteria are sparse and preliminary. As reviewed in Chapter 2,
experimental studies on lactic acid bacteria focus especially on (1) modulations of
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the colonie flora, (2) enhancement of the immune response and (3) mutagen
absorption.
Several investigators explored the first hypothesis and endorse a decline in
activity of several faecal enzymes. However, the role of these enzymes in the
aetiology of colorectal cancer has not been substantiated, the mechanisms by which
lactic cultures decrease enzyme activity is not known and a reliable measurement of
faecal enzymes remains difficult.''' It is not clear whether only strains that are
resistant to gastric acidic conditions and remain viable in the colon exert an
effect.""" Most experimental studies used specific strains that are not normally
present in commercially available fermented dairy products, which might explain
why their results differ from our epidemiological studies. Furthermore, it is still
questionable whether a daily dairy dose of lactic acid bacteria is large enough to
influence colonie metabolism, since the number of bacteria in the colon is much
larger. There is no evidence that lactobacilli can establish themselves in the
intestinal tract and it could be that fermented milk needs to be ingested
continuously, or at least regularly, to maintain a sufficient number of lactobacilli in
the intestine.
Research on the other two hypothesized modes of action of lactic acid cultures is
still very preliminary. It is not clear whether ingestion of large numbers of
lactobacilli stimulates the human immune system more than the normal constant
stimulus by the gut flora already does. Mutagen absorption studies are mainly in
vitro studies whose physiological significance may be limited. There is no evidence
for any specificity of lactobacilli in mutagen binding.
Overall, experimental data on commercially available fermented dairy products
are limited and too preliminary to provide evidence for a protective effect of
fermented dairy products on colorectal cancer risk.
Calcium
j4na/yr/ca/ epiYfe/nio/ogica/ srud/es
Two small retrospective studies have addressed the intake of dietary calcium and
the occurrence of colorectal polyps (Chapter 2): odds ratios of 0.9" and 1.2'* were
reported. These results are in line with the findings in the Health Professionals
Follow-up Study and the Nurses' Health Study respectively (Chapter 3).
Results on dietary calcium intake and colorectal cancer in the Netherlands Cohort
Study are comparable with the results of 4 of the 6 prospective studies on colorectal
cancer addressing dietary calcium intake (Chapter 2). Five of these studies were
conducted in the US. Garland et al.,'" whose study is the most cited study on
calcium and colorectal cancer risk, reported a significant inverse association with
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dietary calcium (RR = 0.32 for highest vs. lowest intake). This study is the smallest
prospective study (n = 49), but used a fairly reliable instrument for the dietary
assessment: two 28-day dietary histories one year apart. The study was restricted to
men. A prospective study based on 24-hour recalls among Hawaiian Japanese men,
with a relatively low intake of calcium and fat, found a non-significant inverse
association for overall colon cancer risk, but a significant inverse association for
cancer of the sigmoid. A previous publication on the same study did not report
important associations (Chapter 2). In the two other well-known prospective studies,
the Nurses' Health Study and the Iowa Women's Health Study, which included only
women and assessed dietary habits through a semi-quantitative food-frequency
questionnaire, no associations with dietary calcium were observed.""'*' The results of
the 6-year follow-up of the Health Professionals Follow-up Study on colorectal
cancer do not support a protective effect of dietary calcium either (E. Giovannucci,
personal communication, 1994)."
The significant positive association between dietary calcium and colon cancer
observed in our case-control study is not supported by previous studies. Three case-
control studies observed a positive association with dietary calcium, albeit none of
these associations were significant (see Chapter 2). Five of the 13 case-control
studies published to date report a significant inverse association with colon cancer
or rectal cancer for either men or women, while 5 reported non-significant inverse
associations. Case-control studies reporting inverse associations did not differ in
size, number of cases, end-point, population, age and sex or dietary methodology
from those reporting positive associations.
As to calcium from supplements, a significant inverse association was found in
the Iowa Women's Health Study. Although supplement use might be a proxy for
other healthy habits, this result might also support the notion that dietary intake of
calcium is not high enough to exert an effect. However, in the Nurses' Health Study
and the Health Professionals Follow-up Study no important association between
supplemental calcium and the occurrence of colorectal adenomas was found. In the
Netherlands the intake of supplements is too infrequent to get reliable estimates.
In summary, the results of our and other epidemiological studies do not
consistently support a substantial protective effect of dietary calcium in the
westernized diet.
Like the results from epidemiological studies mentioned above, the results of human
experimental studies on calcium are not consistent (Chapter 2). Since 1985, at least
15 clinical trials have been conducted investigating the effect of calcium on
reduction of the colorectal epithelial cell proliferation rate. All of these studies were
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small and most of them did not use a double-blind placebo-controlled design. Most
studies have examined the overall cell proliferation rate in the rectal mucosa as the
study end-point. The conduct of these studies relied on the assumption that
reduction of colonie proliferation rate is related to a reduced risk of colorectal
cancer (Chapter 2). In about half of these studies a significant decrease in labelling
index was actually detected, of which 50% were conducted by the groups of Lipkin
and Wargovich (Chapter 2).
The differences in outcomes between the different trials could not be explained
by their design (placebo-controlled or not), the labelling technique used (most
studies used tritiated thymidine), duration of supplementation or the type of calcium
salt supplemented.
Discrepancies might be related to the number of crypts scored, biopsy procedures
used, labelling failure, reader reliability and participant withdrawal as suggested by
Bostick and et al."'
The dose of calcium used for supplementation was found to be a predictor of the
outcome. A placebo-controlled trial by Wargovich et al. showed that an increase in
dose resulted in a significantly stronger decrease in labelling index (Chapter 2). The
daily dose of calcium used in the studies ranged from 1,000 tot 2,000 mg per day.
Besides the dose of supplemented calcium, dietary intake of calcium at baseline and
during the intervention is important. Most studies explicitly state that participants
were asked not to change their dietary patterns during calcium supplementation.
However, only a few studies verified the actual intake before and after
supplementation.*' •* The same investigators reported on the intake of nutrients other
than calcium, which might affect colonie mucosa proliferation as wel l .""
In the above studies biopsies were usually taken from the rectum; as this is an
invasive procedure, most studies were conducted among patients with a genetically
determined increased risk of colon cancer. These persons might have a higher
labelling index at baseline than subjects with sporadic colon cancer. The baseline
labelling index values reported varied considerably, i.e. from 5%'* to 17%^*
(Chapter 2). These large discrepancies may be related to the populations studied or
to technical differences and the reproducibility of the methods used. It is not clear
whether the degree of hyperproliferation at baseline influences the effects of
calcium.""*
The basic assumption in these studies has been that rectal biopsies reflect
hyperproliferation throughout the colon. The only study in which biopsies were
taken from the mid-sigmoid, however, observed an increase in labelling index after
supplementation.* Coincidentally, the results of this latter Dutch study by
Kleibeuker et al. are in line with the positive association observed between calcium
and the risk of colon cancer in our Netherlands Case-Control Study.
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The assumption that a reduction of proliferation rate is related to a reduced risk
of colorectal cancer has not been established; a reduction of proliferation rate may
not be sufficient to reverse the carcinogenic process."^
Most published studies have investigated overall cell proliferation. A reduced
proliferation rate is not supported by the largest placebo-controlled trial on calcium
conducted to date, which included 193 cases with sporadic adenomas, and which
has been completed very recently. However, the results do show an effect of
calcium on the normalizing downwards shift of the proliferative zone (J.D. Potter,
personal communication, 1994) as has also been reported previously by Lipkin et al.
in an uncontrolled trial .**
The results of of the large trial mentioned above suggest that the mechanism by
which calcium reduces colorectal cancer risk might be far more complex than
previously proposed by Newmark et al." who hypothesized that calcium binds toxic
fatty acids and bile acids. For instance, in a recent study by Alder et al., faecal pH
and deoxycholic acid concentrations tended to increase during calcium
supplementation.**
However, even if the precise mechanism is still unknown and if cell proliferation
is a biomarker for colorectal cancer risk, the current data indicate that a total of at
least 2000 mg calcium per day would be necessary to decrease the proliferation of
the mucosa importantly. If so, this dose largely exceeds the usual dietary dose.
Therefore, the relatively low level of calcium intake in our epidemiological studies
can still be compatible with our null findings or with the overall slightly inverse
association reported in the literature.
Concluding remarks
The studies described in this thesis do not substantiate an important preventive
potential for fermented dairy products and dietary calcium. However, it is still
questionable whether our findings contradict the results of experimental studies.
Human experimental studies are usually conducted with fermented dairy products
which are commercially not available, while the dose of lactobacilli or calcium salts
is much higher than the average intake in the population at large. Placebo-controlled
studies with commercially available products and lower doses might help to explain
the differences in findings between epidemiological and human experimental
studies.
Experimental studies exploring different end-points should be conducted. Instead
of overall proliferation rate, more emphasis should be placed on the potential effect
of calcium to shift the zone of proliferation from one that includes the entire crypt
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to one that is confined to the lower zone of the crypt. More evidence need to be
gathered on whether hyperprol iteration is indeed a suitable intermediate stage in
colorectal carcinogenesis. Moreover, hyperproliferation is mainly assessed in rectal
epithelium, while in the only experimental study focusing on the sigmoid part of the
colon, a positive association with calcium was observed. Experimental as well as
epidemiological studies should further explore differences in aetiology between
colon and rectal cancer and between the different sites within the colon.
Large intervention studies are currently being undertaken in the US* and
Europe^' studying the effect of different dietary factors on either the occurrence or
the recurrence of polyps. These studies might provide insight into the effect of diet
on early events relevant to colorectal carcinogenesis. Fermented dairy products and
dietary calcium might be studied in similar designs with an emphasis on different
subsites within the large bowel. However, supplemention with large amounts of
calcium might not be completely harmless. For instance, Paraskeva argued that
caution is necessary with regard to dietary intervention studies." He indicated that
differential sensitivity of normal and malignant tissue to calcium m vz'/ro" raises the
possibility that levels of calcium inhibiting the growth of normal epithelium might
provide a selective growth advantage of both adenoma and carcinoma cells over
normal cells, and thereby promote carcinogenesis in the long run.^ Although this
hypothesis is not supported by human experimental studies, it might be important to
explore this further before large-scale intervention takes place.
Differences between genders in colon cancer risk at specific subsites and the
different associations observed for several dietary factors still provide interesting
leads for research. Sex differences in colon physiology related to the bacterial flora
should be explored more explicitly.
Several lines of inquiry hint at links between epidemiological risk factors and
processes on the molecular level. Some of these are described in Chapter 2 of this
thesis. Genetic susceptibility to colorectal cancer might be more important than one
would expect. Although hypotheses lack specificity, the metabolism of certain
carcinogenic compounds, such as the acetylation of arylamines from cooked meat,
might be under genetic control.** If calcium indeed stimulates DNA repair," this
might be especially important for those who are genetically susceptible to DNA-
damaging compounds. The fact that epidemiological studies have yielded weak
associations and seemingly contradictory results might be explained by the
simultaneous inclusion of colon cancers with distinct aetiologies as one single
disease. Distinction of different types of colon cancer - those with and without ras
mutations or those with a slow or a fast acetylator status - will help disentangle
different aetiologies and might help explain the apparently inconsistent results of
epidemiological studies, e.g. those addressing dietary calcium. Findings of
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epidemiological studies based on molecular tools might strengthen the scientific
rationale for dietary advice relevant to colorectal cancer prevention.
In conclusion, our findings in four epidemiological studies show a neutral effect
of dairy products, in particular fermented dairy products, and calcium in colorectaJ
cancer aetiology. Furthermore, the Netherlands Case-Control Study supports a
protective effect of vegetables, especially in women consuming a diet rich in red
meat. These results are in line with the dietary recommendations put forward by the
Dutch Nutrition Council and the Dutch Cancer Society.
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Summary
Colorectal cancer is one of the most prevalent cancers in westernized countries; in
the Netherlands, about 7000 new cases are diagnosed each year. Since mortality
rates are still relatively high and no major improvements in treatment strategies are
expected in the near future, prevention of colorectal cancer is of major importance.
Chapter 2 provides an overview of the current concepts in the aetiology of
colorectal cancer. In the past decades several stages in the multistep process of
colorectal carcinogenesis have been identified, and it appeared that colorectal cancer
arises as a result of the mutational activation of oncogenes coupled with the
mutational inactivation of tumor suppressor genes. The vast majority of colorectal
tumors are thought to arise in adenomatous polyps. The risk of developing an
adenoma or carcinoma might depend on both genetic and environmental factors.
Diet is considered to be one of the most plausible environmental factors, since the
large bowel is in direct contact with the digested foods and their metabolites. A
widely accepted hypothesis is that a westernized high-fat, low-fiber diet increases
the risk for colorectal cancer. In terms of foods, an increased risk has mainly been
attributed to the consumption of red meat and a decreased risk to the consumption
of vegetables and fruits.
Besides a higher consumption of vegetables and fruits, a higher consumption of
fermented dairy products, such as yogurt, buttermilk and cheese, might provide a
relatively simple and feasible dietary modification for colorectal cancer prevention.
Experimental studies suggest that a protective effect of fermented dairy products
might be attributable to either the presence of lactic acid bacteria or their calcium
content. Certain strains of lactobacilli might positively influence the colonie flora,
stimulate the immune response or bind mutagens. Calcium might reduce the
proliferative activity of the colon mucosa indirectly by diminishing the proliferative
stimulus of secondary bile acids and free fatty acids in the colonie lumen or directly
by inducing cell differentiation. As discussed in Chapter 2, few epidemiological
studies conducted to date have addressed the consumption of fermented dairy
products, while the epidemiological studies on calcium are not conclusive.
This thesis describes the results of four epidemiological studies investigating
whether the consumption of fermented dairy products and the intake of calcium
could provide feasible tools to prevent colorectal cancer. The studies represent
different end-points and levels of exposure, different study designs and dietary
methodologies and different populations (Chapters 3 through 8).
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Chapter 3 describes results of two of these four studies, The Nurses' Health Study
(NHS; 98,464 women; 30-55 years at baseline), and The Health Professionals
Follow-up Study (HPFS; 51,529 men; 40-75 years at baseline); both ongoing studies
have been conducted at the Harvard School of Public Health in Boston, US. In
these large prospective studies, the association between fermented dairy products,
calcium and the occurrence of colorectal adenomatous polyps was investigated
using a self-administered semi-quantitative food frequency questionnaire. Cases (331
men and 350 women) were patients with adenomatous polyps of the left colon or
rectum diagnosed during four years (HPFS and NHS) or eight (NHS) years of
follow-up; controls (9,159 men and 8,585 women) were persons with negative
endoscopies. After adjustment for age, total energy, family history and saturated fat,
fermented dairy product consumption was not related to the risk of adenomas
(NHS: relative risk (RR) for highest vs. lowest cetgory of consumption = 0.8, 95%
confidence interval (CI) = 0.5-1.1; HPFS: RR = 1.1, 95% CI = 0.7-1.6). Adjustment
for other potential confounding variables did not change the results importantly.
Calcium intake from dietary sources and supplements was unrelated to adenoma
risk in men (multivariate RR for highest vs. lowest quintile of intake =1 .1 , 95%
CI = 0.8-1.7) and women (RR = 1.2, 95% CI = 0.8-1.7). No important differences
were observed for dietary or supplemental calcium. Although no association with
dietary vitamin D was found, vitamin D from supplements was slightly, but not
significantly, inversely associated with risk among women only (RR = 0.7, 95%
CI = 0.4-1.1).
The hypothesis was further explored in two Dutch studies since in the Netherlands
the consumption of fermented dairy products is integrated in the traditional food
pattern and the variation in consumption is sufficiently large. A population-based
case-control study was conducted in the eastern and central parts of the Netherlands
(Chapters 4 through 7). Dietary patterns were assessed among 232 colon cancer
cases and 259 controls by means of a structured dietary history questionnaire. As
described in Chapter 4, cases were recruited by surgeons in 14 cooperating
hospitals. The cancer registries of the central and eastern parts of the Netherlands
were used as a check of completeness and provided additional clinical and
pathological information. Controls, frequency-matched to the cases by age (5-year
intervals), gender, region and urbanization grade, were recruited randomly by the
general practitioners of the participating cases. After adjustment for potential
confounding variables, the consumption of fermented milk (odds ratio (OR) for
highest vs. lowest category of consumption = 1.1, 95% CI = 0.6-1.8) and hard
cheese (OR = 1.2, 95% CI = 0.7-2.1) were not significantly associated with risk of
colon cancer (Chapter 5). Dietary calcium was positively associated with colon
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cancer risk (multivariate OR = 1.8; 95% CI = 1.1-3.1). This unexpected finding is
discussed in Chapters 5 and 9. The observed associations differed between men and
women: positive associations were observed in men, while in women non-
significant associations were found. Sex differences in colon cancer risk were also
observed for the consumption of fruits and red meat, for parity and age at the birth
of the first child (Chapters 6 and 7).
In line with previous studies, the consumption of vegetables was significantly
associated with reduced colon cancer risk (OR = 0.4, 95% CI = 0.2-0.7) in the
Netherlands case-control study. The results suggest that this may be especially
important for women consuming a diet high in red meat (Chapter 7).
Since prospective studies are less prone to biases related to the presence of disease
or selection of subjects, the association between fermented dairy products, dietary
calcium and colorectal cancer was additionally studied in The Netherlands Cohort
Study on diet and cancer (Chapter 8). This prospective study started in 1986 when
120,852 Dutch men and women, aged 55-69, completed a food frequency
questionnaire. The case-subcohort analysis was based on 3.3 years of follow-up and
included 215 incident cases of colon cancer and 111 incident cases of rectal cancer,
excluding cases diagnosed in the first year of follow-up. Colorectal cancer risk was
not significantly related to the consumption of fermented milk (RR = 0.9, 95%
CI = 0.6-1.3) and cheese (RR = 0.9, 95% CI = 0.6-1.3).
Dietary calcium intake was not significantly associated with risk either (RR = 0.9,
95% CI = 0.6-1.3). Only calcium from unfermented dairy products was inversely
associated with rectal cancer risk (RR = 0.6, 95% CI = 0.3-1.0, trend p = 0.03).
Chapter 9 summarizes the results and discusses the strengths and limitations of
these four studies. Results are discussed in the context of the findings of previous
epidemiological studies and experimental research. Overall, the results of the four
studies described in this thesis do not support the hypothesized preventive potential
of fermented dairy products and dietary calcium in colorectal carcinogenesis. These
findings contrast with previous case-control studies addressing fermented milk
(yogurt and buttermilk), and strengthen the null findings of 12 out of 21
epidemiological studies that addressed dietary calcium. The null findings of our
studies are not likely to be explained by the end-points studied, the methods of
exposure assessment, the variation in fermented dairy product consumption or
calcium intake, the actual level of calcium intake, or confounding. However, these
studies do not exclude the possibility that inverse associations might still be found
for dairy products cultured with other bacterial strains.
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Further epidemiological studies on fermented dairy products, calcium and colorectal
cancer should especially explore different sites within the colon, preferably
including markers of genetic susceptibility. Epidemiological as well as experimental
research should focus more explicitly on different end-points, sex differences and
the effects of commercially available fermented dairy products in the aetiology of
colorectal cancer.
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Our findings of a neutral effect of dairy products and, as observed in the case-
control study, a protective effect of vegetables especially in women consuming a
high-meat diet (Chapter 7), are in line with the dietary recommendations put
forward by the Dutch Nutrition Council and the Dutch Cancer Society.
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Samenvatting
Dikke darmkanker (colon- en rectumkanker) is één van de belangrijkste vormen van
kanker in westerse landen; in Nederland worden ieder jaar ongeveer 7000 nieuwe
gevallen gediagnostiseerd. Hoewel de vijf-jaars overleving stijgt bij vroege
diagnostiek, wordt geen belangrijke vooruitgang op therapie-gebied verwacht in de
nabije toekomst. Preventie van deze vorm van kanker blijft daarom van groot
belang.
In hoofdstuk 2 wordt een overzicht gegeven van de huidige kennis over de
oorzaken van dikke darmkanker. In de afgelopen 20 jaar zijn verschillende fasen in
de vorming van darmtumoren geïdentificeerd en is gebleken dat darmkanker
ontstaat door verschillende mutaties in oncogenen en tumorsuppressorgenen. De
meeste darmtumoren ontstaan uit adenomateuze poliepen. Zowel genetische factoren
als omgevingsfactoren kunnen het risico op het ontstaan van een darmpoliep of
tumor beïnvloeden. Wat betreft omgevingsfactoren wordt voeding als één van de
belangrijkste risicofactoren beschouwd, aangezien de darmwand in direct contact
staat met voedselbestanddelen en metabolieten hiervan. Een algemeen geaccepteerde
hypothèse betreft een verhoging van het darmkankerrisico door een westers
voedingspatroon dat gekenmerkt wordt door een hoge vet- en een lage vezel-
inneming. Wat voedingsmiddelen betreft lijkt vleesconsumptie het risico te
verhogen, terwijl de consumptie van groente en fruit het risico zou kunnen verlagen.
Naast een toename van de groente- en fruitconsumptie is verondersteld dat een
toename van de consumptie van gefermenteerde zuivelprodukten, zoals yoghurt,
karnemelk en kaas, eveneens een bijdrage zou kunnen leveren aan de preventie van
dikke darmkanker. Experimentele studies suggereren dat een eventuele bescher-
mende werking van gefermenteerde zuivelprodukten toegeschreven zou kunnen
worden aan de Lactobacillus bactérien die deze produkten bevatten of aan het
relatief hoge calcium gehalte van zuivelprodukten in het algemeen. Bepaalde
Lactobacillus stammen kunnen de normale bacterieflora in de dikke darm gunstig
beïnvloeden, het immuunsysteem stimuleren en/of mutagene stoffen binden.
Calcium zou de deling van darmwandcellen indirect kunnen beïnvloeden door
toxische secundaire galzuren en vrije vetzuren te binden of direct door cel-
differentiatie te induceren. Tot nu toe is slechts in een beperkt aantal
epidemiologische studies de relatie tussen de consumptie van gefermenteerde
zuivelprodukten en het ontstaan van darmkanker onderzocht. Meerdere studies zijn
uitgevoerd naar de relatie met calciuminneming, maar de resultaten van deze studies
lijken niet consistent te zijn.
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Dit proefschrift beschrijft en bediscussieert de resultaten van vier epidemiologische
studies waarin is onderzocht of het gebruik van gefermenteerde zuivelprodukten en
de inneming van calcium invers geassocieerd zijn met het ontstaan van dikke
darmkanker. In deze studies zijn verschillende eindpunten van de ziekte bestudeerd
(adenomateuze poliepen en tumoren) en zijn verschillende epidemiologische onder-
zoeksmethoden (retrospectief en prospectief) en verschillende methoden van
voedselconsumptie onderzoek gebruikt (dietary history en schriftelijke
voedselfrequentie vragenlijsten). Tevens zijn de studies uitgevoerd in verschillende
populaties (Amerika, Nederland, mannen en vrouwen) van verschillende leeftijd en
met een verschillend consumptiepatroon van gefermenteerde zuivel.
Hoofdstuk 3 beschrijft de resultaten van twee van deze studies: de Nurses' Health
Study (NHS: 98.464 vrouwen, 30-55 jaar aan het begin van de studie) en de Health
Professionals Follow-up Study (HPFS: 51.529 mannen, 40-75 jaar aan het begin).
Deze prospectieve studies worden momenteel uitgevoerd aan de Harvard School of
Public Health in Boston, Verenigde Staten. De associatie tussen de consumptie van
gefermenteerde zuivelprodukten, de inneming van calcium en het voorkomen van
adenomateuze darmpoliepen is bestudeerd gebruikmakend van een semi-quanti-
tatieve schriftelijke voedselfrequentievragenlijst. Het voedingspatroon van patiënten
(331 mannen en 350 vrouwen) met adenomateuze poliepen in het linker colon en
het rectum gediagnostiseerd binnen vier (NHS en HPFS) of acht jaar (NHS) na het
invullen van de vragenlijst, zijn vergeleken met het patroon van personen bij wie
tijdens endoscopie géén adenomen werden waargenomen (9.159 mannen en 9.858
vrouwen). Na correctie voor leeftijd, totale energie-inneming, het voorkomen van
dikke darmkanker in de familie, en de inneming van verzadigd vet, was de
consumptie van gefermenteerde zuivelprodukten niet geassocieerd met het ontstaan
van darmpoliepen (NHS: relatief risico hoogste versus laagste consumptiecategorie
(RR) = 0,8; 95% betrouwbaarheidsinterval (btbhi) = 0,5-1,1); HPFS: RR = 1,1; 95%
btbhi = 0,7-1,6). Correctie voor andere mogelijk verstorende variabelen veranderde
deze resultaten nauwelijks. De calciuminneming uit de voeding was evenmin
geassocieerd met ontstaan van poliepen, zowel voor mannen (multivariate RR
hoogste versus laagste quintiel van inneming =1 ,1 ; 95% btbhi = 0,8-1,7) als
vrouwen (RR = 1,2; 95% btbhi = 0,8-1,7). Er werden geen belangrijke verschillen
in RRs gevonden voor calcium uit de voeding of uit supplementen. Hoewel geen
associatie met vitamine D uit de voeding werd gevonden, was vitamine D uit
supplementen, hoewel niet significant, invers geassocieerd met het ontstaan van
poliepen bij vrouwen (RR = 0,7; 95% btbhi = 0,4-1,1).
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Omdat de consumptie van gefermenteerde melk (yoghurt en karnemelk) geïnte-
greerd is in het traditionele Nederlandse voedingspatroon en de variatie in
consumptie hoog genoeg lijkt, is de hypothèse verder getest in twee Nederlandse
studies: een patiënt-controle onderzoek en een prospectieve studie. In Midden en
Oost Nederland is tussen 1990 en 1994 een patiënt-controle onderzoek naar darm-
kanker (colonkanker) uitgevoerd (Hoofdstukken 4 tot en met 7).
Voedingsgewoonten zijn nagegaan van 232 patiënten met colonkanker, die voldeden
aan de insluitingscriteria, en 259 controlepersonen, gebruikmakend van een
gestructureerde 'dietary history' vragenlijst (Hoofdstuk 4). Patiënten werden
gerecruteerd door specialisten in 14 ziekenhuizen. De kankerregistraties van het
Intégrale Kankercentrum Midden Nederland en het Intégrale Kankercentrum Oost
werden gebruikt als compleetheidscheck en leverden additionele klinische en
pathologische informatie (Hoofdstuk 4). Contrôles, die qua leeftijd (5-jaar
intervallen), geslacht, regio en urbanisatiegraad overeen kwamen met de patiënten,
werden aselect gerecruteerd via de huisarts van de deelnemende patient
(Hoofdstuk 4). Na correctie voor eventuele verstorende variabelen was de
consumptie van gefermenteerde melkprodukten (odds ratio hoogste versus laagste
consumptie (OR) = 1,1; 95% btbhi = 0,6-1,8) en van kaas (OR = 1,2; 95%
btbhi = 0,7-2,1) niet significant geassocieerd met het risico op darmkanker.
(Hoofdstuk 5). Calcium uit de voeding was positief geassocieerd met het
darmkanker risico (multivariate OR = 1,8; 95% btbhi = 1,1-3,1). Deze onverwachte
bevinding wordt besproken in hoofdstukken 5 en 9. De associaties met darmkanker
verschilden tussen mannen en vrouwen: positieve associaties werden gevonden voor
mannen, terwijl voor vrouwen niet-significante inverse associaties werden gevonden
(Hoofdstuk 5). In dit patiënt-controle onderzoek werden eveneens geslacht-gebonden
verschillen in darmkanker-risico gevonden voor de consumptie van fruit en vlees,
voor het aantal kinderen dat men had en de leeftijd waarop men voor het eerst
moeder of vader werd (Hoofdstukken 6 en 7).
In overeenstemming met de resultaten van eerder epidemiologisch onderzoek, werd
in dit onderzoek een inverse associatie gevonden tussen de consumptie van groente
en het risico op darmkanker. De resultaten suggereren dat dit met name belangrijk
zou kunnen zijn voor vrouwen met een relatief hoge vleesconsumptie
(Hoofdstuk 7).
De resultaten van prospectieve epidemiologische studies worden waarschijnlijk
minder dan patiënt-controle studies vertekend door de aanwezigheid van ziekte
tijdens het interview of door mogelijke differentiële selectie van patiënten en
controlepersonen. Daarom is de relatie tussen de consumptie van gefermenteerde
zuivelprodukten, de inneming van calcium en het ontstaan van colorectaal kanker
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eveneens bestudeerd in de Nederlandse Cohort Studie naar Voeding en Kanker
(Hoofdstuk 8). Deze prospectieve studie is gestart in 1986 toen 120.852 mannen en
vrouwen, in de leeftijd van 55 tot en met 69 jaar, een voedselfrequentie vragenlijst
invulden. In de statistische analyse ('case-subcohort') werden de eerste 3,3 jaar van
follow-up betrokken. Na uitsluiting van patiënten die gediagnostiseerd werden in het
eerste jaar na de start van het onderzoek, werd de analyse uitgevoerd met 215
colonkankerpatiënten en 111 rectumkankerpatiënten. Colorectaal kanker bleek niet
significant geassocieerd te zijn met de consumptie van gefermenteerde melk
(multivariate RR hoogste versus laagste consumptie catégorie = 0,9; 95%
btbhi = 0,1-1,3) en kaas (RR = 0,9; 95% btbhi = 0,6-1,3). Calcium uit de voeding
was eveneens niet geassocieerd met het risico (RR = 0,9; 95% btbhi = 0,6-1,3).
Alleen calcium afkomstig uit niet-gefermenteerde zuivelprodukten was invers
geassocieerd met het risico op rectumkanker (RR = 0,6; 95% btbhi = 0,3-1,0; trend
p = 0,03).
Hoofdstuk 9 vat de resultaten van de vier studies samen en bediscussieert de sterke
en zwakke aspecten van deze studies. De resultaten worden bediscussieerd in de
context van de bevindingen van eerder epidemiologisch en experimenteel onder-
zoek.
De resultaten van de in dit proefschrift opgenomen studies ondersteunen niet de
hypothèse dat gefermenteerde zuivelprodukten en calcium uit de voeding een
belangrijke preventieve rol zouden kunnen spelen in de etiologie van dikke
darmkanker. Deze resultaten zijn niet in overeenstemming met eerder patiënt-
controle onderzoek naar gefermenteerde melk, maar ondersteunen de resultaten van
12 van de 21 epidemiologische studies waarin eveneens geen belangrijke associatie
tussen calciuminneming en colorectaal kanker werd gevonden. Het feit dat in onze
vier studies geen associatie met gefermenteerde zuivel of calcium uit de voeding
werd gevonden kan waarschijnlijk niet verklaard worden door de gebruikte
methoden om voedselconsumptie te schatten, de variatie in gefermenteerde zuivel
consumptie en calciuminneming, de totale calciuminneming, of aan confounding.
Echter, deze studies sluiten een beschermende werking van minder algemeen
gebruikte zuivelprodukten, gefermenteerd met andere bacteriestammen, niet uit.
In volgend epidemiologisch onderzoek naar gefermenteerde zuivelprodukten,
calcium en colorectaal kanker zouden de verschillende sublocalisaties in het colon
nader moeten worden bestudeerd. Hierbij zouden bij voorkeur merkers van
genetische gevoeligheid moeten worden betrokken. Epidemiologisch, zowel als
experimenteel onderzoek zou zich meer moeten richten op verschillende ziekte-
eindpunten en geslachtsverschillen in de etiologie van dikke darmkanker.
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Het neutrale effect van zuivelprodukten en, zoals gevonden in het patiënt-controle
onderzoek, het beschermend effect van groente (speciaal voor vrouwen met een
relatief hoge vleesconsumptie) ondersteunen de voedingsaanbevelingen van de
Nederlandse Kankerbestrijding en de richtlijnen goede voeding van de Nederlandse
Voedingsraad.
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